"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOU_SANTANDREA",2000,4,6.5,1,0.25,0,0.25,1,0.5,0,0.5,0.25,0,1,2,0,1,0.25,0.5,0,0.25,77.25,1.70413267162085,NA,0.5,0.75,0.267,0,0,0,"GIANFRANCO PORCILE;TANIA SILVESTRI;ELISA ADELE COLOMBO;FABIO CALABRÒ;SILVIO RONCELLA;VITTORIO FUSCO;MANLIO FERRARINI;LAURA MERLINI;MONICA COLOMBO;ANDREA GUALA;P. PRONZATO;NICHOLAS CHIORAZZI;RAFFAELLA PALUMBO;ANTONELLA VENTURINO;L REPETTO;ANGELO VALETTO;DANILA COMANDINI;FELICE FESTA;PAOLA GAZZOLA;MARIELLA DONO","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FABIO CALABRÒ;C. CAPELLINI;J. R. JINKINS;TANIA SILVESTRI;ELISA ADELE COLOMBO;ANDREA GUALA;FELICE FESTA;SILVIO RONCELLA;MANLIO FERRARINI;MONICA COLOMBO;NICHOLAS CHIORAZZI;ANGELO VALETTO;PAOLA GAZZOLA;MARIELLA DONO;GIANLUIGI MANCARDI;GIANFRANCO PORCILE;VITTORIO FUSCO;LAURA MERLINI;P. PRONZATO;RAFFAELLA PALUMBO","0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.12;0.09;0.09;0.09;0.09;0.09","SILVIO RONCELLA;ANDREA GUALA;P. PRONZATO;C. CAPELLINI","1;1;1;1","C. CAPELLINI;ANDREA GUALA;SILVIO RONCELLA;P. PRONZATO","0.33;0.25;0.12;0.09","ANGELO VALETTO;GIANLUIGI MANCARDI;MANLIO FERRARINI;MARIELLA DONO;MONICA COLOMBO;NICHOLAS CHIORAZZI;PAOLA GAZZOLA;SILVIO RONCELLA;C. CAPELLINI;FABIO CALABRÒ;J. R. JINKINS;ANTONELLA VENTURINO;C. NASO;CARLOTTA SIMONI;DANILA COMANDINI;GIANFRANCO PORCILE;L REPETTO;LAURA MERLINI;P. PRONZATO;RAFFAELLA PALUMBO","246;246;246;246;246;246;246;246;43;43;43;20;20;20;20;20;20;20;20;20","SILVIO RONCELLA;C. CAPELLINI;P. PRONZATO;ANDREA GUALA","246;43;20;0","C. CAPELLINI;P. PRONZATO;SILVIO RONCELLA;ANDREA GUALA","1;1;1;0","MEDICINE;BIOLOGY;PHILOSOPHY","3;1;1","INTERNAL MEDICINE;PATHOLOGY;ANATOMY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;LINGUISTICS;MOLECULAR BIOLOGY;NEUROSCIENCE;PEDIATRICS;PSYCHIATRY;RADIOLOGY;SURGERY;VIROLOGY","3;2;1;1;1;1;1;1;1;1;1;1;1;1","CEREBROSPINAL FLUID;ANTIBODY;CANCER;CENTRAL NERVOUS SYSTEM;CHEMOTHERAPY;DISEASE;FOOT (PROSODY);GENE;MULTIPLE SCLEROSIS;NEUROLOGY;NEUROSURGERY;OUTBREAK;RANDOMIZED CONTROLLED TRIAL;SPINAL CORD;TOXICITY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTIMETABOLITE;B CELL;BREAST CANCER;CISPLATIN;CLONE (JAVA METHOD);FLUOROURACIL;FOOT-AND-MOUTH DISEASE;GERMLINE;HAND-FOOT-AND-MOUTH DISEASE;MITOXANTRONE;NEURORADIOLOGY;PHASES OF CLINICAL RESEARCH;SPINAL CANAL;SPINAL CORD NEOPLASM;SUBARACHNOID SPACE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","METASTATIC BREAST CANCER;VINORELBINE","1;1","MULTIPLE SCLEROSIS;B-LYMPHOCYTES;BONE NEOPLASMS;BREAST NEOPLASMS;DERMOID CYST;HUMANS;NERVOUS SYSTEM DISEASES;SOFT TISSUE NEOPLASMS;SPINAL CORD NEOPLASMS;VINBLASTINE;ADULT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CLONE CELLS;FEMALE;FLUOROURACIL;HAND, FOOT AND MOUTH DISEASE;LEUCOVORIN;MIDDLE AGED;MITOXANTRONE;AGED","5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2","AETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF MYOCARDITIS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA","1;1;1;1","CLONE (JAVA METHOD);EPIDEMIOLOGY;FOOT (PROSODY);HAND-FOOT-AND-MOUTH DISEASE;MEMORY T CELLS;METASTATIC BREAST CANCER;MITOXANTRONE;MRI IMAGING;NEURORADIOLOGY;SPINAL CORD NEOPLASM;SUBARACHNOID SPACE;VINORELBINE","1;1;1;1;1;1;1;1;1;1;1;1","CEREBROSPINAL FLUID;BREAST CANCER;CLINICAL EXPRESSION;CLONALLY RELATED;DERMOID TUMORS;FAMILIAL VARIABILITY;FATTY DROPLETS;FLUID PATHWAYS;HAND-FOOT-MOUTH DISEASE;II RANDOMIZED;LEUCOVORIN VERSUS;METASTATIC BREAST;MITOXANTRONE -FLUOROURACIL;MULTIPLE SCLEROSIS;PHASE II;RANDOMIZED TRIAL;SALVAGE CHEMOTHERAPY;SCLEROSIS PATIENTS;SPINAL DERMOID;VERSUS -FLUOROURACIL;VERSUS COMBINATION;VINORELBINE VERSUS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VH GENES;CELL ACCUMULATIONS;EXTENSIVELY MUTATED;GENE-SPECIFIC PCR;IG VDJ;INTRACLONAL DIVERSIFICATION;MS PATIENTS;NEUROLOGICAL DISORDERS;VDJ SEQUENCES;VH GENE-SPECIFIC;ACCUMULATIONS REVEALED;ANALYZED SHARED;CEREBROSPINAL FLUID;CHAIN VARIABLE;CLONAL EXPANSION;CLONALLY RELATED;CLONE-SPECIFIC PCR;CLONES ANALYZED;COMPARTMENTALIZED CLONAL;DISORDERS ANALYSES;DRAWN ANALYSES;FLUID CSF;GENE HCDR;GENEALOGICAL TREES;GENES ALBEIT;GENES UTILIZED;GERMLINE SEQUENCES;LYMPHOCYTE CLONES;METHODOLOGIES CLONE-SPECIFIC;MOLECULAR CLONES","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.25,3,5,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,0,0,75,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2001,10,6.6,3.2,0.7,0.3,0.7,1.10344827586207,0.875,0.75,0.875,0.1,0,4,3,0,2,0.4,0.3,0,0.2,28.1,0.614981531982464,NA,0.3,0.7,0.387,0.19,0.167,0.19,"GUIDO PASTORE;E. BIROLI;GIUSEPPE DI CARA;J.W.W. COEBERGH;ANDREA GUALA;P. BASSINI;G. PATRUCCO;EVARISTO BELLI;GEMMA GATTA;OLIVIERO FILIBERTI;A. CONTU;GABRIELLA COUCOURDE;G. BOTTA;C MATTEINI;F CARNINO;D. FRANCESCHINI;C. MERULLI;CORRADO MAGNANI;D. LICATA;SILVIA COMIS","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANDREA GUALA;EVARISTO BELLI;C MATTEINI;GUIDO PASTORE;GUIDO PASTORE;J.W.W. COEBERGH;C. MERULLI;FRANCESCO VIOLI;COSTANTINO CAROSELLI;E. BIROLI;GIUSEPPE DI CARA;P. BASSINI;GEMMA GATTA;ISABELLA CORAZZIARI;W. A. KAMPS;CORRADO MAGNANI;ANDREA PESSION;SILVIA VISCOMI;A. VERDECCHIA;G. BOTTA","0.62;0.5;0.5;0.5;0.47;0.37;0.33;0.33;0.33;0.25;0.25;0.25;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.12","GUIDO PASTORE;ANDREA GUALA;P. BASSINI;OLIVIERO FILIBERTI;A. CONTU;GABRIELLA COUCOURDE;C MATTEINI;F CARNINO;SILVIA COMIS;S. OTTONE;P. PRONZATO;LORELLA VESENTINI;PASQUALINA CECERE;LUIGI GALLO;M. BERGAGLIO;LUIGIA COSTANTINI;GIOVANNA PICCINI;LUCIA DEL MASTRO;RITA LIONETTO;P.C. COLOMBO","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANDREA GUALA;C MATTEINI;GUIDO PASTORE;GUIDO PASTORE;COSTANTINO CAROSELLI;P. BASSINI;OLIVIERO FILIBERTI;GABRIELLA COUCOURDE;S. OTTONE;PASQUALINA CECERE;LUIGIA COSTANTINI;GIOVANNA PICCINI;P.C. COLOMBO;VINCENZO SEPE;MAINARDI PC;C PEONA;GIUSEPPA CAGNA;A. CONTU;F CARNINO;SILVIA COMIS","0.62;0.5;0.5;0.47;0.33;0.25;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.08;0.08;0.08","GUIDO PASTORE;ANGELITA CALÌ;BRICARELLI FD;CHIARA PERFUMO;FEDERICO ZARA;GABRIELLA COUCOURDE;JOAN OVERHAUSER;M. PIERLUIGI;MAINARDI PC;SIMONA CAVANI;J.W.W. COEBERGH;A. CONTU;DOMENICO GUARNERI;F CARNINO;LORELLA VESENTINI;LUCIA DEL MASTRO;LUIGI GALLO;M. BERGAGLIO;MARCO VENTURINI;P. PRONZATO","234;164;164;164;164;164;164;164;164;164;70;40;40;40;40;40;40;40;40;40","GUIDO PASTORE;GABRIELLA COUCOURDE;MAINARDI PC;A. CONTU;DOMENICO GUARNERI;F CARNINO;LORELLA VESENTINI;LUCIA DEL MASTRO;LUIGI GALLO;M. BERGAGLIO;MARCO VENTURINI;P. PRONZATO;RICCARDO ROSSO;RITA LIONETTO;SILVIA COMIS;P. BASSINI;C MATTEINI;C PEONA;GIOVANNA PICCINI;GIUSEPPA CAGNA","234;164;164;40;40;40;40;40;40;40;40;40;40;40;40;3;2;2;2;2","GUIDO PASTORE;P. BASSINI;A. CONTU;C MATTEINI;C PEONA;DOMENICO GUARNERI;F CARNINO;GABRIELLA COUCOURDE;GIOVANNA PICCINI;GIUSEPPA CAGNA;LORELLA VESENTINI;LUCIA DEL MASTRO;LUIGI GALLO;LUIGIA COSTANTINI;M. BERGAGLIO;MAINARDI PC;MARCO VENTURINI;OLIVIERO FILIBERTI;P. PRONZATO;P.C. COLOMBO","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;MATHEMATICS;SOCIOLOGY;ART;CHEMISTRY;COMPUTER SCIENCE","9;4;2;2;1;1;1","PEDIATRICS;INTERNAL MEDICINE;ENVIRONMENTAL HEALTH;GENETICS;PATHOLOGY;ANATOMY;DEMOGRAPHY;RADIOLOGY;BIOCHEMISTRY;CELL BIOLOGY;COMBINATORICS;DENTISTRY;GASTROENTEROLOGY;GEOMETRY;HUMANITIES;LIBRARY SCIENCE;MOLECULAR BIOLOGY;ONCOLOGY;ORTHODONTICS;SURGERY","5;4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GENE;POPULATION;CANCER;CONFIDENCE INTERVAL;DYSPLASIA;OSTEOCHONDRODYSPLASIA;PREGNANCY;RIB CAGE;ULTRASOUND;ALTERNATIVE MEDICINE;ANKYLOSIS;CELL;CHEMOTHERAPY;CITATION;COMPARABILITY;CONDYLE;CORRELATION;CYTOPLASM;DISEASE;ENZYME;FOLIC ACID;FOSSA;HEMODIALYSIS;HOMOCYSTEINE;LYMPHOMA;MULTIVARIATE ANALYSIS;REACTIVE OXYGEN SPECIES;SURVIVAL ANALYSIS;SURVIVAL RATE;TEMPOROMANDIBULAR JOINT;VITAMIN B12;ZYGOMATIC ARCH","3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER REGISTRY;DWARFISM;FETUS;BREAST CANCER;CAUSE OF DEATH;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CYCLOPHOSPHAMIDE;CYTOSKELETON;CYTOSOL;EUROPEAN POPULATION;FIXATION (POPULATION GENETICS);FLUOROURACIL;GENOTYPE;HYPERHOMOCYSTEINEMIA;METHYLMALONIC ACID;NADPH OXIDASE;PHENOTYPE;PSYCHOMOTOR RETARDATION;STANDARDIZED RATE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","IN UTERO;PRENATAL DIAGNOSIS;RELATIVE SURVIVAL;BREAKPOINT;CYTOGENETICS;DEATH CERTIFICATE;EPIRUBICIN;EZRIN;GENOTYPE-PHENOTYPE DISTINCTION;KARYOTYPE;METASTATIC BREAST CANCER","2;2;2;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;EUROPE;;ADOLESCENT;ANKYLOSIS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;BREAST NEOPLASMS;CHILD;CHILD, PRESCHOOL;CRI-DU-CHAT SYNDROME;INFANT;MANDIBULAR FRACTURES;SURVIVAL RATE;TEMPOROMANDIBULAR JOINT DISORDERS;AGED;BONE DISEASES, DEVELOPMENTAL;CHROMOSOMES, HUMAN, PAIR 5","7;7;6;5;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF MAXILLOFACIAL TRAUMA;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;LYMPHOID NEOPLASMS;PROTEIN TYROSINE PHOSPHATASES IN HUMAN HEALTH AND DISEASE;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS IN IMMUNITY;ROLE OF VITAMIN K IN HEALTH","1;1;1;1;1;1;1;1;1;1","CHILDHOOD CANCER;CHILDHOOD CANCER SURVIVOR STUDY;DWARFISM;OSTEOCHONDRODYSPLASIA;PRENATAL ULTRASOUND;RELATIVE SURVIVAL;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ANKYLOSIS;BREAKPOINT;CHROMOSOME DUPLICATION;COLLAGEN DISORDERS;COMPARABILITY;DEATH CERTIFICATE;EPIRUBICIN;EUROPEAN POPULATION;FACIAL FRACTURES;FOSSA;GENOTYPE-PHENOTYPE DISTINCTION;GROWTH CONTROL;HYPERHOMOCYSTEINEMIA","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","KYPHOMELIC DYSPLASIA;PRENATAL DIAGNOSIS;ACCELERATED-INTENSIFIED CYCLOPHOSPHAMIDE;ACUTE LYMPHOBLASTIC;ASPIRIN TREATMENT;BILATERAL FRACTURE;BILATERAL POST-TRAUMATIC;BREAST CANCER;CANCER PATIENTS;CEF COMPARED;CHILDHOOD LYMPHOMAS;CYCLOPHOSPHAMIDE EPIRUBICIN;DEFICIENCY BLEEDING;DELETION GENOTYPE-PHENOTYPE;EUROPEAN CHILDREN;FLUOROURACIL CEF;FOLATES VITAMINS;FREE RADICAL;GENOTYPE-PHENOTYPE CORRELATION;GRUPPO ONCOLOGICO;HEMODIALYSED PATIENTS;III STUDY;INTER GRUPPO;ITALIAN GRUPPO;LEUKAEMIA DIAGNOSED;LYMPHOBLASTIC LEUKAEMIA;METASTATIC BREAST;MOLECULAR CHARACTERISATION;MULTICENTER RANDOMIZED;NORD-OUESTMAMMELLA INTER","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CAT CRY;DE NOVO;GENOTYPE-PHENOTYPE CORRELATION;TERMINAL DELETION;ANALYSED MOLECULAR;ANOMALIES INVOLVING;BREAKPOINT INTERVALS;CDCS REGISTER;CELL LINES;CHAT SYNDROME;CLINICAL MANIFESTATION;CORRELATION PATIENTS;CRI DU;CRITICAL REGIONS;CRY REGION;CYTOGENETIC ANALYSIS;CYTOGENETIC VARIABILITY;DELETED CHROMOSOME;DELETION CHARACTERISED;DELETION CONFIRMED;DELETION ORIGINATING;DELETIONS HIGHLIGHTED;DISTALLY NARROWED;DU CHAT;FAMILIAL TRANSLOCATION;INTERSTITIAL DELETION;INTERSTITIAL DELETIONS;INTERVALS RANGING;ITALIAN CDCS;LENDS SUPPORT","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",1,0.1,3.5,7,0,0,0,0,0,0,0,7,0,0,1,0,6,0,0,1,0,0,0,96,96,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,700,3.57,0,0,147,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PATIENT SAFETY;RARE DISEASES;UROLOGIC DISEASES","1;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","BLADDER CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2002,8,5,1.75,0.75,0.375,0.625,1,0.857142857142857,0.75,0.833333333333333,0.5,2,4,0,0,3,0.5,0,0,0.38,31.88,0.57777315622495,NA,0.25,0.625,0.472,0.119,0,0.133,"MARCO MERCIERI;EVARISTO BELLI;ANDREA VECCHIONE;FRANCESCA CALABRETTA;FRANCESCO TRAPASSO;EDITH LAHNER;NADIA PALLOTTA;A. DI GIULIO;HANSJÜERG ALDER;ARGANTE BOZZI;C MATTEINI;FRANCESCO PAGANO;M. RAITERI;A. MERCIERI;CARLA LUZI;ANDREA C. RINALDI;RAFFAELE BAFFA;BRUNO ANNIBALE;MAURIZIO SIMMACO;FEDERICO ALGHISI","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MARCO MERCIERI;MASSIMO LA RAJA;EVARISTO BELLI;C MATTEINI;F MARINI BALESTRA;M. RAITERI;A. MERCIERI;MAURIZIO ARMANINI;FRANCESCA CALABRETTA;FEDERICO ALGHISI;NELLO SALESI;BARBARA DI COCCO;GIANDOMINIK BOSSONE;EDITH LAHNER;NADIA PALLOTTA;BRUNO ANNIBALE;FRANCESCO PANZUTO;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE;ANDREA VECCHIONE","1.25;1;0.33;0.33;0.33;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.1","MARCO MERCIERI;EVARISTO BELLI;ANDREA VECCHIONE;EDITH LAHNER;M. RAITERI;BRUNO ANNIBALE;MAURIZIO SIMMACO;FRANCESCO PANZUTO;NELLO SALESI;MASSIMO LA RAJA;DONATELLA BARRA;MARIA LUISA MANGONI;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE","2;1;1;1;1;1;1;1;1;1;1;1;1;1","MARCO MERCIERI;MASSIMO LA RAJA;EVARISTO BELLI;M. RAITERI;NELLO SALESI;EDITH LAHNER;BRUNO ANNIBALE;FRANCESCO PANZUTO;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE;ANDREA VECCHIONE;MAURIZIO SIMMACO;DONATELLA BARRA;MARIA LUISA MANGONI","1.25;1;0.33;0.25;0.2;0.17;0.17;0.17;0.17;0.17;0.1;0.1;0.1;0.1","A. DI GIULIO;ANDREA C. RINALDI;ANNA RUFO;ARGANTE BOZZI;CARLA LUZI;DONATELLA BARRA;HONGXIA ZHAO;MARIA LUISA MANGONI;MAURIZIO SIMMACO;PAAVO K.J. KINNUNEN;ANDREA VECCHIONE;CARLO M. CROCE;FRANCESCO PAGANO;FRANCESCO TRAPASSO;GUSTAVO BALDASSARRE;HANSJÜERG ALDER;HIDESHI ISHII;LEONARD G. GOMELLA;PIERFRANCESCO BASSI;RAFFAELE BAFFA","176;176;176;176;176;176;176;176;176;176;42;42;42;42;42;42;42;42;42;42","DONATELLA BARRA;MARIA LUISA MANGONI;MAURIZIO SIMMACO;ANDREA VECCHIONE;MASSIMO LA RAJA;BRUNO ANNIBALE;EDITH LAHNER;FRANCESCO PANZUTO;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE;MARCO MERCIERI;M. RAITERI;NELLO SALESI;EVARISTO BELLI","176;176;176;42;15;9;9;9;9;9;6;4;2;1","ANDREA VECCHIONE;BRUNO ANNIBALE;DONATELLA BARRA;EDITH LAHNER;EVARISTO BELLI;FRANCESCO PANZUTO;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE;M. RAITERI;MARCO MERCIERI;MARIA LUISA MANGONI;MASSIMO LA RAJA;MAURIZIO SIMMACO;NELLO SALESI","1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY","7;6;1","INTERNAL MEDICINE;PATHOLOGY;BIOCHEMISTRY;GENETICS;SURGERY;GASTROENTEROLOGY;ANESTHESIA;BOTANY;CANCER RESEARCH;CARDIOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;MICROBIOLOGY;RADIOLOGY;UROLOGY;VIROLOGY","5;4;3;3;3;2;1;1;1;1;1;1;1;1;1;1","CANCER;COMPLICATION;GENE;ALTERNATIVE MEDICINE;ANEMIA;BACTERIA;CARCINOMA;CELL;CELL CULTURE;CELL GROWTH;DISEASE;ENDOSCOPY;ENZYME;GENUS;ISCHEMIA;LESION;LIPOSOME;MALARIA;MAXILLARY SINUS;MEMBRANE;MONOCYTE;MYOCARDIAL INFARCTION;NOSE;PARANASAL SINUSES;PEPTIDE;PERIPHERAL;PERIPHERAL BLOOD;PREGNANCY;STROMAL CELL;SUBARACHNOID HEMORRHAGE;TRANSPLANTATION;URINARY BLADDER;URINARY SYSTEM","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTIMICROBIAL PEPTIDES;BILAYER;BLADDER CANCER;BONE MARROW TRANSPLANTATION;CARCINOGENESIS;CELL CYCLE;CEREBRAL INFARCTION;COLORECTAL CANCER;CYSTOSCOPY;EPIDURAL BLOOD PATCH;ESCHERICHIA COLI;INFARCTION;INFLAMMATORY BOWEL DISEASE;IRON DEFICIENCY;IRON-DEFICIENCY ANEMIA;LACTATE DEHYDROGENASE;LIPID BILAYER;MIDDLE CEREBRAL ARTERY;OCCULT;PLASMODIUM FALCIPARUM;POSTPARTUM PERIOD;SINUS (BOTANY);VASOSPASM;VESICLE;WESTERN BLOT","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLONOSCOPY;TRANSITIONAL CELL CARCINOMA;TUMOR SUPPRESSOR GENE","1;1;1","HUMANS;CARCINOMA, TRANSITIONAL CELL;CELL DIVISION;ILEAL DISEASES;MALARIA, FALCIPARUM;ULCER;URINARY BLADDER NEOPLASMS;ATHLETIC INJURIES;BLOOD CELLS;DNA-BINDING PROTEINS;MALE;MAXILLARY SINUSITIS;MONOCYTES;TUMOR SUPPRESSOR PROTEINS;ADENOVIRIDAE;ADULT;ALPHA-FETOPROTEINS;ANEMIA;ANEMIA, IRON-DEFICIENCY;ANIMALS","7;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2","ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;CHRONIC RHINOSINUSITIS AND NASAL POLYPS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EPIDEMIOLOGY AND TREATMENT OF CHAGAS DISEASE;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES);TESTICULAR GERM CELL TUMORS AND TREATMENT;VENOUS ANOMALIES AND SYNDROMES IN VASCULAR SYSTEM","1;1;1;1;1;1;1;1","ACCIDENTAL;ANTIMICROBIAL PEPTIDES;BLADDER CANCER;CARDIOMYOPATHY;CEREBRAL ISCHAEMIA;CEREBRAL VASOSPASM;CHRONIC RHINOSINUSITIS;EPIDURAL BLOOD PATCH;MONOCYTE;OBSCURE GASTROINTESTINAL BLEEDING;OCCULT;RENAL FUNCTION;SINUS (BOTANY);TESTICULAR CANCER","1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACCIDENTAL DURAL;ANAEMIA CAUSED;ANTIMICROBIAL HAEMOLYTIC;BLADDER CANCER;BLOOD PATCH;BONE MARROW;BOWEL ULCERATION;CANCER MARKERS;CARCINOMA CELLS;CELL CARCINOMA;CEREBRAL ISCHAEMIA;CYTOTOXIC ACTIVITIES;DEFICIENCY ANAEMIA;DURAL PUNCTURE;EPIDURAL BLOOD;EXERTIONAL HAEMATURIA;FALCIPARUM MALARIA;HIGH-GRADE BLADDER;IRON DEFICIENCY;LIPID VESICLES;MARKERS CLINICAL;MARROW TRANSPLANTATION;MEMBRANE PERMEABILIZATION;NONSPECIFIC IDIOPATHIC;PATIENTS UNDERGOING;PERIPHERAL MONOCYTES;PLASMODIUM FALCIPARUM;POSTPARTUM CEREBRAL;RESTORATION SUPPRESSES;RHINO-SINUSAL ENDOSCOPY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CROSSREF PUBMED;PUBMED SCOPUS;FEZ EXPRESSION;CROCE CM;PUBMED GOOGLE;CELL CYCLE;CELL GROWTH;TUMOR SUPPRESSOR;CELL LINES;FEZ POSITIVE;FEZ PROTEIN;RES -PUBMED;CEREBRAL ISCHAEMIA;DURAL PUNCTURE;POSITIVE CELLS;URINARY BLADDER;CANCER CELL;SW CELLS;TRANSITIONAL CELL;ACAD SCI;NATL ACAD;SCI USA;SUPPRESSOR GENE;USA -CROSSREF;CELL CARCINOMA;FEZLZTS GENE;GM PHASE;NUDE MICE;EPIDURAL BLOOD;FEZLZTS ALTERATIONS","31;30;19;16;14;13;13;13;12;12;12;12;11;11;11;11;10;10;10;9;9;9;9;9;8;8;8;8;7;7",2,0.25,5.38,15.25,0,0,0,0,15,0,0,15.25,0,0,1,0,0,0,0,1,0,0,0,80.25,80.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,5,3737.5,14.29,0,0,174.5,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","2;1;1","CARDIOVASCULAR;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEART DISEASE;NUTRITION","2;2;2;2;1","CARDIOVASCULAR","2","6.1 PHARMACEUTICALS","2",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2003,34,5.64705882352941,1.82352941176471,0.794117647058823,0.235294117647059,0.823529411764706,1.08771929824561,1.03846153846154,0.888888888888889,1.03703703703704,0.235294117647059,6,7,7,5,13,0.21,0.21,0.15,0.38,12.68,0.239504499098456,NA,0.0882352941176471,0.441176470588235,0.454,0.172,0,0.169,"ALESSANDRO BOZZAO;M. BONAMINI;V BELTRAMI;ENRICO GIARNIERI;GRAZIELLA MARINO;BRUNO ANNIBALE;V A CIROLLA;FRANCESCO PANZUTO;MASSIMO VOLPE;L COVOTTA;G ANGELI;FRANCESCO COSENTINO;L. M. FANTOZZI;GIUSEPPE RUSSO;MAURIZIO PERA;G TUCCI;BRUNO SPOSATO;DAVID IAPAOLO;ANDREA VECCHIONE;ALESSANDRO GIORDANO","3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","MASSIMO VOLPE;FRANCESCO COSENTINO;CARMINE SAVOIA;ERINO ANGELO RENDINA;EMANUELA PILOZZI;ALESSANDRO BOZZAO;BRUNO ANNIBALE;FRANCESCO PANZUTO;PAOLO MARTELLETTI;ALESSANDRO SILVESTRI;MATILDE LEONARDI;V INCISIVO;M. BONAMINI;L. M. FANTOZZI;MATTEO GUZZINI;MARIA CHIARA VULPIANI;ANDREA FERRETTI;G ANGELI;DAVID IAPAOLO;FRANCESCA CALABRETTA","2;1.14;1;1;1;0.66;0.6;0.6;0.5;0.5;0.5;0.5;0.46;0.46;0.33;0.33;0.33;0.27;0.2;0.2","ALESSANDRO BOZZAO;M. BONAMINI;ENRICO GIARNIERI;BRUNO ANNIBALE;FRANCESCO PANZUTO;MASSIMO VOLPE;G ANGELI;FRANCESCO COSENTINO;L. M. FANTOZZI;MAURIZIO PERA;E. BIROLI;ANTONIO OTTINETTI;PAOLO MARTELLETTI;MATTEO GUZZINI;PAOLA DE PAOLIS;PIETRO FRANCIA;GIULIANO TOCCI;MARZIA SCHIAVONI;BEATRICE MUSUMECI;CARMINE SAVOIA","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MASSIMO VOLPE;FRANCESCO COSENTINO;CARMINE SAVOIA;ERINO ANGELO RENDINA;EMANUELA PILOZZI;ALESSANDRO BOZZAO;BRUNO ANNIBALE;FRANCESCO PANZUTO;PAOLO MARTELLETTI;V INCISIVO;M. BONAMINI;L. M. FANTOZZI;MATTEO GUZZINI;MARIA CHIARA VULPIANI;ANDREA FERRETTI;G ANGELI;CLAUDIO COLONNESE;MAURIZIO SIMMACO;C. AMANTI;BARBARA DI COCCO","2;1.14;1;1;1;0.66;0.6;0.6;0.5;0.5;0.46;0.46;0.33;0.33;0.33;0.27;0.2;0.2;0.2;0.2","DONATELLA BARRA;DONATELLA PONTI;GIUSEPPINA MIGNOGNA;MARIA LUISA MANGONI;MAURIZIO SIMMACO;ALESSANDRA GASBARRI;ARMANDO BARTOLAZZI;FABRIZIO DEL PRETE;LEONARD GIRNITA;MARCO PAOLO MARTEGANI;PIER GIORGIO NATALI;ANDREA FERRETTI;MARIA CHIARA VULPIANI;MATTEO GUZZINI;G ANGELI;ANNALISA CHIRIATTI;BRUNO ANNIBALE;F. PISTILLI;FRANCESCO PANZUTO;GABRIELE CAPURSO","52;52;52;52;52;47;47;47;47;47;47;42;42;42;40;37;37;37;37;37","DONATELLA BARRA;MARIA LUISA MANGONI;MAURIZIO SIMMACO;ARMANDO BARTOLAZZI;ANDREA FERRETTI;MARIA CHIARA VULPIANI;MATTEO GUZZINI;BRUNO ANNIBALE;FRANCESCO PANZUTO;GABRIELE CAPURSO;GIANFRANCO DELLE FAVE;LUCIANA CHESSA;LORELLA BARBONAGLIA;ANTONIO OTTINETTI;E. COLOMBO;EMILIO FALCO;FABRIZIO DARDANO;FRANCA PUCCIANTI;G CELORIA;GIOVANNI BRANCACCIO","52;52;52;47;42;42;42;37;37;37;37;33;27;25;25;25;25;25;25;25","ALESSANDRO BOZZAO;BRUNO ANNIBALE;FRANCESCO COSENTINO;M. BONAMINI;MASSIMO VOLPE;ANDREA FERRETTI;ANDREA PETRUCCA;ANGELO GIOVANNI BONADIO;ANTONIO OTTINETTI;ANTONIO ROMANO;ARMANDO BARTOLAZZI;C. AMANTI;CLAUDIO COLONNESE;DONATELLA BARRA;E. BIROLI;E. COLOMBO;EMANUELA PILOZZI;EMILIO FALCO;F. FLORA;FABRIZIO DARDANO","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;MATERIALS SCIENCE;COMPUTER SCIENCE;ECONOMICS;PHYSICS;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY","30;13;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;CANCER RESEARCH;CARDIOLOGY;RADIOLOGY;BIOCHEMISTRY;ONCOLOGY;PSYCHIATRY;ANATOMY;ANESTHESIA;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;IMMUNOLOGY;MICROBIOLOGY;PEDIATRICS;PHARMACOLOGY","21;9;8;7;6;5;5;4;4;4;3;2;2;2;2;2;2;2;2;2","CANCER;GENE;BLOOD PRESSURE;IMMUNOHISTOCHEMISTRY;RECEPTOR;CARCINOMA;CHEMOTHERAPY;CHOLESTEROL;MAGNETIC RESONANCE IMAGING;NEUROLOGY;VASODILATION;ABDOMINAL PAIN;ABNORMALITY;ACCIDENTAL;ADJUVANT;ALTERNATIVE MEDICINE;ANASTOMOSIS;ANEMIA;ANESTHESIOLOGY;ANTIGEN;ANTIMICROBIAL;APOPTOSIS;ASYMPTOMATIC;BACTERIA;BETA (PROGRAMMING LANGUAGE);CELL;CEREBELLUM;CLINICAL TRIAL;COMPLICATION;CONCOMITANT;CONNECTIVE TISSUE;CONSTIPATION;CRANIOFACIAL;CYSTIC FIBROSIS;DEPRESSION (ECONOMICS);DIFFERENTIAL DIAGNOSIS;DISEASE;DISSECTION (MEDICAL);DNA;EATING DISORDERS;ENDOTHELIAL DYSFUNCTION;ENDOTHELIUM;ENZYME;FIRST LINE;FORAMEN;FORAMEN MAGNUM;GIRL;GLUE;GLYCOSYLATION;GOLD STANDARD (TEST);HEART FAILURE;HELICOBACTER PYLORI;HERNIA;IMMUNE SYSTEM;IN VITRO;INTERVENTIONAL RADIOLOGY;INTRACELLULAR;ISCHEMIA;KIDNEY;KIDNEY DISEASE;LARYNX;LUNG CANCER;MALIGNANCY;MARFAN SYNDROME;MICROTUBULE;MIGRAINE;MONOCYTE;MYASTHENIA GRAVIS;NITRIC OXIDE;NOTICE;ODDS RATIO;ORTHOPEDIC SURGERY;OXIDATIVE STRESS;PATHOLOGICAL;PATIENT SATISFACTION;PEPTIDE;PHAGOCYTOSIS;PHOSPHORYLATION;PLASTIC SURGERY;PLATELET;POISON CONTROL;POPULATION;PREDICTIVE VALUE;PREGNANCY;PROSTACYCLIN;PSYCHOPATHOLOGY;PUNCHING;SCINTIGRAPHY;SIGNAL TRANSDUCTION;SISTER;STAGE (STRATIGRAPHY);STATIN;STENOSIS;SYNCOPE (PHONOLOGY);TECHNETIUM;TENDON;THYMOMA;THYROID;VASOCONSTRICTION;VIRUS","9;6;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;ANGIOTENSIN II;BREAST CANCER;ACHILLES TENDON;ADENOCARCINOMA;ADRENOMEDULLIN;ANOREXIA NERVOSA;ANTIMICROBIAL PEPTIDES;ARACHNODACTYLY;ATP SYNTHASE;AUTOCRINE SIGNALLING;AUTOSOMAL RECESSIVE INHERITANCE;BLOATING;BULIMIA NERVOSA;BURKHOLDERIA;CANCER ANTIGEN;CARCINOGENESIS;CD44;CELL CYCLE;CEREBELLAR VERMIS;CEREBRAL ISCHAEMIA;CEREBROTENDINOUS XANTHOMATOSIS;CHROMOGRANIN A;CISPLATIN;CONSTRUCT VALIDITY;CYTOKERATIN;DIAPHRAGMATIC HERNIA;DNA DAMAGE;DNA REPAIR;ECTODOMAIN;ENDOTHELIAL STEM CELL;ENDOTHELIN RECEPTOR;EPIDURAL BLOOD PATCH;ETOPOSIDE;EUTHYROID;EXON;FETUS;FIBRILLIN;GENETIC DIVERSITY;GENOTYPE;HEART RATE;IMMUNOTHERAPY;INHERITANCE (GENETIC ALGORITHM);IRON DEFICIENCY;MERKEL CELL CARCINOMA;METASTASIS;MIGRAINE DISORDERS;MYOEPITHELIAL CELL;NEUROENDOCRINE CARCINOMA;NEURORADIOLOGY;NICOTIANA TABACUM;OVARIAN CANCER;PAIN MEDICINE;PERFORATION;PERTECHNETATE;PI3K/AKT/MTOR PATHWAY;PLACEBO;PLANT VIRUS;PLATELET ACTIVATION;PROSTATE CANCER;PROTEIN KINASE B;REDUCTASE;REFLUX;RENAL BLOOD FLOW;SERINE;SOLANACEAE;SUICIDE PREVENTION;SYRINGOMYELIA;TECHNETIUM TC 99M SESTAMIBI;TENDINITIS;TENDINOPATHY;THROMBOXANE A2;THYMECTOMY;TOBACCO MOSAIC VIRUS;TRANSGENE;TUBULIN;TUMOR MARKER;VASOVAGAL SYNCOPE;VIMENTIN;X CHROMOSOME","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALPHA (FINANCE);ALTERNATIVE SPLICING;BRADYCARDIA;BREAST CARCINOMA;BREAST SURGERY;BURKHOLDERIA CENOCEPACIA;BURKHOLDERIA CEPACIA COMPLEX;CARBOPLATIN;CHIARI I MALFORMATION;CHIARI MALFORMATION;COLONOSCOPY;CROSSOVER STUDY;EPITHELIAL OVARIAN CANCER;FAMILIAL ADENOMATOUS POLYPOSIS;FARNESYL PYROPHOSPHATE;GASTRIC ADENOCARCINOMA;GASTRO-;GENETICALLY MODIFIED CROPS;GERANYLGERANYL PYROPHOSPHATE;HIATAL HERNIA;HMG-COA REDUCTASE;IFOSFAMIDE;MAMMAGLOBIN;MASTECTOMY;MERKEL CELL;MEVALONATE PATHWAY;MOLECULAR EPIDEMIOLOGY;NEUROENDOCRINE DIFFERENTIATION;NICOTIANA;OMPHALOCELE;POTYVIRUS;PRENATAL DIAGNOSIS;PRESYNCOPE;RAPD;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;SUICIDE ATTEMPT;TENDINOSIS;TUMOR ASSOCIATED ANTIGEN;X-LINKED RECESSIVE INHERITANCE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;COLORECTAL NEOPLASMS;;ABNORMALITIES, MULTIPLE;MIDDLE AGED;ADULT;AGED;CARCINOMA;NEOPLASM PROTEINS;SKIN NEOPLASMS;HEART DEFECTS, CONGENITAL;BIOMARKERS, TUMOR;BURKHOLDERIA CEPACIA;ITALY;ADENOMA;ADOLESCENT;ANTIMICROBIAL CATIONIC PEPTIDES;ANTINEOPLASTIC AGENTS","25;12;12;11;8;8;8;7;7;7;7;7;6;5;5;5;4;4;4;4","MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANORECTAL SURGICAL PROCEDURES;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;BREAST PATHOLOGY AND IMAGING TECHNIQUES;CEREBROSPINAL FLUID DISORDERS AND HEMATOMAS;CHOLESTEROL-LOWERING TREATMENT;CYCLOOXYGENASE-2 INHIBITORS IN INFLAMMATION AND CANCER;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;EATING DISORDERS AND BODY IMAGE CONCERNS;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;MOLECULAR BIOLOGY OF STEROIDOGENESIS AND DISORDERS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HYPERTENSION;BLOOD PRESSURE;P53;ABDOMINAL WALL DEFECTS;ABNORMALITY;ACCIDENTAL;ADRENAL VEIN SAMPLING;ADRENOMEDULLIN;ALPHA (FINANCE);ANOREXIA NERVOSA;ANTI-OBESITY DRUGS;ANTIHYPERTENSIVE DRUGS;ANTIMICROBIAL PEPTIDES;ARACHNODACTYLY;AUTOSOMAL RECESSIVE INHERITANCE;AXILLARY DISSECTION;BARIUM ENEMA;BETA (PROGRAMMING LANGUAGE);BLOATING;BREAST CARCINOMA","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR DISEASE;COLORECTAL CANCER;DISEASE ROLE;ABNORMALITY REPORT;ABUNDANT MYOEPITHELIAL;ACCIDENTAL DURAL;ACHILLES TENDINOPATHY;ACRYLIC GLUE;ADHESIVE FUNCTION;AKT ACTIVATION;AMPHIBIAN ANTIMICROBIAL;ANASTOMOSIS CONSIDERATIONS;ANOREXIA NERVOSA;ANTI-SECRETORY PREVENTIVE;ANTIMICROBIAL PEPTIDE;ATM-DEFECTIVE CELLS;ATTEMPTED SUICIDE;AUTOSOMAL RECESSIVE;BASIC RESEARCH;BENIGN CICATRICIAL;BETA TUBULINS;BLOOD PATCH;BREAST CARCINOMA;BREAST-CONSERVING SURGERY;BULIMIA NERVOSA;BURKHOLDERIA CEPACIA;CANCER BASIC;CANCER SURVEY;CARE PHYSICIANS;CD CLEAVAGE","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CEPACIA COMPLEX;CEREBRAL ISCHAEMIA;CF PATIENTS;COMPLEX STRAINS;TRANSGENIC PLANTS;ANTIMICROBIAL PEPTIDE;CF CENTER;DURAL PUNCTURE;EMBOLIZATION PROCEDURE;EPIDURAL BLOOD;SUPERIOR LEFT;ACHILLES TENDINOPATHIES;ADENOCARCINOMATHE MUTATIONAL;ANIMALS LONG-TERM;ANTHINA GENOMOVAR;ANTRO-PYLORIC REGION;ARGININE MUTATION;ARTERIAL OCCLUSION;AVERAGE AGE;AVERAGE FOLLOW-UP;BINDING DOMAIN;BLOOD FLOW;BLOOD PATCH;BLOOD PATCHES;BURKHOLDERIA CEPACIA;CAULIFLOWER MOSAIC;CAUSATIVE MECHANISM;CEREBRAL ARTERY;CEREBRAL INFARCTION;CHAIN REACTION","5;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",3,0.09,3,4,0,0,0,0,7,0,1,4.5,0,0,1,0,0,0,1,0,0,0,0,49,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,13,1093,1.82,0,0,52,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1","CANCER;CLINICAL RESEARCH;HEMATOLOGY;LYMPHOMA;RARE DISEASES","1;1;1;1;1",NA,NA,"4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1","NON-HODGKIN'S LYMPHOMA","1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2004,41,6.5609756097561,2.34146341463415,0.780487804878049,0.341463414634146,0.829268292682927,1.23076923076923,1.03225806451613,1.07692307692308,1.03030303030303,0.170731707317073,4,15,8,3,13,0.37,0.2,0.07,0.32,22.39,0.47584536976847,NA,0.0731707317073171,0.51219512195122,0.337,0.182,0.241,0.199,"MASSIMO VOLPE;LUIGI RUCO;SARA LATTUADA;S. MONFARDINI;ENRICO GIARNIERI;ARIANNA DI NAPOLI;MICHELE IESTER;ANDREA PERDICCHI;C. CAROTI;P. PRONZATO;C. AMANTI;SARA LONARDI;SALVATORE MARIOTTA;F MANNINO;PAOLO GIRARDI;ROBERTO TATARELLI;EDOARDO MONACO;G. CALABRIA;ALBERTO RÍCCI;ANTONIO JIRILLO","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MASSIMO VOLPE;PAOLA CERRUTI MAINARDI;ANTONELLA TEGGI;GIAN DOMENICO DI NUCCI;LUIGI RUCO;EDOARDO MONACO;PAOLO GIRARDI;ROBERTO TATARELLI;AMEDEO RUBERTO;PAOLO MERCANTINI;C. URANI;ANTONIO ACETI;H DOĞRU;MARIANA BARRETO;C. PASQUAZZI;A. CAROSELLI;BARBARA ZECHINI;R RONCHETTI;M P VILLA;COSTANTINO CAROSELLI","1.27;1;1;1;0.49;0.45;0.42;0.42;0.42;0.37;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","MASSIMO VOLPE;LUIGI RUCO;SARA LATTUADA;S. MONFARDINI;ENRICO GIARNIERI;ARIANNA DI NAPOLI;ANDREA PERDICCHI;C. CAROTI;P. PRONZATO;C. AMANTI;SARA LONARDI;SALVATORE MARIOTTA;F MANNINO;EDOARDO MONACO;ALBERTO RÍCCI;ANTONIO JIRILLO;EMANUELA PILOZZI;PAOLO MERCANTINI;C. ASCHELE;M. D’AMICO","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MASSIMO VOLPE;PAOLA CERRUTI MAINARDI;ANTONELLA TEGGI;GIAN DOMENICO DI NUCCI;LUIGI RUCO;EDOARDO MONACO;PAOLO MERCANTINI;ANTONIO ACETI;H DOĞRU;C. PASQUAZZI;A. CAROSELLI;BARBARA ZECHINI;R RONCHETTI;COSTANTINO CAROSELLI;MAURIZIO BARBARA;Е. ТОСКАЛА;EMANUELA PILOZZI;SALVATORE MARIOTTA;F MANNINO;ALBERTO RÍCCI","1.27;1;1;1;0.49;0.45;0.37;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.32;0.31;0.31;0.31","ALBERTO RÍCCI;F MANNINO;SALVATORE MARIOTTA;LUIGI RUCO;BRUNO SPOSATO;FRANCESCA DE CLEMENTI;LAURA GUIDI;MARIA PAPALE;A AZZARÀ;AGOSTINO CORTELEZZI;ALBERTO GROSSI;ANTONIO SPADANO;BRUNO MONARCA;D PAGNINI;DANIELE PEREGO;DARIS FERRARI;E VOLPE;E. DE BIASI;ENRICO BALLEARI;ENRICO CAPOCHIANI","144;144;144;133;131;131;131;131;108;108;108;108;108;108;108;108;108;108;108;108","SALVATORE MARIOTTA;LUIGI RUCO;MARIA ANTONIETTA ALOE SPIRITI;ANNA PASQUINI;ANTONELLA MARZULLO;ARIANNA DI NAPOLI;FRANCESCA CANCELLARIO D’ALENA;STEFANIA SCARPINO;ANTONIO ACETI;BARBARA ZECHINI;C. PASQUAZZI;MASSIMO VOLPE;EMANUELA PILOZZI;LINDA COTA;SPERANZA RUBATTU;MAURIZIO POMPILI;PAOLA CERRUTI MAINARDI;A TUBARO;MARIADELE RAPAZZOTTI ONELLI;PAOLO MERCANTINI","144;117;108;78;78;78;78;78;63;63;63;58;55;54;54;52;43;39;39;39","MASSIMO VOLPE;ANDREA PERDICCHI;ANTONIO JIRILLO;C. ASCHELE;C. CAROTI;EDOARDO MONACO;EMANUELA PILOZZI;ENRICO GIARNIERI;LUIGI GALLO;LUIGI RUCO;M. D’AMICO;M. STEFANI;MYRIAM PARIS;P. PRONZATO;S. MONFARDINI;SALVATORE MARIOTTA;SARA LATTUADA;SARA LONARDI;A TUBARO;ALBERTO RÍCCI","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;ENGINEERING;MATHEMATICS;PHYSICS;PSYCHOLOGY;POLITICAL SCIENCE;COMPUTER SCIENCE;ECONOMICS;PHILOSOPHY;SOCIOLOGY","39;11;3;3;3;3;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;CARDIOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;GENETICS;PSYCHIATRY;CANCER RESEARCH;IMMUNOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;ENDOCRINOLOGY;GENERAL SURGERY;MECHANICAL ENGINEERING;PHYSICAL THERAPY;ASTROBIOLOGY;CLINICAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;GEOMETRY;GYNECOLOGY;LAW;MEDICAL EMERGENCY;NURSING;ONCOLOGY;OPHTHALMOLOGY;PEDIATRICS;SOCIAL PSYCHOLOGY","30;15;13;6;6;5;5;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","CANCER;DISEASE;BLOOD PRESSURE;CHEMOTHERAPY;GENE;IMMUNOHISTOCHEMISTRY;BIOPSY;ISCHEMIA;LUNG;REGIMEN;STROKE (ENGINE);TOXICITY;AUTOPSY;BONE MARROW;CONCOMITANT;ESOPHAGUS;GLAUCOMA;INFLAMMATION;LYMPH NODE;MAGNETIC RESONANCE IMAGING;NEUROLOGY;POPULATION;PREGNANCY;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;RECEPTOR;REFRACTORY (PLANETARY SCIENCE);TUBERCULOSIS","8;7;5;5;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;COLORECTAL CANCER;ACHALASIA;FLUOROURACIL;GEMCITABINE;GENE EXPRESSION;NEURORADIOLOGY;NEUTROPENIA;PHASES OF CLINICAL RESEARCH;REFLUX;SALVAGE THERAPY;ACUTE STROKE;ALKALINE PHOSPHATASE;ALLELE;BONE DISEASE;BRAIN ISCHEMIA;BRONCHIOLITIS;BRONCHOALVEOLAR LAVAGE;CANCER CELL;CARCINOGENESIS;CARDIAC FUNCTION CURVE;CARDIOMYOPATHY;CD20;CD30;CD8;CHRONIC HEPATITIS;CHRONIC LIVER DISEASE;CISPLATIN;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;CYCLOPHOSPHAMIDE;CYSTIC ECHINOCOCCOSIS;CYTOTOXIC T CELL;DEMENTIA;DIABETOLOGY;DIAPHRAGMATIC HERNIA;DIASTOLE;DIFFUSION MRI;DILATED CARDIOMYOPATHY;EJECTION FRACTION;EPOETIN ALFA;ETOPOSIDE;EXON;FETUS;GENE SILENCING;GLUTAMATE RECEPTOR;HEPATITIS C VIRUS;HISTIOCYTOSIS;HISTOGENESIS;HYPERTENSIVE CRISIS;IMMUNOSTAINING;INFERTILITY;INJURY PREVENTION;INTERSTITIAL LUNG DISEASE;ISCHAEMIC STROKE;ISCHEMIC STROKE;KIDNEY CANCER;LEFT VENTRICULAR HYPERTROPHY;LIVER BIOPSY;LOCUS (GENETICS);LUNG BIOPSY;LUNG DISEASE;MASS INDEX;MECHANICAL HEART-VALVE;METABOLIC BONE DISEASE;METASTASIS;METHYLATION;MUCOSITIS;MUTATION;MYELODYSPLASTIC SYNDROMES;NEPHRECTOMY;NEUROPSYCHOLOGY;NEUROTROPHIC FACTORS;NEUROTROPHIN;OCCUPATIONAL LUNG DISEASE;OCCUPATIONAL MEDICINE;OCULAR HYPERTENSION;OPEN ANGLE GLAUCOMA;PENUMBRA;PERSONALITY DISORDERS;PHENOTYPE;PROGRAMMED CELL DEATH;PROSTATE;PROSTATE CANCER;PSYCINFO;RARE DISEASE;RENIN–ANGIOTENSIN SYSTEM;SOFT TISSUE SARCOMA;SPIROMETRY;SPONTANEOUSLY HYPERTENSIVE RAT;SPUTUM;SUICIDE PREVENTION;T CELL;THYROID CARCINOMA;TOLERABILITY;TRANSCRIPTION FACTOR;VIMENTIN;WHITE (MUTATION)","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EPIRUBICIN;IRINOTECAN;OXALIPLATIN;ANTHRACYCLINE;ANTISOCIAL PERSONALITY DISORDER;ASPARTATE TRANSAMINASE;AZOOSPERMIA;BIMATOPROST;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREAST RECONSTRUCTION;BREAST SURGERY;CIRCULATING TUMOR CELL;COGNITIVE DEFICIT;CONCENTRIC HYPERTROPHY;CONGENITAL DIAPHRAGMATIC HERNIA;DESMIN;DIFFUSION IMAGING;DNA METHYLATION;ESOPHAGEAL MOTILITY DISORDER;ESOPHAGEAL SPASM;EXCITOTOXICITY;EXHALED NITRIC OXIDE;FRACTIONAL SHORTENING;GRANZYME B;IFOSFAMIDE;INTRACYTOPLASMIC SPERM INJECTION;LOSS OF HETEROZYGOSITY;MALE INFERTILITY;MASTECTOMY;METASTATIC BREAST CANCER;MICROMETASTASIS;MYOTOMY;PERFORIN;PERIPHERAL T-CELL LYMPHOMA;PROMOTER;SADISTIC PERSONALITY DISORDER;STROKE RISK;SUICIDE ATTEMPT;TUMOR SUPPRESSOR GENE;VINORELBINE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;BREAST NEOPLASMS;BRAIN NEOPLASMS;HEART VENTRICLES;IMMUNOHISTOCHEMISTRY;AGED, 80 AND OVER;HYPERTENSION;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ASTHMA;BRAIN ISCHEMIA;COLORECTAL NEOPLASMS;ECHINOCOCCOSIS;ESOPHAGUS;NEOPLASMS, NEUROEPITHELIAL","31;21;21;16;15;11;9;8;7;7;7;6;6;5;5;5;5;5;5;5","ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIOLOGICAL EFFECTS OF ELECTROMAGNETIC FIELDS;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;BIOLOGY AND PATHOLOGY OF KERATINS AND RELATED DISORDERS;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CANCER STEM CELLS AND TUMOR METASTASIS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHRONIC CEREBRAL HYPOPERFUSION-RELATED NEURODEGENERATIVE DISEASES;DIAGNOSIS AND MANAGEMENT OF ALZHEIMER'S DISEASE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC ADAPTATION OF LACTASE PERSISTENCE IN HUMANS;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;STROKE (ENGINE);CONCOMITANT;EPIRUBICIN;GLAUCOMA;HYPERTENSION;NEURORADIOLOGY;PRIMARY OPEN-ANGLE GLAUCOMA;REFRACTORY (PLANETARY SCIENCE);SALVAGE THERAPY;TREATMENT GUIDELINES;;ABSOLUTE DEVIATION;ACUTE STROKE;ALANINE AMINOTRANSFERASE;ALBENDAZOLE;ALDOSTERONE;ALZHEIMER'S DISEASE;AMBULATORY MONITORING;ANAMNESIS","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ADVANCED COLORECTAL;BREAST CANCER;CANCER CRC;COLORECTAL CANCER;CRC REFRACTORY;FLUOROURACIL FU;FU IRINOTECAN;GEMCITABINE GEM;GLAUCOMA PATIENTS;IRINOTECAN IRI;OXALIPLATIN OXA;PATIENTS PTS;SALVAGE THERAPY;ABSTRACT SELECTION;ACL RECONSTRUCTION;ALTERNATIVE TECHNIQUE;ALVEOLAR MICROLITHIASIS;ALZHEIMERS DISEASE;ANTHRACYCLINE-NAÏVE METASTATIC;ANTICOAGULATION THERAPY;AZOOSPERMIC PATIENT;BEHAVIOURAL ASSESSMENT;BOCHDALEK HERNIA;BREAST SURGERY;CANCER CELLS;CANCER PATIENTS;CDX EXPRESSION;CELL LYMPHOMA;CEREBRAL ASTROBLASTOMA;CHILDHOOD ASTHMA","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MYOCARDIAL TISSUE;ZFHXB SIP;REFLUX SYMPTOMS;AL REPORTED;CARDIAC FUNCTION;DESMIN CONTENT;ENDSTAGE HEART;ESOPHAGEAL CLEARANCE;HEART FAILURE;DESMINPOSITIVE MYOCYTES;DISEASE HSCR;ESOPHAGEAL MOTOR;HEART TRANSPLANTATION;HIRSCHSPRUNG DISEASE;INTERSTITIAL LUNG;ISCHAEMIC ORIGIN;LOW-AMPLITUDE PERISTALTIC;LUNG DISEASES;MISCELLANEOUS DISORDERS;MOTOR DISORDERS;NONPROPAGATED ACTIVITY;NONSPECIFIC ESOPHAGEAL;NORMAL CONTROLS;NORMAL MANOMETRY;OCCUPATIONAL EXPOSURE;PATIENTS COMPARED;PERISTALTIC CONTRACTIONS;PREDOMINANTLY LOW-AMPLITUDE;PREDOMINANTLY NONPROPAGATED;PROTEIN EXPRESSION","5;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",1,0.02,3,1,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,21,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,9,542.75,5.33,1,0.25,39.5,0,0,0,1,2,0,0,1,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy;Belgium","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE","4;2;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;COLO-RECTAL CANCER;DIGESTIVE DISEASES;HEART DISEASE;HEMATOLOGY;HYPERTENSION;PEDIATRIC;PEDIATRIC CANCER;RARE DISEASES","3;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;GENERIC HEALTH RELEVANCE","1;1;1","6.1 PHARMACEUTICALS","2","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2005,61,8.08196721311475,2.80327868852459,0.491803278688525,0.377049180327869,0.491803278688525,1.30769230769231,1.15384615384615,1.21052631578947,1.15384615384615,0.278688524590164,3,26,16,4,12,0.43,0.26,0.07,0.2,34.64,0.6542671843329,NA,0.278688524590164,0.721311475409836,0.402,0.351,0.42,0.351,"ANDREA TUBARO;MARIA ROSARIA TORRISI;ANDREA VECCHIONE;EMMANUEL CHARTIER‐KASTLER;GIOVANNI RAMACCIATO;MASSIMO VOLPE;HERMAN STOEVELAAR;MARIA PIA VILLA;R. BERGES;KOSHI MIMORI;MARIO BARRETO;R RONCHETTI;HIDESHI ISHII;ALBERTO RÍCCI;VINCENZO ZIPARO;PAOLO MERCANTINI;SUSY MARTELLA;LUIGI FRATI;PHILIP VAN KERREBROECK;SPERANZA RUBATTU","8;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2","ANDREA TUBARO;GIOVANNI RAMACCIATO;M BADIALI;SALVATORE DI SOMMA;EMMANUEL CHARTIER‐KASTLER;ANDREA VECCHIONE;MARIA ROSARIA TORRISI;MASSIMO VOLPE;KOSHI MIMORI;HIDESHI ISHII;MARIA PIA VILLA;ALBERTO RÍCCI;GIOVANNI PALLESCHI;ERINO ANGELO RENDINA;LUCIO MIANO;ANNA MARIA CICCONE;GIULIANO TOCCI;HERMAN STOEVELAAR;R. BERGES;PASQUALE PARISI","1.56;1.28;1;1;0.92;0.78;0.68;0.64;0.56;0.56;0.53;0.51;0.5;0.5;0.5;0.5;0.43;0.42;0.42;0.42","ANDREA TUBARO;MARIA ROSARIA TORRISI;ANDREA VECCHIONE;GIOVANNI RAMACCIATO;MASSIMO VOLPE;MARIA PIA VILLA;MARIO BARRETO;R RONCHETTI;ALBERTO RÍCCI;VINCENZO ZIPARO;PAOLO MERCANTINI;SUSY MARTELLA;SPERANZA RUBATTU;MARIA T. DARDER;GIULIANO TOCCI;GIOVANNI PALLESCHI;ROSITA STANZIONE;GIORGIO ERCOLANI;LUCIO MIANO;LAURA LEONE","8;6;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2","ANDREA TUBARO;GIOVANNI RAMACCIATO;M BADIALI;SALVATORE DI SOMMA;ANDREA VECCHIONE;MARIA ROSARIA TORRISI;MASSIMO VOLPE;MARIA PIA VILLA;ALBERTO RÍCCI;GIOVANNI PALLESCHI;ERINO ANGELO RENDINA;LUCIO MIANO;ANNA MARIA CICCONE;GIULIANO TOCCI;PASQUALE PARISI;JACOPO PAGANI;VINCENZO ZIPARO;G. PINTO;MARIO BARRETO;R RONCHETTI","1.56;1.28;1;1;0.78;0.68;0.64;0.53;0.51;0.5;0.5;0.5;0.5;0.43;0.42;0.42;0.37;0.37;0.36;0.36","MARIA ROSARIA TORRISI;ANDREA VECCHIONE;ALFONSO COLOMBATTI;ANDREA MORRIONE;BARBARA BELLETTI;GUSTAVO BALDASSARRE;MILENA S. NICOLOSO;MÓNICA SCHIAPPACASSI;PAOLA SPESSOTTO;VINCENZO CANZONIERI;LUIGI FRATI;ALBERTO FAGGIONI;ANTONELLA FARINA;ANTONIO ANGELONI;HENRI‐JACQUES DELECLUSE;REGINA FEEDERLE;ROBERTA GONNELLA;ROBERTA SANTARELLI;SALVATORE RAFFA;ANDREA TUBARO","413;349;276;276;276;276;276;276;276;276;245;212;212;212;212;212;212;212;212;209","MARIA ROSARIA TORRISI;ANDREA VECCHIONE;SALVATORE RAFFA;ANDREA TUBARO;SIMONA CECCARELLI;MARIA PIA VILLA;GIOVANNI RAMACCIATO;MASSIMO VOLPE;CARLO POZZILLI;ALESSANDRO BRUNELLI;FRANCESCO VIOLI;GIULIANO TOCCI;LUCIANO DE BIASE;LUISA LENTI;PASQUALE PIGNATELLI;ROBERTO CANGEMI;SILVIA RIONDINO;SUSANNA GREGO;MOSCARINI MASSIMO;L. CHESSA","413;349;212;208;120;113;112;106;104;102;102;102;102;102;102;102;102;102;99;77","ANDREA TUBARO;MARIA ROSARIA TORRISI;ANDREA VECCHIONE;GIOVANNI RAMACCIATO;MARIA PIA VILLA;MASSIMO VOLPE;MARIO BARRETO;R RONCHETTI;SUSY MARTELLA;ALBERTO RÍCCI;FABIANA MONTI;G. PINTO;GIOVANNI PALLESCHI;JACOPO PAGANI;MARIA T. DARDER;MARILISA MONTESANO;PAOLO MERCANTINI;PASQUALE PARISI;SALVATORE RAFFA;SERGIO PETROCCA","7;6;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;PHYSICS;BUSINESS","48;22;6;5;5;3;2;2;2;2;1","INTERNAL MEDICINE;GENETICS;SURGERY;ANESTHESIA;IMMUNOLOGY;CELL BIOLOGY;UROLOGY;BIOCHEMISTRY;PATHOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;GYNECOLOGY;PEDIATRICS;CARDIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;NURSING;PSYCHIATRY;RADIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;ONCOLOGY;VIROLOGY","39;11;11;10;10;9;9;8;8;7;6;6;6;4;4;4;4;4;4;3;3;3;3","CANCER;GENE;DISEASE;RECEPTOR;BLOOD PRESSURE;ANTIBODY;ASTHMA;QUALITY OF LIFE (HEALTHCARE);URINARY SYSTEM;ALTERNATIVE MEDICINE;CHEMOTHERAPY;HEART FAILURE;LUNG;POPULATION;VIRUS;ADVERSE EFFECT;ALDOSTERONE;ANTIGEN;BIOPSY;CARCINOMA;CELL CULTURE;COLOCALIZATION;DEPRESSION (ECONOMICS);DNA;HYPERPLASIA;IMMUNE SYSTEM;IN VITRO;MULTIPLE SCLEROSIS;MULTIVARIATE ANALYSIS;RADIATION THERAPY;RESECTION;STAGE (STRATIGRAPHY);TUMOR NECROSIS FACTOR ALPHA","14;11;10;7;5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PROSTATE;CARCINOGENESIS;CELL CYCLE;MUTATION;NOCTURIA;ANTAGONIST;ATOPY;BREAST CANCER;DNA DAMAGE;DNA REPAIR;ENDOCYTOSIS;EPSTEIN–BARR VIRUS;HERPES SIMPLEX VIRUS;IMMUNOGLOBULIN E;INTERNALIZATION;LYTIC CYCLE;METASTASIS;RENIN–ANGIOTENSIN SYSTEM;SPIROMETRY;TOLERABILITY;TRANSCRIPTION FACTOR;VIRAL REPLICATION","7;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LOWER URINARY TRACT SYMPTOMS;BENIGN PROSTATIC HYPERPLASIA (BPH);ENDOCYTIC CYCLE;EXHALED NITRIC OXIDE;KERATINOCYTE GROWTH FACTOR;TUMOR SUPPRESSOR GENE;ADJUVANT CHEMOTHERAPY;ANGIOTENSIN II RECEPTOR TYPE 1;ANGIOTENSIN RECEPTOR;ANTIGEN PRESENTATION;APPLANATION TONOMETRY;ATROPHIC GASTRITIS;BRONCHIAL HYPERRESPONSIVENESS;CDNA LIBRARY;CELL CYCLE CHECKPOINT;CHROMOSOMAL FRAGILE SITE;CHRONIC GASTRITIS;COMET ASSAY;CTL*;CYCLIN;CYCLIN D1;DUTASTERIDE;E2F;FUSION PROTEIN;GASTRIC BYPASS;HORMONE ANTAGONIST;ICTAL-INTERICTAL SPECT ANALYSIS BY SPM;IMATINIB MESYLATE;INTERFERON BETA-1A;LDL RECEPTOR;LUBIPROSTONE;MALE BREAST CANCER;METHACHOLINE;MHC CLASS I;MIGRAINE WITH AURA;MISSENSE MUTATION;MORBID OBESITY;MYOTOMY;NORTHERN BLOT;NUCLEOPLASM;OXYBUTYNIN;PHONOPHOBIA;PROSTATE BIOPSY;RECEPTOR ANTAGONIST;REPRESSOR;RETINOBLASTOMA PROTEIN;RILUZOLE;SENTINEL LYMPH NODE;TOLTERODINE;WWOX;ZINC FINGER","6;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;AGED;DNA-BINDING PROTEINS;ASTHMA;ADOLESCENT;AGED, 80 AND OVER;PHOSPHOPROTEINS;UROLOGIC DISEASES;VIRAL PROTEINS;;CELL LINE;DNA;FIBROBLASTS;HERPESVIRUS 4, HUMAN;HYPERSENSITIVITY, IMMEDIATE;ITALY","52;32;26;18;18;12;10;9;8;8;8;8;8;7;7;7;7;7;7;7","STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ASTHMA;FIBROBLAST GROWTH FACTOR SIGNALING PATHWAY;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;THE P53 SIGNALING NETWORK IN CANCER RESEARCH;VIRAL-RELATED CANCERS IN IMMUNOCOMPROMISED PATIENTS;ADVANCEMENTS IN LUNG CANCER RESEARCH;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;BIOMECHANICAL PROPERTIES OF THE CORNEA AND RELATED DISEASES;CHOLANGIOCARCINOMA;CLASSIFICATION AND TREATMENT OF CUTANEOUS LYMPHOMAS;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;DIAGNOSIS AND TREATMENT OF HEART FAILURE","7;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LOWER URINARY TRACT SYMPTOMS;NOCTURIA;ATOPY;CELL CYCLE;COLOCALIZATION;DEPRESSION (ECONOMICS);DIAGNOSIS;DNA DAMAGE;INTERNALIZATION;KERATINOCYTE GROWTH FACTOR;LYTIC CYCLE;MIGRAINE;NEUROGENIC LOWER URINARY TRACT DYSFUNCTION;TOLERABILITY;ADJUVANT CHEMOTHERAPY;ADJUVANT THERAPY;ADRENAL INCIDENTALOMA;ADRENAL VEIN SAMPLING;ANGIOTENSIN;ANTIGEN PRESENTATION","6;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","DISEASE PROGRESSION;EPSTEIN-BARR VIRUS;EXHALED NITRIC;GROWTH FACTOR;HEART FAILURE;HEPATOCELLULAR CARCINOMA;KERATINOCYTE GROWTH;LOWER URINARY;MULTIPLE SCLEROSIS;NITRIC OXIDE;PROSTATIC HYPERPLASIA;SYMPTOMSBENIGN PROSTATIC;TRACT SYMPTOMSBENIGN;URINARY TRACT;AARSKOGSCOTT SYNDROME;ACM ANEURYSM;ACUTE MASTOIDITIS;ADAPTOR PROTEIN;ADDITIVE EFFECT;ADRENALECTOMY LESSON;ALZHEIMERS DISEASE;AMERICAN JOINT;AMYOTROPHIC LATERAL;ANESTHESIA REDUCES;ANIECHINOCOCCUS GRANULOSUSICDNA;ANP GENE;ANTIGENS TRANSDUCED;ANTIMIGRAINE THERAPY;ANTIMUSCARINIC THERAPY;APPROACH EXPERIENCE","2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;MELANOSOME TRANSFER;GROWTH FACTOR;ARH PROTEIN;KERATINOCYTE GROWTH;HEPG CELLS;PLASMA MEMBRANE;BROWN MS;GOLDSTEIN JL;LDL-LDLR COMPLEX;RES -CROSSREF;CELL RES;DERMATOL -CROSSREF;HOBBS HH;INVEST DERMATOL;LATEX BEADS;SERUM STARVED;CELL SURFACE;CLATHRIN-COATED PITS;KGF TREATMENT;PUBMED GOOGLE;BIOL CHEM;HUMAN KERATINOCYTES;MONOCLONAL ANTIBODY;NUCLEAR MEMBRANE;POLYCLONAL ANTIBODIES;WESTERN BLOTTING;ACAD SCI;BIOL -CROSSREF","70;61;28;24;17;15;13;13;12;12;12;11;10;10;9;9;9;9;8;8;8;8;7;7;7;7;7;7;6;6",11,0.18,3,2,0,0,0,0,3,0,1,2,0,0,1,0,1.75,0,0,1,0,0,0,37.5,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2006,62,6.90322580645161,2.7258064516129,0.5,0.467741935483871,0.532258064516129,1.3739837398374,1.10714285714286,1.20833333333333,1.1,0.274193548387097,0,30,15,4,9,0.48,0.24,0.06,0.15,31.48,0.616385591932199,NA,0.258064516129032,0.645161290322581,0.376,0.301,0.261,0.3,"ANDREA PERDICCHI;GIANLUCA SCUDERI;ROBERTO TATARELLI;EDOARDO MONACO;SANTI MARIA RECUPERO;STEFANO AMODEO;MAURIZIO SIMMACO;E.M. MEDORI;PAOLO GIRARDI;ANDREA TUBARO;ANDREA FERRETTI;MAURIZIO POMPILI;ALFREDO MOLTENI;A CANCRINI;FRANCESCO PASSAMONTI;ANTONINO ROSCITANO;CESARE GUGLIELMI;MARINA BORRO;MARCO PAULLI;PIETRO FRANCIA","5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","ANDREA TUBARO;COSIMO DE NUNZIO;ROBERTO TATARELLI;FRANCESCO COSENTINO;ANDREA PERDICCHI;MAURIZIO POMPILI;EDOARDO MONACO;GIANLUCA SCUDERI;SANTI MARIA RECUPERO;PIETRO FRANCIA;DAVID LESTER;PAOLO GIRARDI;ANDREA FERRETTI;CAMILLO AUTORE;SALVATORE BARBERI;MASSIMILIANO VARIO;SIMONA DI PILATO;P. PRONZATO;E.M. MEDORI;F. JÄNICKE","1.14;1;0.91;0.83;0.82;0.78;0.77;0.7;0.7;0.6;0.58;0.58;0.57;0.5;0.5;0.5;0.5;0.5;0.5;0.5","ANDREA PERDICCHI;GIANLUCA SCUDERI;ROBERTO TATARELLI;EDOARDO MONACO;SANTI MARIA RECUPERO;STEFANO AMODEO;MAURIZIO SIMMACO;E.M. MEDORI;PAOLO GIRARDI;ANDREA TUBARO;ANDREA FERRETTI;ANTONINO ROSCITANO;CESARE GUGLIELMI;MARINA BORRO;PIETRO FRANCIA;RAFFAELE D’AMELIO;UMBERTO BENEDETTO;ANTONELLA LEONARDI;FRANCESCO D’ANGELO;G. PINTO","5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","ANDREA TUBARO;COSIMO DE NUNZIO;ROBERTO TATARELLI;FRANCESCO COSENTINO;ANDREA PERDICCHI;EDOARDO MONACO;GIANLUCA SCUDERI;SANTI MARIA RECUPERO;PIETRO FRANCIA;PAOLO GIRARDI;ANDREA FERRETTI;CAMILLO AUTORE;SALVATORE BARBERI;MASSIMILIANO VARIO;P. PRONZATO;E.M. MEDORI;PAOLO SPIRITO;STEFANO AMODEO;MAURIZIO SIMMACO;CARMELO DʼARRIGO","1.14;1;0.91;0.83;0.82;0.77;0.7;0.7;0.6;0.58;0.57;0.5;0.5;0.5;0.5;0.5;0.5;0.46;0.4;0.4","ANTONELLA FRANCHI;BRUNO ANNIBALE;GIANFRANCO DELLE FAVE;GIANLUCA CANETTIERI;LUCILLA GARGANO;MARCO CENTANNI;N VICECONTI;MAURIZIO SIMMACO;ALBERTO FABBRI;ALESSANDRO PULSONI;ALFREDO MOLTENI;ANDREA ROSSI;CRISTIANA PASCUTTO;ENRICA MORRA;ERCOLE BRUSAMOLINO;FRANCESCA MONTANARI;FRANCESCO PASSAMONTI;FRANCESCO ZAJA;LORELLA ORSUCCI;LUCA ARCAINI","313;313;313;313;313;313;313;240;186;186;186;186;186;186;186;186;186;186;186;186","BRUNO ANNIBALE;GIANFRANCO DELLE FAVE;MARIA CHRISTINA COX;FLAVIA DEL PORTO;LAGANÀ BRUNO;RAFFAELE D’AMELIO;MARIA LUISA MANGONI;ANNA COSTANTINI;FRANCESCA MARIA ROSSI;PATRIZIA CARDELLI;EDOARDO MONACO;ANGELO DE CARLI;FABIO CONTEDUCA;CARMELO DʼARRIGO;ANDREA TUBARO;MARINA BORRO;MAURIZIO SIMMACO;G. PINTO;ANTONELLA STOPPACCIARO;COSIMO DE NUNZIO","313;313;186;166;166;166;159;145;138;138;129;125;125;123;107;103;103;86;85;85","ANDREA PERDICCHI;EDOARDO MONACO;GIANLUCA SCUDERI;ROBERTO TATARELLI;SANTI MARIA RECUPERO;ANDREA TUBARO;ANGELO DE CARLI;E.M. MEDORI;FABIO CONTEDUCA;PAOLO GIRARDI;STEFANO AMODEO;ANDREA FERRETTI;ANNA COSTANTINI;ANTONELLA LEONARDI;ANTONELLA STOPPACCIARO;ANTONINO ROSCITANO;CARMELO DʼARRIGO;COSIMO DE NUNZIO;EUCLIDE TONELLI;FLAVIA DEL PORTO","5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;ENGINEERING;CHEMISTRY;ECONOMICS;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;HISTORY;SOCIOLOGY","58;12;12;4;3;3;3;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;IMMUNOLOGY;PSYCHIATRY;RADIOLOGY;CARDIOLOGY;ONCOLOGY;CELL BIOLOGY;OPHTHALMOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;GENERAL SURGERY;PHYSICAL THERAPY;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;CLINICAL PSYCHOLOGY;GYNECOLOGY;MICROBIOLOGY;NUCLEAR MEDICINE;ORGANIC CHEMISTRY","33;19;12;9;9;8;7;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3","CANCER;GENE;RECEPTOR;ANTERIOR CRUCIATE LIGAMENT;ANTIBODY;POPULATION;ARTERY;BIOPSY;COGNITION;MOOD;POISON CONTROL;TRANSPLANTATION;VISUAL ACUITY;ADJUVANT;ALTERNATIVE MEDICINE;BACTERIA;BLOOD PRESSURE;CARCINOMA;CLINICAL TRIAL;CONFIDENCE INTERVAL;CORONARY ARTERY DISEASE;DEPRESSION (ECONOMICS);EPILEPSY;HEART FAILURE;HEPATITIS C;IMMUNOHISTOCHEMISTRY;IN VITRO;INTRAOCULAR PRESSURE;LEUKEMIA;LYMPH NODE;LYMPHOMA;MULTIVARIATE ANALYSIS;MYELOID LEUKEMIA;OBESITY;OCCLUSION;PSYCHOPATHOLOGY;QUALITY OF LIFE (HEALTHCARE);RETINAL;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;STENOSIS;VIRUS","8;6;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;B CELL;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;CENTRAL RETINAL VEIN;ESCHERICHIA COLI;FIXATION (POPULATION GENETICS);HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS C VIRUS;INJURY PREVENTION;MACULAR EDEMA;MALT LYMPHOMA;METASTASIS;NEUROPSYCHOLOGY;SUICIDE PREVENTION;ADJUSTMENT DISORDERS;ADJUVANT THERAPY;AMOXICILLIN;ANTIDEPRESSANT;ANTIMICROBIAL PEPTIDES;APELIN;APYRASE;ATRIUM (ARCHITECTURE);BIPOLAR DISORDER;BLOCKADE;BYPASS GRAFTING;C-REACTIVE PROTEIN;CALCINEURIN;CARDIOMYOPATHY;CD34;CD5;CHROMOSOME;CHRONIC MIGRAINE;COGNITIVE IMPAIRMENT;CRYOPRESERVATION;CUMULATIVE INCIDENCE;CYTOTOXIC T CELL;DEFENSIN;DEMENTIA;DIASTOLE;EJECTION FRACTION;EMBRYONIC STEM CELL;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;ETANERCEPT;FIBROBLAST GROWTH FACTOR;GASTRECTOMY;GASTRIC CARCINOMA;GASTRITIS;GASTRODUODENAL ARTERY;GENE DUPLICATION;GENE EXPRESSION;GOITER;GONADOTROPIN;HAMILTON ANXIETY RATING SCALE;HAZARD RATIO;HELICOBACTER INFECTIONS;HELICOBACTER PYLORI INFECTION;HEPATITIS B VIRUS;HOSPITAL ANXIETY AND DEPRESSION SCALE;HYPERURICEMIA;HYPOXIA (ENVIRONMENTAL);IMMUNOGENICITY;INFERTILITY;INFLIXIMAB;INFLUENZA VACCINE;INHERITANCE (GENETIC ALGORITHM);INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS;JUVENILE MYOCLONIC EPILEPSY;KERATINOCYTE;KIDNEY PELVIS;LACTIC ACID;MEAN DIFFERENCE;MINNESOTA MULTIPHASIC PERSONALITY INVENTORY;MOOD DISORDERS;NERVE FIBER LAYER;NERVE GROWTH FACTOR;NEUROTROPHIC FACTORS;OPTIC DISK;PARACRINE SIGNALLING;PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY;PERIPHERAL BLOOD MONONUCLEAR CELL;PHACOEMULSIFICATION;PLASMID;PLEOMORPHISM (CYTOLOGY);POSTERIOR CRUCIATE LIGAMENT;PROSTATE CANCER;PSEUDOANEURYSM;PSYCHOMOTOR LEARNING;PSYCHOMOTOR RETARDATION;RAVEN'S PROGRESSIVE MATRICES;RECEPTOR TYROSINE KINASE;REMIFENTANIL;RENAL COLIC;RENAL PELVIS;RENAL STONE;RETINAL VEIN;RHEUMATOID FACTOR;SEROTONIN;SINUS RHYTHM;SPERM MOTILITY;STREPTOCOCCACEAE;T CELL;TIBIAL NERVE;TOLERABILITY;TRANSCRIPTION FACTOR;TRIPTANS;TUMOR LYSIS SYNDROME;ULTIMATE LOAD;UNIVARIATE ANALYSIS;VIRAL LOAD;VIRULENCE;WEIGHT LOSS","5;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BRANCH RETINAL VEIN OCCLUSION;BREAST CARCINOMA;CENTRAL RETINAL VEIN OCCLUSION;DUCTAL CARCINOMA;MARGINAL ZONE;MASTECTOMY;NEUROPSYCHOLOGICAL TEST;ANTIGEN-PRESENTING CELL;AROMATASE;AXILLA;BACTERIAL OUTER MEMBRANE;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREAKPOINT;CARDIAC RESYNCHRONIZATION THERAPY;CD38;CD40;CHRONIC GASTRITIS;CITALOPRAM;DIETING;DONOR LYMPHOCYTE INFUSION;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;ESCITALOPRAM;FEBUXOSTAT;FIBROBLAST GROWTH FACTOR RECEPTOR 1;FLUOXETINE;GENE PRODUCT;GERMINAL CENTER;GRAM-NEGATIVE BACTERIA;INTERLEUKIN 21;INVASIVE DUCTAL CARCINOMA;KERATINOCYTE GROWTH FACTOR;LACTOCOCCUS LACTIS;MAMMOTOME;MANIA;METASTATIC BREAST CANCER;MUCOSA-ASSOCIATED LYMPHOID TISSUE;MYB;NEUROPSYCHOLOGICAL ASSESSMENT;NFAT;OPERON;PROSTATECTOMY;RASBURICASE;SCANNING LASER POLARIMETRY;SELF POISONING;SEMEN ANALYSIS;SEMEN CRYOPRESERVATION;SENTINEL NODE;SEROSTATUS;SHIGELLA;SHIGELLA FLEXNERI;SPHEROPLAST;SUICIDE RISK;TAMOXIFEN;TANDEM EXON DUPLICATION;TRAIL MAKING TEST;VASCULAR DEMENTIA;VERBAL FLUENCY TEST","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;AGED;;CARCINOMA, LOBULAR;STOMACH NEOPLASMS;TREATMENT OUTCOME;AGED, 80 AND OVER;ARTHRITIS, RHEUMATOID;BREAST NEOPLASMS;LYMPHOMA, B-CELL, MARGINAL ZONE;SUICIDE;TIME FACTORS;FOLLOW-UP STUDIES;NEOPLASMS;ALPHA-DEFENSINS;GOITER","46;32;30;25;20;17;13;8;8;8;7;7;7;7;7;7;6;6;5;5","ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;EFFICACY AND RESISTANCE IN CML TREATMENT;LYMPHOID NEOPLASMS;MALE REPRODUCTIVE HEALTH;METASTATIC CARCINOMAS FROM LUNG AND BREAST;ANESTHESIA AND SEDATION MANAGEMENT;APELIN SIGNALING AND PHYSIOLOGY;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CHALLENGES AND OPPORTUNITIES IN TRANSLATIONAL RESEARCH;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;CUTANEOUS ADNEXAL NEOPLASMS AND RELATED SYNDROMES;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EATING DISORDERS AND BODY IMAGE CONCERNS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER","5;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","B-CELL RECEPTOR SIGNALING;ANTERIOR CRUCIATE LIGAMENT;BREAST CANCER;BREAST CARCINOMA;CENTRAL RETINAL VEIN;EPILEPSY;HEPATITIS C;LOBULAR CARCINOMA;MACULAR DEGENERATION;METASTATIC CARCINOMAS;NEUROPSYCHOLOGICAL TEST;OCULAR FINDINGS;RETINAL ARTERY OCCLUSION;REVISION SURGERY;TREATMENT;ABSOLUTE DEVIATION;ACETAZOLAMIDE;ADJUSTMENT DISORDERS;ADJUVANT THERAPY;AFFECT (LINGUISTICS)","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","CRUCIATE LIGAMENT;ANTERIOR CRUCIATE;ARTERY BYPASS;BRANCH VEIN;BYPASS GRAFTING;CELL TRANSPLANT;CHRONIC MYELOID;CORONARY ARTERY;DOUBLED SEMITENDINOSUS;EXTRA-ARTICULAR RECONSTRUCTION;GRACILIS TENDONS;GROWTH FACTOR;LATERAL EXTRA-ARTICULAR;LIGAMENT RECONSTRUCTION;MACULAR EDEMA;MYELOID LEUKEMIA;RETINAL OCCLUSION;REVISION ANTERIOR;SCIATIC NERVE;STEM CELL;SURGICAL TREATMENT;VEIN RETINAL;VISUAL ACUITY;ACADEMIC LADDER;ACHROMATIC PERIMETRY;ACL RECONSTRUCTION;ACTIVATED IIN;ACUTE SODIUM;ADJUVANT SETTING;ALLOGENEIC HEMATOPOIETIC","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","PUBMED SCOPUS;TESTICULAR BIOPSIES;ATRIAL FIBRILLATION;CROSSREF PUBMED;TISSUE DOPPLER;REPROD -CROSSREF;FOLLICLE-STIMULATING HORMONE;FSH TREATMENT;GONADOTROPIN TREATMENT;POSTOPERATIVE ATRIAL;NONOBSTRUCTIVE AZOOSPERMIA;LEFT ATRIUM;PATIENTS TREATED;SPERMATOGONIAL POPULATION;ATRIAL SYSTOLIC;BONE MARROW;CORONARY ARTERY;GONADOTROPIN THERAPY;HCV INFECTION;HORMONAL PROFILES;MATURATION ARREST;NORMAL HORMONAL;STERIL -ABSTRACT;ANNULAR TISSUE;ATRIAL DYSFUNCTION;AZOOSPERMIC PATIENTS;COGNITIVE IMPAIRMENT;DOPPLER VELOCITY;LARGER LEFT;LEFT ATRIAL","17;12;11;11;11;10;9;9;8;8;7;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4",11,0.18,3,2,1,0,0,0,2,0,1,2,0,1,6,0,1,0,2,4,0,0,0,52.5,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4,452,1.67,0,0,46,0,0,0,0,1,0,0,1,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Canada;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;LUNG;LUNG CANCER;NUTRITION;PREVENTION","2;2;1;1;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL","1;1","6.1 PHARMACEUTICALS","2","COLON AND RECTAL CANCER;LUNG CANCER","1;1","3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2007,65,7.92307692307692,2.38461538461538,0.538461538461538,0.338461538461538,0.584615384615385,1.24,1.12903225806452,1.29411764705882,1.11764705882353,0.307692307692308,0,32,15,4,11,0.49,0.23,0.06,0.17,86.75,1.64381273773736,NA,0.323076923076923,0.615384615384615,0.351,0.235,0.373,0.269,"PAOLO GIRARDI;ROBERTO TATARELLI;MARIA ROSARIA TORRISI;MAURIZIO POMPILI;DAVID LESTER;MARIA PIA VILLA;ANGELO DE CARLI;CINZIA MARCHESE;FABIO CONTEDUCA;ANDREA FERRETTI;ANDREA VECCHIONE;ALDO SCARPA;ITALO NOFRONI;GUIDO PAOLINI;ANDREA PELLICCIA;ELENA ORTONA;SIMONA MARCHITTI;SPERANZA RUBATTU;EMANUELE DI ANGELANTONIO;JAMES R. ROGERS","6;6;5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MARIA PIA VILLA;PAOLO GIRARDI;MARIA ROSARIA TORRISI;ROBERTO TATARELLI;MAURIZIO POMPILI;ANGELO DE CARLI;FABIO CONTEDUCA;GIUSEPPE NIGRI;ANDREA FERRETTI;DAVID LESTER;GUIDO PAOLINI;FABIO SANTANELLI DI POMPEO;ESTER FRANZESE;ANDREA PELLICCIA;PASQUALE PARISI;CINZIA MARCHESE;ANDREA TUBARO;CHRISTOPHER P. EVANS;JAMES R. ROGERS;EDOARDO MONACO","0.82;0.82;0.73;0.7;0.6;0.6;0.6;0.58;0.57;0.52;0.5;0.5;0.5;0.48;0.48;0.42;0.42;0.42;0.4;0.4","PAOLO GIRARDI;ROBERTO TATARELLI;MARIA ROSARIA TORRISI;MAURIZIO POMPILI;MARIA PIA VILLA;ANGELO DE CARLI;FABIO CONTEDUCA;ANDREA FERRETTI;ANDREA VECCHIONE;ITALO NOFRONI;ANDREA PELLICCIA;SPERANZA RUBATTU;FABIO SANTANELLI DI POMPEO;GIOVANNI RAMACCIATO;ARIANNA DI NAPOLI;ERINO ANGELO RENDINA;ATHANASIOS KOUKOPOULOS;ANTONELLA TEGGI;STEFANIA SCARPINO;ELEONORA DE PISA","6;6;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MARIA PIA VILLA;PAOLO GIRARDI;MARIA ROSARIA TORRISI;ROBERTO TATARELLI;MAURIZIO POMPILI;ANGELO DE CARLI;FABIO CONTEDUCA;ANDREA FERRETTI;FABIO SANTANELLI DI POMPEO;ESTER FRANZESE;ANDREA PELLICCIA;PASQUALE PARISI;ANDREA TUBARO;EDOARDO MONACO;CARMELO DʼARRIGO;ITALO NOFRONI;R RONCHETTI;GUGLIELMO BRUNO;ATHANASIOS KOUKOPOULOS;ANTONIO IVAN LAZZARINO","0.82;0.82;0.73;0.7;0.6;0.6;0.6;0.57;0.5;0.5;0.48;0.48;0.42;0.4;0.4;0.36;0.34;0.33;0.33;0.33","EMANUELA PILOZZI;LUIGI RUCO;ADRIANA ERAMO;ANTONIO DI VIRGILIO;C PESCHLE;CONCETTA CONTICELLO;FIORENZA LOTTI;GIOVANNI SETTE;MAURO BIFFONI;RUGGERO DE MARIA;ALDO SCARPA;ALBERTO FAGGIONI;BARBARA ROSICARELLI;BARBARA SERAFINI;DIEGO FRANCIOTTA;FRANCESCA ALOISI;LAURA ANDREONI;MARCO SALVETTI;PANKAJ TRIVEDI;PAOLA CINQUE","1741;1741;1646;1646;1646;1646;1646;1646;1646;1646;687;684;684;684;684;684;684;684;684;684","EMANUELA PILOZZI;LUIGI RUCO;MARCO SALVETTI;PAOLO GIRARDI;ANDREA VECCHIONE;MAURIZIO POMPILI;ROBERTO TATARELLI;ROBERTO CIROMBELLA;MARIA ROSARIA TORRISI;G. F. DELLE FAVE;C MALAGOLA;ANTONELLA TEGGI;ANNA PAOLA MITTERHOFER;FRANCESCA TINTI;ITALO NOFRONI;M.F. VITALE;SILVIA LAI;SALVATORE RAFFA;ATHANASIOS KOUKOPOULOS;GABRIELE SANI","1646;1646;684;534;466;424;403;396;297;291;244;176;155;155;155;155;155;140;131;131","MARIA ROSARIA TORRISI;PAOLO GIRARDI;ROBERTO TATARELLI;ANDREA FERRETTI;EDOARDO MONACO;MAURIZIO POMPILI;ANGELO DE CARLI;FABIO CONTEDUCA;ANDREA PELLICCIA;ANDREA TUBARO;ANDREA VECCHIONE;ANTONELLA TEGGI;CARMELO DʼARRIGO;ERINO ANGELO RENDINA;FABIO SANTANELLI DI POMPEO;GIOVANNI QUARTA;MARIA PIA VILLA;MASSIMO VOLPE;PASQUALE PARISI;SALVATORE RAFFA","5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;MATHEMATICS;PHYSICS;POLITICAL SCIENCE;ART;BUSINESS;PHILOSOPHY","51;30;10;9;5;5;3;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;BIOCHEMISTRY;CELL BIOLOGY;GENETICS;PATHOLOGY;IMMUNOLOGY;PSYCHIATRY;ENDOCRINOLOGY;CANCER RESEARCH;ONCOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ANESTHESIA;MACROECONOMICS;NUCLEAR MEDICINE;PALEONTOLOGY;RADIOLOGY;SOCIAL PSYCHOLOGY;ANATOMY;CARDIOLOGY;CLINICAL PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;MEDICAL EMERGENCY;MOLECULAR BIOLOGY;NURSING;PHYSICAL THERAPY","31;14;13;13;13;13;11;11;9;8;8;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3","GENE;CANCER;RECEPTOR;ANTIBODY;POPULATION;DISEASE;IMMUNOHISTOCHEMISTRY;CELL CULTURE;DEPRESSION (ECONOMICS);SIGNAL TRANSDUCTION;THYROID;ANTERIOR CRUCIATE LIGAMENT;ANTIGEN;CELL;EPILEPSY;IMMUNE SYSTEM;LUNG;POISON CONTROL;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);STAGE (STRATIGRAPHY)","15;12;9;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","DOWNREGULATION AND UPREGULATION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;CANCER CELL;FIBROBLAST GROWTH FACTOR;GENE EXPRESSION;KERATINOCYTE;THYROID CANCER;THYROID CARCINOMA;ALLELE;CARCINOGENESIS;CONFIRMATORY FACTOR ANALYSIS;CONSTRUCT VALIDITY;CYTOSKELETON;EXPLORATORY FACTOR ANALYSIS;GROWTH FACTOR;METASTASIS;MICRORNA;PROTEIN KINASE B;SUICIDE PREVENTION;TEST VALIDITY","4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","KERATINOCYTE GROWTH FACTOR;FGF10;SUICIDE ATTEMPT;ACTIN CYTOSKELETON;ALLELE FREQUENCY;ANAPLASTIC THYROID CANCER;ANEUPLOIDY;APNEA–HYPOPNEA INDEX;AUTOIMMUNE REGULATOR;BCL-XL;BECK HOPELESSNESS SCALE;BRONCHUS;CD23;CD40;CD86;CHOLESTERYLESTER TRANSFER PROTEIN;CORTACTIN;CROSS-REACTIVITY;CYCLIN-DEPENDENT KINASE 1;ENDOCYTIC CYCLE;ENTEROENDOCRINE CELL;EPIRUBICIN;EVANS SYNDROME;FIBROBLAST GROWTH FACTOR RECEPTOR;FOOD ALLERGENS;GLUCAGONOMA;HAPLOTYPE;HERPESVIRIDAE;HINDGUT;HYPOPNEA;IDIOPATHIC INTERSTITIAL PNEUMONIA;IMMUNOGLOBULIN D;INSULIN RECEPTOR;LAMELLIPODIUM;LYMPHANGIOGENESIS;MICROARRAY;MICROARRAY ANALYSIS TECHNIQUES;MICROVESICLES;MIGRAINE WITH AURA;NEURAL CELL ADHESION MOLECULE;NOCODAZOLE;PHOTIC STIMULATION;POLYMORPHISM (COMPUTER SCIENCE);SENILE PLAQUES;SENTINEL NODE;SLEEP MEDICINE;STENOTROPHOMONAS;STENOTROPHOMONAS MALTOPHILIA;TRANSCRIPTOME;TROPOMYOSIN RECEPTOR KINASE A;TROPOMYOSIN RECEPTOR KINASE B;UBIQUITIN LIGASE;USUAL INTERSTITIAL PNEUMONIA","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;KERATINOCYTES;BRAIN;THYROID NEOPLASMS;FIBROBLAST GROWTH FACTOR 7;DEPRESSIVE DISORDER;ITALY;STOMACH NEOPLASMS;AGED, 80 AND OVER;CELL DIFFERENTIATION;EPITHELIAL CELLS;HEMORRHAGE;LIVER NEOPLASMS;PHOSPHORYLATION","50;29;22;22;20;16;13;12;10;10;9;8;8;8;7;7;7;7;7;7","ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;CULTURAL PSYCHOLOGY AND VALUES RESEARCH;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPILEPSY AND SEIZURES;FIBROBLAST GROWTH FACTOR SIGNALING PATHWAY;;ACUTE MYELOID LEUKEMIA;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AND THERAPY;ATP SYNTHASE FUNCTION AND REGULATION;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CANCER STEM CELLS AND TUMOR METASTASIS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF LUNG CANCER","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTERIOR CRUCIATE LIGAMENT;DEPRESSION (ECONOMICS);FIBROBLAST GROWTH FACTOR;KERATINOCYTE GROWTH FACTOR;ADRENAL VEIN SAMPLING;ANGIOGENESIS;CROSS-CULTURAL VARIABILITY;DIAGNOSIS;ETIOLOGY;EXPLORATORY FACTOR ANALYSIS;FACTOR (PROGRAMMING LANGUAGE);PANCREATIC NEUROENDOCRINE TUMORS;RADIOTHERAPY;REVISION SURGERY;SAMPLE (MATERIAL);STROKE (ENGINE);SUICIDE RISK;TREATMENT;ACUTE MYELOID LEUKEMIA;ACUTE PANCREATITIS","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","GROWTH FACTOR;ANTERIOR CRUCIATE;CRUCIATE LIGAMENT;KERATINOCYTE GROWTH;LIGAMENT RECONSTRUCTION;BREAST CANCER;CONSTRUCT VALIDITY;CROSS-CULTURAL CONSTRUCT;DENDRITIC CELL;DOUBLED SEMITENDINOSUS;EXTRA-ARTICULAR RECONSTRUCTION;FIBROBLAST GROWTH;GRACILIS TENDONS;INVENTORY CROSS-CULTURAL;LATERAL EXTRA-ARTICULAR;LIVING INVENTORY;REVISION ANTERIOR;SUICIDE RISK;ABSENCE IMPAIRS;ACTIN ASSEMBLY;ACTIVE RHEUMATOID;ACUTE DECOMPENSATED;ACUTE MYELOID;ADRENAL TUMORS;AFFECTIVE DISORDERS;AGROALIMENTARY BIOTECHNOLOGIES;AIPITCH UBIQUITINATES;ALLERGIES CROSS-REACTIONS;ALPHA BLOCKADE;ALZHEIMERS DISEASE","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","PULMONARY ARTERY;PUBMED SCOPUS;CARDIOPULMONARY BYPASS;CATHETER-INDUCED PULMONARY;SURG -ABSTRACT;THORAC SURG;SLEEVE LOBECTOMY;ARTERY RUPTURE;LUNG CANCER;SWAN-GANZ CATHETER;ARTERY RUPTUREANN;COUYANT MA;MH ANGELOPOULOS;MULLERWORTH MH;RUPTUREANN THORAC;CD CELLS;RISK FACTORS;T-WEIGHTED IMAGING;SPINAL CORD;AGITATED DEPRESSION;BLOOD FLOW;KIM LUDWIG;LOCAL RECURRENCE;MIXED DEPRESSION;PARENCHYMAL SPARING;SIGNIFICANT CORRELATION;SLEEVE RESECTION;VALVE REPLACEMENT;AIRWAY HEMORRHAGE;ARTERY CATHETERIZATION","29;14;11;11;10;10;9;8;8;8;7;7;7;7;7;6;6;6;5;4;4;4;4;4;4;4;4;4;3;3",12,0.18,7.5,11.75,1,1,1,2.75,16,1,0,14.5,0,1,6.5,1,4,0,1,5.25,1,1,0.25,232.75,234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,5.6,1781.8,4.17,2,0.4,120.6,0,0,0,0,4,0,0,1,0,4,1,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Germany;Italy;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","5;4;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;PATIENT SAFETY;AUTOIMMUNE DISEASE;BRAIN DISORDERS;BREAST CANCER;CHRONIC PAIN;COLO-RECTAL CANCER;HEMATOLOGY;MULTIPLE SCLEROSIS;NEURODEGENERATIVE;NEUROSCIENCES;PAIN RESEARCH","5;5;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","2;1;1","6.1 PHARMACEUTICALS","3","BREAST CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2008,74,8.21621621621622,2.55405405405405,0.527027027027027,0.297297297297297,0.5,1.35971223021583,1.14705882352941,1.22222222222222,1.12121212121212,0.243243243243243,1,34,13,10,13,0.46,0.18,0.14,0.18,46.93,0.855309502738233,NA,0.283783783783784,0.689189189189189,0.332,0.269,0.327,0.274,"PAOLO GIRARDI;ROBERTO TATARELLI;GIOVANNI RAMACCIATO;GIUSEPPE NIGRI;M. ARRAIZA;GORKA BASTARRIKA;FRANCESCO D’ANGELO;MARCO INNAMORATI;DAVID LESTER;AUGUSTO LAURO;PAOLO AURELLO;CARLO N. DE CECCO;MARIA PIA VILLA;MAURIZIO POMPILI;ANDREA VECCHIONE;GIORGIO ERCOLANI;PAOLA CIPRIANI;STEFANO MASTROBUONI;GREGORIO RÁBAGO;PATRIZIA CARDELLI","6;6;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","MASSIMILIANO VARIO;PAOLO GIRARDI;ROBERTO TATARELLI;M. ARRAIZA;GORKA BASTARRIKA;CARLO N. DE CECCO;MARIA PIA VILLA;GIOVANNI RAMACCIATO;GIUSEPPE NIGRI;FRANCESCO BOTRÈ;ANTONIO PAVAN;MARCO INNAMORATI;DAVID LESTER;MAURIZIO POMPILI;STEFANO MASTROBUONI;GREGORIO RÁBAGO;M. UBILLA;FRANCESCO D’ANGELO;PAOLO AURELLO;PATRIZIA CARDELLI","1.33;0.67;0.64;0.6;0.6;0.6;0.6;0.51;0.51;0.5;0.5;0.46;0.46;0.46;0.45;0.45;0.45;0.4;0.4;0.39","PAOLO GIRARDI;ROBERTO TATARELLI;GIOVANNI RAMACCIATO;GIUSEPPE NIGRI;CARLO N. DE CECCO;MARIA PIA VILLA;ANDREA VECCHIONE;PAOLA CIPRIANI;GREGORIO RÁBAGO;PATRIZIA CARDELLI;MARIA ANTONIETTA ALOE SPIRITI;ALESSANDRO BOZZAO;ANDREA PETRUCCA;MARIA ROSARIA TORRISI;ROSSELLA MARINO;ALESSANDRA RIZZOLI;BRUNO MONARCA;ESMERALDA CONTE;ANTONIO STIGLIANO;MASSIMILIANO VARIO","6;6;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2","MASSIMILIANO VARIO;PAOLO GIRARDI;ROBERTO TATARELLI;CARLO N. DE CECCO;MARIA PIA VILLA;GIOVANNI RAMACCIATO;GIUSEPPE NIGRI;ANTONIO PAVAN;GREGORIO RÁBAGO;PATRIZIA CARDELLI;ALESSANDRO BOZZAO;MAURIZIO SIMMACO;LUANA LIONETTO;ALFONSO M. LOSTIA;PAOLA CIPRIANI;ANDREA PETRUCCA;SALVATORE MARIOTTA;GIOVANNI BRANCACCIO;ALEXIA E. KOUKOPOULOS;ALBERTO RÍCCI","1.33;0.67;0.64;0.6;0.6;0.51;0.51;0.5;0.45;0.39;0.38;0.34;0.34;0.34;0.34;0.34;0.33;0.33;0.33;0.33","LUIGI RUCO;ANDREA VECCHIONE;GUSTAVO BALDASSARRE;CARLO M. CROCE;CHANG GONG LIU;DIMITRIOS ILIOPOULOS;EMANUELA PILOZZI;FABIO PETROCCA;HANSJÜERG ALDER;IVANA DE MARTINO;LUIGI CAVAZZINI;MANISHA H. SHAH;MARIADELE RAPAZZOTTI ONELLI;MASSIMO NEGRINI;MILENA S. NICOLOSO;ROSA VISONE;STEFANO VOLINIA;ROBERTO TATARELLI;PAOLO GIRARDI;ANTONELLA STOPPACCIARO","927;892;874;840;822;822;822;822;822;822;822;822;822;822;822;822;822;412;391;362","ANDREA VECCHIONE;EMANUELA PILOZZI;MARIADELE RAPAZZOTTI ONELLI;ROBERTO TATARELLI;PAOLO GIRARDI;ANTONELLA STOPPACCIARO;CAMILLO AUTORE;GIOVANNI QUARTA;MARCELLO DE SANTIS;FRANCESCO MATRISCIANO;A RICCIARDI;AMEDO RUBERTO;STEFANIA BONACCORSO;PATRIZIA CARDELLI;MARIA PIA VILLA;RACHELE AMODEO;ALESSANDRO BOZZAO;ANTONELLA FERRARI;ENRICO MONTEFUSCO;ESMERALDA CONTE","892;822;822;393;391;362;307;307;307;291;243;243;243;240;224;173;143;128;128;128","PAOLO GIRARDI;ROBERTO TATARELLI;MARIA PIA VILLA;CARLO N. DE CECCO;GIOVANNI RAMACCIATO;PATRIZIA CARDELLI;ANDREA PETRUCCA;ANDREA VECCHIONE;PAOLA CIPRIANI;ALESSANDRA RIZZOLI;ALESSANDRO BOZZAO;ANDREA PERDICCHI;ANDREA SINISCALCO;ANTONELLA FERRARI;ANTONELLA STOPPACCIARO;ENRICO MONTEFUSCO;ESMERALDA CONTE;FRANCESCO MATRISCIANO;GABRIELE SANI;GEORGIOS D. KOTZALIDIS","6;5;5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;ART;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY","66;17;10;8;6;5;4;2;2;2;2;1;1;1;1","INTERNAL MEDICINE;PSYCHIATRY;SURGERY;CARDIOLOGY;RADIOLOGY;GENETICS;PATHOLOGY;ANESTHESIA;CANCER RESEARCH;GENERAL SURGERY;GASTROENTEROLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PALEONTOLOGY;PEDIATRICS;ANATOMY;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;ENDOCRINOLOGY;MACROECONOMICS;MICROBIOLOGY;NURSING;ONCOLOGY;OPERATING SYSTEM;OPHTHALMOLOGY;PHYSICAL THERAPY","36;16;16;13;12;10;10;8;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","CANCER;GENE;HEART FAILURE;POPULATION;BLOOD PRESSURE;DEPRESSION (ECONOMICS);DISEASE;POISON CONTROL;RECEPTOR;RESECTION;ANXIETY;ARTERY;ASTHMA;CHEMOTHERAPY;CLINICAL TRIAL;GLAUCOMA;ISCHEMIA;MYOCARDIAL INFARCTION;NEUROLOGY;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANEMIA;ANTIBODY;BACTERIA;BIOPSY;CONFIDENCE INTERVAL;DETECTION LIMIT;DRUG;EMERGENCY DEPARTMENT;EXHALATION;HIPPOCAMPUS;IMAGE (MATHEMATICS);INTENSIVE CARE UNIT;LAPAROSCOPY;LEUKEMIA;LINEAR DISCRIMINANT ANALYSIS;MAGNETIC RESONANCE IMAGING;MASS SPECTROMETRY;MORTALITY RATE;MULTIPLE SCLEROSIS;MULTIVARIATE ANALYSIS;NEUROSURGERY;OBSERVATIONAL STUDY;OBSTRUCTIVE SLEEP APNEA;OPTIC NERVE;PERIOPERATIVE;PRESENTATION (OBSTETRICS);PROSPECTIVE COHORT STUDY;QUALITY OF LIFE (HEALTHCARE);RECEIVER OPERATING CHARACTERISTIC;REFERRAL;SLEEP (SYSTEM CALL);SLEEP APNEA;TRANSPLANTATION;URINE","11;7;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SUICIDE PREVENTION;ANTIDEPRESSANT;INJURY PREVENTION;NATRIURETIC PEPTIDE;TRANSCRIPTION FACTOR;BRAIN NATRIURETIC PEPTIDE;CELL CYCLE;COLORECTAL CANCER;CORONARY ARTERIES;DIASTOLE;GENE EXPRESSION;GENE SILENCING;HEART RATE;HEART TRANSPLANTATION;IMAGE QUALITY;MICRORNA;NEURORADIOLOGY;PROGRESSION-FREE SURVIVAL;SPIROMETRY;TUMOR PROGRESSION","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","VENLAFAXINE;5-HYDROXYINDOLEACETIC ACID;ACUTE PROMYELOCYTIC LEUKEMIA;AMPLIFIED FRAGMENT LENGTH POLYMORPHISM;ATROPHIC GASTRITIS;AXILLA;BACILLALES;BEHAVIOURAL DESPAIR TEST;BRAIN-DERIVED NEUROTROPHIC FACTOR;BRONCHUS;CELL CYCLE CHECKPOINT;CITALOPRAM;COLONOSCOPY;E2F1;ESCITALOPRAM;EXHALED NITRIC OXIDE;GENE PRODUCT;GENOTYPING;GLOMERULOPATHY;HEMICOLECTOMY;HERPESVIRIDAE;HOMOVANILLIC ACID;IMMUNOPEROXIDASE;INGUINAL CANAL;INTERFERON BETA-1A;INTERNATIONAL PROGNOSTIC INDEX;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;INTRAOPERATIVE MRI;MESANGIUM;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;MILAN CRITERIA;NUCLEAR PROTEIN;ONCOMIR;OPEN READING FRAME;OPERON;PAROXETINE;PERIPLASMIC SPACE;PROSTATECTOMY;RIGHT HEMICOLECTOMY;RUNX1;SENTINEL LYMPH NODE;SENTINEL NODE;SERTRALINE;SHIGELLA FLEXNERI;SLEEP STAGES;SLEEP STUDY;STERILIZATION (ECONOMICS);SUICIDE ATTEMPT;SUICIDE RISK;TRACTOGRAPHY;TUMOR SUPPRESSOR GENE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;AGED, 80 AND OVER;DEPRESSIVE DISORDER, MAJOR;SUICIDE;ADENOCARCINOMA;ASTHMA;;POSTOPERATIVE COMPLICATIONS;PROSPECTIVE STUDIES;TOMOGRAPHY, X-RAY COMPUTED;TREATMENT OUTCOME;ADRENAL GLAND NEOPLASMS;BIOMARKERS;BRAIN NEOPLASMS;GLIOBLASTOMA","61;41;41;24;23;23;11;11;11;10;10;9;9;9;9;9;8;8;8;8","SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ASTHMA;DIAGNOSIS AND TREATMENT OF HEART FAILURE;ACUTE MYELOID LEUKEMIA;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ESOPHAGEAL INTERVENTION TECHNIQUES;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BACTERIAL BIOFILMS AND QUORUM SENSING MECHANISMS;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS;CATARACT SURGERY TECHNIQUES AND COMPLICATIONS;COGNITIVE MECHANISMS OF ANXIETY AND DEPRESSION;COMPLICATIONS OF GALLSTONE DISEASE;CRANIOFACIAL RECONSTRUCTION TECHNIQUES;DETECTION AND MANAGEMENT OF RETINAL DISEASES;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS","4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CARDIAC IMAGING;B-TYPE NATRIURETIC PEPTIDE;DEPRESSION (ECONOMICS);SUICIDAL BEHAVIOR;BRAIN NATRIURETIC PEPTIDE;CORONARY ARTERIES;ENDOSCOPIC STENTING;GLAUCOMA;NEURORADIOLOGY;OBSTRUCTIVE SLEEP APNEA;PEDIATRIC SLEEP APNEA;PRESENTATION (OBSTETRICS);PRIMARY OPEN-ANGLE GLAUCOMA;PROGRESSION-FREE SURVIVAL;PSYCHOLOGICAL AUTOPSY;SUICIDE;TREATMENT;TUMOR PROGRESSION;5-HYDROXYINDOLEACETIC ACID;ADRENAL INCIDENTALOMA","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","DUAL-SOURCE CT;HEART TRANSPLANT;ANALYSIS MODELS;AUTOPSY STUDY;B-TYPE NATRIURETIC;CARE UNIT;DISCRIMINANT ANALYSIS;GLAUCOMA PROBABILITY;GLAUCOMATOUS OPTIC;HEART FAILURE;INTENSIVE CARE;LEFT VENTRICULAR;MAGNETIC RESONANCE;MULTIPLE SCLEROSIS;NATRIURETIC PEPTIDE;NERVE HEAD;OPTIC NERVE;PATIENTS ADMITTED;PROBABILITY SCORE;PROSTATE CANCER;PSYCHOLOGICAL AUTOPSY;SERUM LEVELS;SPECTROMETRY METHOD;TRANSPLANT RECIPIENTS;-HYDROXYBUTIL NITROSAMINE;ABSOLUTE LYMPHOCYTE;ACID HOMOVANILLIC;ACUTE DECOMPENSATED;ACUTE HEART;ACUTE MYELOID","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","BDNF LEVELS;PREMENOPAUSAL WOMEN;HEART RATE;COMPUTED TOMOGRAPHIC;GENE THERAPY;GT NGML;HEART TRANSPLANT;NUCLEAR MEMBRANE;RECONSTRUCTION INTERVAL;SD NGML;SERUM BDNF;TRANSPLANT RECIPIENTS;ADMINISTRATION DRUG;ANTIDEPRESSANT DRUGS;ARTIFICIAL NEURAL;ATROPHIC BODY;BLADDER CANCER;BODY GASTRITIS;CHRONIC DAILY;CONCENTRATION LEVELS;DAILY HEADACHE;DRUG CONCENTRATION;DRUG RESULTS;DUAL-SOURCE CT;ERGOT TOXICITY;IMAGE QUALITY;IRON MALABSORPTION;LOWER EXTREMITY;NATRIURETIC PEPTIDE;NEURAL NETWORKS","9;7;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",11,0.15,7.5,8.5,0,1,0,0,23.75,1,1,9.5,0,0,2,0,1.75,0,0,2.5,1,0,0,99,99.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,8,4343.8,3.79,2,0.4,52.6,0,0,1,0,0,0,2,2,0,3,2,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Italy;Switzerland;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","5;4;1","CLINICAL RESEARCH;CARDIOVASCULAR;HEART DISEASE;ATHEROSCLEROSIS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIABETES;HEART DISEASE - CORONARY HEART DISEASE;PATIENT SAFETY;PREVENTION;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BRAIN DISORDERS;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;COMPARATIVE EFFECTIVENESS RESEARCH;COMPLEMENTARY AND INTEGRATIVE HEALTH;EMERGENCY CARE;HEALTH SERVICES;KIDNEY DISEASE;LUNG","5;4;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;METABOLIC AND ENDOCRINE;NEUROLOGICAL;RENAL AND UROGENITAL;RESPIRATORY","4;2;1;1;1","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.7 PHYSICAL;7.3 MANAGEMENT AND DECISION MAKING","2;1;1;1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2009,100,10.4,2.62,0.42,0.33,0.56,1.2970297029703,1.05,1.17857142857143,1.16666666666667,0.26,2,51,23,10,10,0.51,0.23,0.1,0.1,51.89,1.12177077453371,NA,0.36,0.84,0.37,0.268,0.332,0.266,"ROBERTO TATARELLI;ANDREA TUBARO;AGOSTINO CORTELEZZI;PAOLO GIRARDI;MAURIZIO POMPILI;MARIA ROSARIA TORRISI;ROBERTO LATAGLIATA;FORTUNATO MORABITO;FRANCESCO DI RAIMONDO;MARCO INNAMORATI;DAVID LESTER;ANTONELLA STOPPACCIARO;MASSIMO BRECCIA;ENRICO MONTEFUSCO;ESTHER NATALIE OLÍVA;CESARE HASSAN;CHRISTOPHER SEXTON;DAMIANO MAGRÌ;ERINO ANGELO RENDINA;PAOLO ILICETO","7;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","MICHELE RAJA;G. MORABITO;ROBERTO TATARELLI;MARIA ROSARIA TORRISI;ANDREA TUBARO;MAURIZIO POMPILI;PAOLO GIRARDI;ANTONELLA STOPPACCIARO;ERINO ANGELO RENDINA;MASSIMO VOLPE;ANTONELLA AZZONI;MARCO INNAMORATI;DAVID LESTER;CHRISTOPHER SEXTON;ZOË KOPP;KARIN S. COYNE;LALITHA P. AIYER;PAOLO ILICETO;PAOLO GIRARDI;ANDREA FERRETTI","1.5;1;0.78;0.65;0.64;0.64;0.56;0.53;0.51;0.5;0.5;0.47;0.47;0.42;0.42;0.42;0.42;0.39;0.37;0.37","ROBERTO TATARELLI;ANDREA TUBARO;PAOLO GIRARDI;MAURIZIO POMPILI;MARIA ROSARIA TORRISI;MARCO INNAMORATI;DAVID LESTER;ANTONELLA STOPPACCIARO;ENRICO MONTEFUSCO;CESARE HASSAN;DAMIANO MAGRÌ;ERINO ANGELO RENDINA;PAOLO ILICETO;MASSIMO VOLPE;LORENZO MAZZARINI;PAOLO GIRARDI;ISABELLA PACCHIAROTTI;COSIMO DE NUNZIO;EMILIO DI GIULIO;ANDREA VECCHIONE","7;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2","MICHELE RAJA;G. MORABITO;ROBERTO TATARELLI;MARIA ROSARIA TORRISI;ANDREA TUBARO;MAURIZIO POMPILI;PAOLO GIRARDI;ANTONELLA STOPPACCIARO;ERINO ANGELO RENDINA;MASSIMO VOLPE;MARCO INNAMORATI;DAVID LESTER;PAOLO ILICETO;PAOLO GIRARDI;ANDREA FERRETTI;CESARE HASSAN;EMILIO DI GIULIO;MARIA TERESA CONTESTABILE;ANTONELLA TEGGI;PAOLO MARCHETTI","1.5;1;0.78;0.65;0.64;0.64;0.56;0.53;0.51;0.5;0.47;0.47;0.39;0.37;0.37;0.35;0.35;0.34;0.33;0.32","ALESSANDRA NICOLETTI;ALFREDO PETRONE;ANGELO ANTONINI;ANNA RITA BENTIVOGLIO;ANTONINO CANNAS;ANTONIO PISANI;CARLO COLOSIMO;FABRIZIO STOCCHI;FRANCESCA MORGANTE;FRANCESCO E. PONTIERI;FRANCESCO IEMOLO;G. MECO;GIORGIO TRIANNI;GIULIO CICARELLI;M. MANFREDI;MARIA GABRIELLA CERAVOLO;MASSIMO PEDERZOLI;PAOLO BARONE;PAOLO DEL DOTTO;R. QUATRALE","1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453","FRANCESCO E. PONTIERI;ANDREA TUBARO;PAOLO GIRARDI;ROBERTO TATARELLI;ANNA COSTANTINI;MAURIZIO POMPILI;ELEONORA DE PISA;COSIMO DE NUNZIO;PAOLO ILICETO;DAMIANO MAGRÌ;GIUSEPPE MINNITI;ISABELLA PACCHIAROTTI;LORENZO MAZZARINI;GEORGIOS D. KOTZALIDIS;ANNA MARIA CICCONE;ERINO ANGELO RENDINA;MOHSEN IBRAHIM;LUANA BENEDETTI;MARIA ROSARIA TORRISI;JUAN SONG","1453;702;399;394;344;253;208;206;185;182;181;163;163;146;130;130;130;123;119;104","PAOLO GIRARDI;ROBERTO TATARELLI;ANDREA TUBARO;ENRICO MONTEFUSCO;ANTONELLA STOPPACCIARO;COSIMO DE NUNZIO;DAMIANO MAGRÌ;EMILIO DI GIULIO;ISABELLA PACCHIAROTTI;LORENZO MAZZARINI;MARIA ROSARIA TORRISI;MAURIZIO POMPILI;PAOLO ILICETO;ANDREA VECCHIONE;ANNA MARIA CICCONE;ELEONORA DE PISA;ERINO ANGELO RENDINA;FRANCESCO E. PONTIERI;G ALIBERTI;GABRIELE SANI","8;7;5;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;ECONOMICS;PHYSICS;COMPUTER SCIENCE;ENGINEERING;SOCIOLOGY;MATHEMATICS;PHILOSOPHY;MATERIALS SCIENCE;POLITICAL SCIENCE;ART;GEOGRAPHY;HISTORY","93;23;16;6;6;6;4;4;4;3;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;PSYCHIATRY;GENETICS;ONCOLOGY;PATHOLOGY;RADIOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;GASTROENTEROLOGY;NURSING;ANATOMY;CLINICAL PSYCHOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;CANCER RESEARCH;CELL BIOLOGY;MACROECONOMICS;NEUROSCIENCE","64;19;16;15;15;15;14;12;11;9;9;9;7;7;7;7;6;6;6;6","CANCER;GENE;POPULATION;DISEASE;QUALITY OF LIFE (HEALTHCARE);RECEPTOR;DEPRESSION (ECONOMICS);HEART FAILURE;COGNITION;MAGNETIC RESONANCE IMAGING;POISON CONTROL;URINARY SYSTEM;BLOOD PRESSURE;HORMONE;IMMUNOHISTOCHEMISTRY;LEUKEMIA;LUNG;TRANSPLANTATION;ANXIETY;BONE MARROW;CELL GROWTH;CLINICAL TRIAL;DIABETES MELLITUS;INCIDENCE (GEOMETRY);LESION;LOGISTIC REGRESSION;MYELOID LEUKEMIA;PERSONALITY;PROSPECTIVE COHORT STUDY;RADIATION THERAPY;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);STEM CELL;STROKE (ENGINE);VIRUS","18;15;10;8;8;8;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","BREAST CANCER;SUICIDE PREVENTION;GENOTYPE;PROSTATE;BIPOLAR DISORDER;COLORECTAL CANCER;IMATINIB;INJURY PREVENTION;METASTASIS;MYELODYSPLASTIC SYNDROMES;PHENOTYPE;ALLELE;CD34;CELL CYCLE;CHROMOSOME;CHRONIC LYMPHOCYTIC LEUKEMIA;FIBROBLAST GROWTH FACTOR;FIXATION (POPULATION GENETICS);GRAFT-VERSUS-HOST DISEASE;HEPATITIS B VIRUS;HEPATOCYTE GROWTH FACTOR;HUMAN FACTORS AND ERGONOMICS;KERATINOCYTE;LENALIDOMIDE;LUNG FUNCTION;MESSENGER RNA;NOCTURIA;PROSTATE CANCER;TEMPERAMENT;THYROID CARCINOMA","5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","IMATINIB MESYLATE;BREAST CARCINOMA;COLONOSCOPY;DASATINIB;DIFFUSING CAPACITY;KERATINOCYTE GROWTH FACTOR;LOWER URINARY TRACT SYMPTOMS;METASTATIC BREAST CANCER;METHYLENETETRAHYDROFOLATE REDUCTASE;NILOTINIB;SUICIDE RISK;ACROMEGALY;AMISULPRIDE;AMPLICON;ANTIPSYCHOTIC AGENT;ANTIVIRAL THERAPY;ANTIVIRAL TREATMENT;ASYMMETRIC DIMETHYLARGININE;ATYPICAL ANTIPSYCHOTIC;AUTONOMIC NERVOUS SYSTEM;AXILLARY LYMPH NODES;BACTERIAL OUTER MEMBRANE;BRONCHOPLEURAL FISTULA;CAROTID ARTERY DISEASE;CAROTID STENTING;CD117;CD38;CELL CYCLE CHECKPOINT;COGNITIVE DEFICIT;CORONAVIRUS DISEASE 2019 (COVID-19);CORTICOBASAL DEGENERATION;CYTOGENETICS;DEMENTIA WITH LEWY BODIES;DESMIN;DIROFILARIA REPENS;ENDOCYTIC CYCLE;ERLOTINIB;EXTRAPYRAMIDAL SYMPTOMS;FIBROBLAST GROWTH FACTOR RECEPTOR;FIBROBLAST GROWTH FACTOR RECEPTOR 3;FLUORESCENCE IN SITU HYBRIDIZATION;GEFITINIB;GENE EXPRESSION PROFILING;GENICULATE GANGLION;GENOTYPING;GRANULOMATOSIS WITH POLYANGIITIS;HAPLOINSUFFICIENCY;HAPLOTYPE;HBSAG;HEART RATE VARIABILITY;HEPACIVIRUS;HORMONAL THERAPY;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KARYOTYPE;LAMIVUDINE;LEWY BODY;LOSS OF HETEROZYGOSITY;LYMPHOVASCULAR INVASION;MISSENSE MUTATION;MOOD STABILIZER;OXAZEPAM;PARATHYROIDECTOMY;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;PROSTATITIS;SENTINEL LYMPH NODE;SERTRALINE;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBVENTRICULAR ZONE;SUICIDAL BEHAVIOR;SUICIDAL IDEATION;SUICIDE ATTEMPT;SUICIDE RATES;TEMAZEPAM;TETRAPLEGIA;TREATMENT-RESISTANT DEPRESSION;TUMOR SUPPRESSOR GENE;WEGENER GRANULOMATOSIS;WISCONSIN CARD SORTING TEST","3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;;ITALY;YOUNG ADULT;COGNITION DISORDERS;SUICIDE;TREATMENT OUTCOME;URINATION DISORDERS;SURVEYS AND QUESTIONNAIRES;ANIMALS;BIPOLAR DISORDER;ADOLESCENT;RISK FACTORS;AGED, 80 AND OVER;BIOMARKERS","68;51;50;43;36;35;24;22;16;13;13;13;13;12;11;11;10;10;9;9","EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;EFFICACY AND RESISTANCE IN CML TREATMENT;ACUTE MYELOID LEUKEMIA;CLINICAL AND PATHOLOGICAL ASPECTS OF URACHAL CARCINOMA;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;HEPATITIS B INFECTION AND TREATMENT;IMPACT OF PARENTAL ILLNESS ON CHILDREN AND FAMILIES;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;OSTEOPOROSIS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;SCHIZOPHRENIA RESEARCH AND TREATMENT;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIOLOGICAL, EPIDEMIOLOGICAL, AND CLINICAL ASPECTS OF ECHINOCOCCOSIS","4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","DEPRESSION (ECONOMICS);IMATINIB;IMATINIB MESYLATE;LOWER URINARY TRACT SYMPTOMS;STROKE (ENGINE);SUICIDE RISK;BREAST CANCER;BREAST CARCINOMA;COLONOSCOPY;CONCORDANCE;DASATINIB;DEPRESSION;FIBROBLAST GROWTH FACTOR;HBV INFECTION;HEPATITIS B;KERATINOCYTE GROWTH FACTOR;LATERAL VENTRICLES;LIVER DISEASE;METASTATIC TUMORS;NERVE REGENERATION","4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HEART FAILURE;BREAST CANCER;URINARY TRACT;GROWTH FACTOR;PRELIMINARY RESULTS;ACUTE HEART;ATRIAL FIBRILLATION;CARDIOVASCULAR RISK;CHRONIC MYELOID;CML PATIENTS;COLORECTAL CANCER;COMPLETED SUICIDE;GENE EXPRESSION;ISCHEMIC STROKE;ITALIAN REGION;KERATINOCYTE GROWTH;LEUKEMIA CML;LOWER URINARY;LYMPH NODE;MYELOID LEUKEMIA;PRIAMO STUDY;PROSTATE CANCER;SUICIDE RISK;SYNCHRONOUS URINARY;TRACT METASTASES;TRACT SYMPTOMS;ABBOTT REALTIME;ABSORBED DOSE;ABUSED ACUTE;ACETYLCHOLINE RECEPTOR","6;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MTHFR- MICE;LEFT VENTRICULAR;BIPOLAR DEPRESSION;HCV GENOTYPE;MICE FED;PULMONARY ARTERY;CARDIOVASCULAR RISK;DIFFUSION CAPACITY;DIOXIDE PRODUCTION;GENICULATE GANGLION;HEART FAILURE;MEMBRANE DIFFUSION;PLASMA SPB;RISK FACTORS;SUICIDAL IDEATION;SYMPATHETIC ACTIVITY;ABBOTT REALTIME;ALOXAP GENES;ARTERY RECONSTRUCTION;BRONCHIAL STUMP;CARBON MONOXIDE;CARDIOPULMONARY BYPASS;CHECKPOINT PROTEINS;EXPRESSION PROFILING;GENE EXPRESSION;GENOTYPE II;II ASSAY;INT--RISK MDS;LUNG DIFFUSION;LVEF DYSFUNCTION","7;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3",16,0.16,4.94,2,1.75,1,0,1,2,1,1,3.75,0,1,6.5,0,1,1,1,5.75,1,0,0,113.25,114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4,331.5,2.14,0,0,47.5,0,0,0,0,2,0,1,1,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","4;3;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;PATIENT SAFETY;BRAIN DISORDERS;CANCER;COLO-RECTAL CANCER;KIDNEY DISEASE;NEUROSCIENCES;STROKE","4;3;2;2;1;1;1;1;1;1","CANCER;RENAL AND UROGENITAL;STROKE","1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;1","COLON AND RECTAL CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2010,136,9.27941176470588,3.40441176470588,0.595588235294118,0.411764705882353,0.904411764705882,1.71375464684015,1.55769230769231,1.80645161290323,1.98387096774194,0.301470588235294,4,62,41,8,17,0.46,0.3,0.06,0.12,34.97,0.773846622302207,NA,0.279411764705882,0.75,0.466,0.418,0.466,0.385,"ROBERTO TATARELLI;MAURIZIO POMPILI;PAOLO GIRARDI;SALVATORE DI SOMMA;MASSIMO VOLPE;MARCO INNAMORATI;DAVID LESTER;GIACINTO LA VERDE;EDITH LAHNER;BRUNO MONARCA;GIULIANO TOCCI;ENRICO FERRI;FORTUNATO MORABITO;L. MAGRINI;BRUNO ANNIBALE;FRANCESCA SALTARELLI;PATRIZIA CARDELLI;ALESSANDRO MOSCETTI;AGOSTINO CORTELEZZI;ANDREA FERRUCCI","15;14;13;9;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5","MAURIZIO POMPILI;ROBERTO TATARELLI;PAOLO GIRARDI;SALVATORE DI SOMMA;STIGLIANO;ENRICO FERRI;L. MAGRINI;MASSIMO VOLPE;MARCO INNAMORATI;GIACINTO LA VERDE;DAVID LESTER;EDITH LAHNER;BRUNO ANNIBALE;FRANCESCA SALTARELLI;ALESSANDRO MOSCETTI;BRUNO MONARCA;MARIA ROSARIA TORRISI;EMILIO DI GIULIO;EDOARDO MONACO;ANDREA FERRETTI","4.9;2.16;1.92;1.54;1;0.9;0.84;0.81;0.78;0.72;0.71;0.66;0.66;0.64;0.64;0.62;0.61;0.61;0.6;0.6","ROBERTO TATARELLI;MAURIZIO POMPILI;PAOLO GIRARDI;SALVATORE DI SOMMA;MASSIMO VOLPE;MARCO INNAMORATI;GIACINTO LA VERDE;EDITH LAHNER;BRUNO MONARCA;GIULIANO TOCCI;ENRICO FERRI;L. MAGRINI;BRUNO ANNIBALE;FRANCESCA SALTARELLI;PATRIZIA CARDELLI;ALESSANDRO MOSCETTI;ANDREA FERRUCCI;NICCOLÒ PETRUCCIANI;PAOLO MERCANTINI;EMILIO DI GIULIO","15;14;13;9;7;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5","MAURIZIO POMPILI;ROBERTO TATARELLI;PAOLO GIRARDI;SALVATORE DI SOMMA;ENRICO FERRI;L. MAGRINI;MASSIMO VOLPE;MARCO INNAMORATI;GIACINTO LA VERDE;EDITH LAHNER;BRUNO ANNIBALE;FRANCESCA SALTARELLI;ALESSANDRO MOSCETTI;BRUNO MONARCA;MARIA ROSARIA TORRISI;EMILIO DI GIULIO;EDOARDO MONACO;ANDREA FERRETTI;B MOSSA;NICCOLÒ PETRUCCIANI","4.9;2.16;1.92;1.54;0.9;0.84;0.81;0.78;0.72;0.66;0.66;0.64;0.64;0.62;0.61;0.61;0.6;0.6;0.58;0.58","PAOLO GIRARDI;ROBERTO TATARELLI;MAURIZIO POMPILI;DAVID LESTER;MARCO INNAMORATI;EMILIO DI GIULIO;GIUSEPPE MINNITI;CESARE HASSAN;RICCARDO MAURIZI ENRICI;GEORGIOS D. KOTZALIDIS;GAETANO LANZETTA;MAURIZIO SALVATI;ALFREDO PAPA;ANDREA DE GIGLIO;ANTONIO GASBARRINI;ANTONIO TURSI;FRANCESCO LUZZA;GIACOMO FORTI;GIAN MARCO GIORGETTI;GIOVANNI BRANDIMARTE","1124;883;692;636;614;601;593;552;516;500;465;465;460;460;460;460;460;460;460;460","PAOLO GIRARDI;ROBERTO TATARELLI;MAURIZIO POMPILI;EMILIO DI GIULIO;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;GEORGIOS D. KOTZALIDIS;MARCO INNAMORATI;GIANLUCA SERAFINI;GIOVANNI DOMINICI;GIULIA SERRA;STEFANO FERRACUTI;STEFANIA SCARPINO;ALESSANDRO BOZZAO;R. MUNI;ANDREA VECCHIONE;ALBERTO SIGNORE;LUCIO CRINÓ;RACHELE AMODEO;ANGELA KOVERECH","1123;883;661;601;593;516;500;480;429;429;429;429;376;272;272;225;210;172;167;161","PAOLO GIRARDI;ROBERTO TATARELLI;MAURIZIO POMPILI;SALVATORE DI SOMMA;MASSIMO VOLPE;GIACINTO LA VERDE;ANDREA FERRUCCI;ENRICO FERRI;GIULIANO TOCCI;PATRIZIA CARDELLI;EMILIO DI GIULIO;L. MAGRINI;BRUNO ANNIBALE;BRUNO MONARCA;EDITH LAHNER;GIUSEPPE MINNITI;PAOLO MERCANTINI;RICCARDO MAURIZI ENRICI;NICCOLÒ PETRUCCIANI;GIANFRANCO DELLE FAVE","14;13;12;9;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;3","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;SOCIOLOGY;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;ENGINEERING;BUSINESS;MATERIALS SCIENCE;PHILOSOPHY","128;33;25;15;12;10;8;8;7;5;4;3;2;2","INTERNAL MEDICINE;PSYCHIATRY;SURGERY;PATHOLOGY;GENETICS;CARDIOLOGY;IMMUNOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;ONCOLOGY;BIOCHEMISTRY;MEDICAL EMERGENCY;DEMOGRAPHY;ENDOCRINOLOGY;NEUROSCIENCE;PEDIATRICS;CELL BIOLOGY;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE;OPTICS","87;37;33;28;18;17;17;17;15;15;15;10;10;9;9;9;9;8;8;8;8","CANCER;POISON CONTROL;POPULATION;DISEASE;EMERGENCY DEPARTMENT;GENE;ALTERNATIVE MEDICINE;ANTIBODY;HEART FAILURE;RADIATION THERAPY;BLOOD PRESSURE;INCIDENCE (GEOMETRY);ADVERSE EFFECT;ANXIETY;CLINICAL TRIAL;EPILEPSY;OCCUPATIONAL SAFETY AND HEALTH;BACTERIA;CHEMOTHERAPY;COGNITION;CONCOMITANT;DEPRESSION (ECONOMICS);MULTIPLE MYELOMA;RETROSPECTIVE COHORT STUDY","20;13;12;11;10;10;9;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5","INJURY PREVENTION;SUICIDE PREVENTION;BIPOLAR DISORDER;COLORECTAL CANCER;IMMUNOGLOBULIN LIGHT CHAIN;PLACEBO;HUMAN FACTORS AND ERGONOMICS;LENALIDOMIDE;CHROMOSOME;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;FIXATION (POPULATION GENETICS);GASTRITIS;GENOTYPE;MONOCLONAL ANTIBODY;MOOD DISORDERS;STAPHYLOCOCCUS AUREUS;SYSTEMIC DISEASE;SYSTEMIC INFLAMMATION;TEMOZOLOMIDE;THALIDOMIDE;UNIVARIATE ANALYSIS","10;10;7;6;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","AL AMYLOIDOSIS;SUICIDE ATTEMPT;KARYOTYPE;AA AMYLOIDOSIS;ACE INHIBITOR;ATROPHIC GASTRITIS;CD38;CYTOGENETICS;INJURY SEVERITY SCORE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KERATINOCYTE GROWTH FACTOR;MANIA;RADIOIMMUNOTHERAPY;VANCOMYCIN;ACINETOBACTER BAUMANNII;ANDROSTENEDIONE;BIPOLAR II DISORDER;BONE MARROW TRANSPLANT;BRAIN-DERIVED NEUROTROPHIC FACTOR;BREAST RECONSTRUCTION;CANDESARTAN;CAPECITABINE;CARDIAC RESYNCHRONIZATION THERAPY;CAROTID STENTING;CATECHOL-O-METHYL TRANSFERASE;CATENIN;CELL CORTEX;CELL CYCLE CHECKPOINT;CLINICAL GLOBAL IMPRESSION;COLECTOMY;COLONOSCOPY;COMPLEMENTARITY DETERMINING REGION;CONCENTRIC HYPERTROPHY;CYCLIN;CYCLIN-DEPENDENT KINASE 1;DIFFERENCE GEL ELECTROPHORESIS;DYSCRASIA;EXTERNAL BEAM RADIOTHERAPY;FLUORESCENCE IN SITU HYBRIDIZATION;GENOTYPE-PHENOTYPE DISTINCTION;GREY MATTER;HAPLOINSUFFICIENCY;HEROIN DEPENDENCE;HIATAL HERNIA;IGHV@;IL-2 RECEPTOR;IRINOTECAN;LITHIUM CARBONATE;LOW-AFFINITY NERVE GROWTH FACTOR RECEPTOR;LUNG VOLUME REDUCTION SURGERY;MASTECTOMY;MEROPENEM;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;METHYLTRANSFERASE;MONOCLONAL;MULTILOCUS SEQUENCE TYPING;NEOPLASTIC TRANSFORMATION;OVARIAN CARCINOMA;OXALIPLATIN;PHOTIC STIMULATION;POSTERIOR CEREBRAL ARTERY;POUCHITIS;PROBAND;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;PTEN;SEXUAL ABUSE;SINGLE-NUCLEOTIDE POLYMORPHISM;STEREOTACTIC RADIOTHERAPY;SUICIDAL IDEATION;SUICIDE AND THE INTERNET;SUICIDE RATES;SUICIDOLOGY;SUPERFICIAL TEMPORAL ARTERY;VINCRISTINE","4;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;;AGED;ITALY;TREATMENT OUTCOME;BIPOLAR DISORDER;AGED, 80 AND OVER;SUICIDE;BRAIN NEOPLASMS;GLIOBLASTOMA;RISK FACTORS;TOMOGRAPHY, X-RAY COMPUTED;ADOLESCENT;YOUNG ADULT;SUICIDE, ATTEMPTED;COLONIC NEOPLASMS","86;63;63;50;47;45;39;23;23;17;16;16;13;13;13;13;12;12;11;10","SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPILEPSY AND SEIZURES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;GLIOMAS;MOLECULAR MECHANISMS OF AMYLOIDOSIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;ACUTE MYELOID LEUKEMIA;ATRIAL FIBRILLATION;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;DUAL-ENERGY COMPUTED TOMOGRAPHY;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GLOBAL TRENDS IN OBESITY AND OVERWEIGHT RESEARCH;GYNECOLOGIC ONCOLOGY;HEALTHCARE POLICY REFORMS AND INEQUALITIES IN FRANCE;INTEROCEPTION AND SOMATIC SYMPTOMS","8;6;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2","TREATMENT;SUICIDE;CONCOMITANT;DEPRESSION (ECONOMICS);AL AMYLOIDOSIS;CARDIOVASCULAR EVALUATION;KNEE BIOMECHANICS;RADIOTHERAPY;CARDIAC AMYLOIDOSIS;CHROMOSOME ABNORMALITY;CLINICAL ENDPOINT;HYPERTENSION;LIGHT CHAIN AMYLOIDOSIS;STROKE (ENGINE);SUICIDAL BEHAVIOR;TEMOZOLOMIDE;UNIVARIATE ANALYSIS;AA AMYLOIDOSIS;ADULT CONGENITAL HEART DISEASE;ALCOHOL ABUSE","7;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2","EMERGENCY DEPARTMENT;HEART FAILURE;AL AMYLOIDOSIS;BIPOLAR DISORDER;CHRONIC LYMPHOCYTIC;LYMPHOCYTIC LEUKEMIA;ABDOMINAL TRAUMA;ACUTE HEART;ADJUVANT TEMOZOLOMIDE;ALCOHOL ABUSE;ANGIOTENSIN II;ANTERIOR CRUCIATE;ATROPHIC BODY;BLOOD PRESSURE;BODY GASTRITIS;BONE MARROW;CENTRAL ITALY;CLINICAL TRIALS;COLON CANCER;COMMUNITY SAMPLE;CRUCIATE LIGAMENT;DEPRESSIVE SYMPTOMS;FRACTIONATED STEREOTACTIC;GLIOBLASTOMA TREATED;HUMAN KERATINOCYTES;II RECEPTOR;LONG-TERM FOLLOW-UP;LUNG CANCER;META-ANALYSIS PP;MITRAL VALVE","6;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACE INHIBITORS;AVERAGE AGE;CLINICAL TRIALS;MM SD;SD MM;BREAST CANCER;CARDIOVASCULAR RISK;ITT NA;NOD INCIDENCE;RISK FACTORS;ADMISSION RATES;EMERGENCY DEPARTMENT;HYPERTENSIVE PATIENTS;SIGNIFICANT DIFFERENCES;SIGNIFICANTLY REDUCED;ANNUAL VISITS;BLOOD PRESSURE;CELL LINES;CVA PATIENTS;DEPARTMENT ED;HOPE ENDPOINT;LUNG TRANSPLANTATION;MEDIAN PGML;MET ALLELE;ML NA;MULTINODULAR HCCS;NON-CARDIAC SURGERY;PGML MEDIAN;REDUCED NOD;AFFECTIVE MORBIDITY","8;7;7;7;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3",25,0.18,4.5,2,1,4.75,1,11,2,1,1,3,0,0,2.75,1,4,1,2.5,4,1,0,0,113,113,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,5.71,675.86,2.75,3,0.43,17.29,0,0,0,0,2,0,1,4,0,3,4,0,0,0,0,0,0,7,0,0,7,0,0,0,0,0,0,0,0,0,"Italy;United States;Switzerland","2;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","7;4;2;1;1;1","CLINICAL RESEARCH;PATIENT SAFETY;BIOENGINEERING;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;HEMATOLOGY;NEUROSCIENCES;PREVENTION;RARE DISEASES;AGING;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;CHRONIC PAIN;COLO-RECTAL CANCER;DIGESTIVE DISEASES;EMERGENCY CARE;HEART DISEASE","7;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;NEUROLOGICAL","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;6.4 SURGERY;8.1 ORGANISATION AND DELIVERY OF SERVICES","2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;COLON AND RECTAL CANCER","2;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2011,95,9.86315789473684,3.82105263157895,0.610526315789474,0.536842105263158,0.91578947368421,1.5125,1.13725490196078,1.41666666666667,1.31818181818182,0.368421052631579,1,45,25,15,6,0.47,0.26,0.16,0.06,37.24,0.875578454674432,NA,0.305263157894737,0.757894736842105,0.378,0.377,0.418,0.408,"ROBERTO TATARELLI;MAURIZIO POMPILI;PAOLO GIRARDI;GEORGIOS D. KOTZALIDIS;GIANLUCA SERAFINI;MARIA ROSARIA TORRISI;MARCO INNAMORATI;DAVID LESTER;GIUSEPPE NIGRI;PAOLO GIRARDI;RAFFAELE PORRINI;MAURIZIO SIMMACO;MASSIMO MOSCARINI;ENRICO MONTEFUSCO;DONATELLA CASERTA;XÉNIA GONDA;GABRIELE SANI;ENRICO DURANTI;MARIA PIA VILLA;ANTONELLA FERRARI","10;10;8;7;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4","MAURIZIO POMPILI;GIANLUCA SERAFINI;MARIA ROSARIA TORRISI;ROBERTO TATARELLI;MICHELE RAJA;PAOLO GIRARDI;FRANCESCA BELLEUDI;MARIA PIA VILLA;GEORGIOS D. KOTZALIDIS;MARCO INNAMORATI;GIUSEPPE NIGRI;DAVID LESTER;MAURIZIO SIMMACO;MASSIMO MOSCARINI;DONATELLA CASERTA;VALERIA PURPURA;PAOLO GIRARDI;ANTONELLA FERRARI;XÉNIA GONDA;ZOLTÄN RIHMER","1.97;1.57;1.12;1.06;1;0.95;0.75;0.74;0.73;0.72;0.69;0.69;0.65;0.63;0.51;0.5;0.48;0.45;0.44;0.44","ROBERTO TATARELLI;MAURIZIO POMPILI;PAOLO GIRARDI;GEORGIOS D. KOTZALIDIS;GIANLUCA SERAFINI;MARIA ROSARIA TORRISI;MARCO INNAMORATI;GIUSEPPE NIGRI;PAOLO GIRARDI;RAFFAELE PORRINI;MAURIZIO SIMMACO;MASSIMO MOSCARINI;ENRICO MONTEFUSCO;DONATELLA CASERTA;GABRIELE SANI;ENRICO DURANTI;MARIA PIA VILLA;ANTONELLA FERRARI;ESMERALDA CONTE;GIUSY ANTOLINO","10;10;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;3;3","MAURIZIO POMPILI;GIANLUCA SERAFINI;MARIA ROSARIA TORRISI;ROBERTO TATARELLI;MICHELE RAJA;PAOLO GIRARDI;MARIA PIA VILLA;GEORGIOS D. KOTZALIDIS;MARCO INNAMORATI;GIUSEPPE NIGRI;MAURIZIO SIMMACO;MASSIMO MOSCARINI;DONATELLA CASERTA;PAOLO GIRARDI;ANTONELLA FERRARI;LUANA LIONETTO;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;MARIO BARRETO;FRANCESCO LA PENNA","1.97;1.57;1.12;1.06;1;0.95;0.74;0.73;0.72;0.69;0.65;0.63;0.51;0.48;0.45;0.42;0.42;0.42;0.41;0.41","PAOLO GIRARDI;AMY MORGAN;BORKO JOVANOVIC;ERIC RUDERMAN;FRANCESCA MILANETTI;IKUO HIRANO;JAMES CARR;JAMES SCHROEDER;KARIN E. DILL;KARIN MARSHALL;KRISTIN BOYCE;MIHAI GHEORGHIADE;RICHARD K. BURT;ROBERT M. CRAIG;SANDEEP JAIN;SANJIV J. SHAH;THOMAS GRANT;WALTER G. BARR;CARLO POZZILLI;GIANCARLO COMI","580;512;512;512;512;512;512;512;512;512;512;512;512;512;512;512;512;512;431;431","FRANCESCA MILANETTI;PAOLO GIRARDI;LUCA AUSILI CEFARO;ANDREA FERRETTI;MAURIZIO POMPILI;EMANUELA PILOZZI;A. SPERANZA;BARBARA MAESTRI;CARMELO DʼARRIGO;EDOARDO MONACO;LUCA LABIANCA;MATTHEW KELLY;ROBERTO TATARELLI;GEORGIOS D. KOTZALIDIS;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;CLAUDIA SCARINGI;GABRIELE SANI;ENRICO DURANTI;ISABELLA PACCHIAROTTI","512;458;412;379;296;272;263;263;263;263;263;263;261;247;214;214;205;205;199;190","PAOLO GIRARDI;MAURIZIO POMPILI;GIUSEPPE NIGRI;ROBERTO TATARELLI;GEORGIOS D. KOTZALIDIS;MASSIMO MOSCARINI;RAFFAELE PORRINI;GIANLUCA SERAFINI;DONATELLA CASERTA;MARIA PIA VILLA;MARIA ROSARIA TORRISI;MARCO INNAMORATI;MAURIZIO SIMMACO;ANTONELLA FERRARI;GABRIELE SANI;ANNA COSTANTINI;ENRICO DURANTI;FRANCESCA CIARDO;FRANCESCO D’ANGELO;FRANCESCO LA PENNA","11;8;6;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;ECONOMICS;COMPUTER SCIENCE;CHEMISTRY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;BUSINESS;GEOGRAPHY;ENGINEERING;MATHEMATICS","89;20;16;12;7;6;5;3;3;3;2;2;1;1","INTERNAL MEDICINE;PSYCHIATRY;SURGERY;PATHOLOGY;GASTROENTEROLOGY;GENETICS;CLINICAL PSYCHOLOGY;ONCOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;RADIOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;MACROECONOMICS;CARDIOLOGY;MEDICAL EMERGENCY;PEDIATRICS;SOCIAL PSYCHOLOGY;CANCER RESEARCH;CELL BIOLOGY;DERMATOLOGY;GYNECOLOGY;INTENSIVE CARE MEDICINE;OPTICS;PHARMACOLOGY;PHYSICAL THERAPY","60;26;22;16;14;13;12;10;9;9;9;8;7;7;6;5;5;5;4;4;4;4;4;4;4;4","CANCER;POISON CONTROL;DEPRESSION (ECONOMICS);ANXIETY;DISEASE;GENE;POPULATION;ADVERSE EFFECT;CHEMOTHERAPY;CLINICAL TRIAL;MOOD;PREGNANCY;TRANSPLANTATION;CYTOLOGY;HORMONE;INCIDENCE (GEOMETRY);PERSONALITY;PSYCHOMETRICS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TOXICITY","18;9;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","BIPOLAR DISORDER;INJURY PREVENTION;SUICIDE PREVENTION;CYCLOPHOSPHAMIDE;PROSTATE CANCER;TEMPERAMENT;ADENOCARCINOMA;HUMAN FACTORS AND ERGONOMICS;MOOD DISORDERS;PROSTATE;TYROSINE KINASE;UNIVARIATE ANALYSIS;ALLELE;AUTOLOGOUS STEM-CELL TRANSPLANTATION;BREAST CANCER;CERVIX;CHROMOSOME;CLINICAL ENDPOINT;COLORECTAL CANCER;ENDOCRINE SYSTEM;ENDOCYTOSIS;EPIDERMAL GROWTH FACTOR RECEPTOR;FIBROBLAST GROWTH FACTOR;GESTATION;GROWTH FACTOR;IMATINIB;LENALIDOMIDE;NATRIURETIC PEPTIDE;NEURORADIOLOGY;NEUTROPENIA;POLYSOMNOGRAPHY;RECEPTOR TYROSINE KINASE","7;7;6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SUICIDAL IDEATION;KERATINOCYTE GROWTH FACTOR;SUICIDE ATTEMPT;BECK HOPELESSNESS SCALE;DASATINIB;ENDOCYTIC CYCLE;GEFITINIB;MANIA;PROSTATE BIOPSY;RECTAL EXAMINATION;ACROMEGALY;ADAMANTINOMA;AMINO TERMINAL;AMNIOTIC FLUID;AMYLOID PRECURSOR PROTEIN;ASENAPINE;ATROPHIC GASTRITIS;BIPOLAR II DISORDER;CADASIL;CELL CYCLE CHECKPOINT;CERVICAL CANAL;CERVICAL INTRAEPITHELIAL NEOPLASIA;CERVICAL PREGNANCY;CETUXIMAB;CHILD ABUSE;CHRONIC GASTRITIS;CONTROLLED OVARIAN HYPERSTIMULATION;CONVERGENT VALIDITY;CORTACTIN;DOPAMINE AGONIST;DOPAMINE RECEPTOR D3;DOPAMINE TRANSPORTER;ENDOCRINE DISRUPTOR;ENDOTHELIAL PROGENITOR CELL;ERLOTINIB;ESOPHAGEAL SPHINCTER;ESOPHAGECTOMY;EXHALED NITRIC OXIDE;FEBRILE NEUTROPENIA;FIBROBLAST GROWTH FACTOR RECEPTOR;FLUDARABINE;FLUORESCENCE IN SITU HYBRIDIZATION;FOLLICLE-STIMULATING HORMONE;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HORMONAL THERAPY;HORMONE THERAPY;HPV INFECTION;IMATINIB MESYLATE;IN UTERO;LEVODOPA;LNCAP;LOSS OF HETEROZYGOSITY;MEDULLARY THYROID CANCER;MITOTIC CATASTROPHE;MONOCLONAL;MYOTOMY;OVARIAN HYPERSTIMULATION SYNDROME;OXCARBAZEPINE;PERFLUOROOCTANE;PLASMA CELL DYSCRASIA;POMALIDOMIDE;PRAMIPEXOLE;PRENATAL DIAGNOSIS;PRESYNCOPE;REM SLEEP BEHAVIOR DISORDER;RIBAVIRIN;SELECTED REACTION MONITORING;SENTINEL LYMPH NODE;SENTINEL NODE;SEXUAL ABUSE;SIGNET RING CELL CARCINOMA;SINGLE-NUCLEOTIDE POLYMORPHISM;SUICIDE RATES;SUICIDE RISK;UTERINE ARTERY;VALIDATION TEST;VENLAFAXINE","4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;;SUICIDE;ADOLESCENT;BIPOLAR DISORDER;PROSTATIC NEOPLASMS;TREATMENT OUTCOME;RISK ASSESSMENT;RETROSPECTIVE STUDIES;YOUNG ADULT;KERATINOCYTES;PSYCHOTIC DISORDERS;AGED, 80 AND OVER;ANTINEOPLASTIC AGENTS","73;55;52;39;36;34;23;21;17;15;15;15;15;14;13;13;11;11;10;10","EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;FIBROBLAST GROWTH FACTOR SIGNALING PATHWAY;ADVANCEMENTS IN LUNG CANCER RESEARCH;ASTHMA;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EFFICACY AND RESISTANCE IN CML TREATMENT;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;IMPACT OF HEALTH LITERACY ON HEALTH OUTCOMES;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PROSTATE CANCER RESEARCH AND TREATMENT;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ANORECTAL SURGICAL PROCEDURES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BODY DYSMORPHIC DISORDER: PSYCHOSOCIAL, CLINICAL, AND TREATMENT ASPECTS;CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY;CHOLANGIOCARCINOMA","5;5;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","DEPRESSION (ECONOMICS);TREATMENT;PSYCHOLOGICAL AUTOPSY;SUICIDE;CONCOMITANT;KERATINOCYTE GROWTH FACTOR;REFRACTORY (PLANETARY SCIENCE);SUICIDAL BEHAVIOR;UNIVARIATE ANALYSIS;ASSOCIATION (PSYCHOLOGY);AUTOLOGOUS STEM-CELL TRANSPLANTATION;B-TYPE NATRIURETIC PEPTIDE;BECK HOPELESSNESS SCALE;BIPOLAR I DISORDER;CANCER COMMUNICATION;CELL SIGNALING;CLINICAL ENDPOINT;COUGH REFLEX SENSITIVITY;DEPRESSION;EGFR MUTATIONS","5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","PROSTATE CANCER;BIPOLAR DISORDER;CANCER PATIENTS;ELDERLY PATIENTS;MULTIPLE SCLEROSIS;PATIENTS UNDERGOING;PERIPHERAL BLOOD;AFFECTIVE TEMPERAMENTS;AUTOLOGOUS PERIPHERAL;BLOOD STEM;CANCER INFORMATION;CARDIOVASCULAR RISK;CELL CARCINOMA;CELL TRANSPLANTATION;CENTRE EXPERIENCE;CHRONIC MYELOID;DIRECT SEQUENCING;EUROPEAN ORGANIZATION;GLOBAL CARDIOVASCULAR;INFORMATION SERVICE;LYMPH NODE;MYELOID LEUKAEMIA;NATIONAL CANCER;NATRIURETIC PEPTIDE;PILOT STUDY;PROVIDING INFORMATION;PSYCHIATRIC INPATIENTS;PSYCHOMETRIC PROPERTIES;RETROSPECTIVE ANALYSIS;RISK FACTORS","5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GE PH;ATROPHIC GASTRITIS;CHRONIC ATROPHIC;GROWTH FACTOR;CV RISK;BD TYPE;CERVICAL ECTOPIC;ECTOPIC PREGNANCY;HCV RNA;HYPOECHOIC-INHOMOGENEOUS THYROID;LEADING EDGE;MM SD;NONDIABETIC PATIENTS;PROSTATE CANCER;SD MM;THYROID VOLUME;ALVEOLAR PROTEINOSIS;AO SANTANDREA;BLASTOID MCL;CELL GROWTH;CELL MIGRATION;CHK INHIBITORS;CLINICAL TRIALS;DIABETIC PATIENTS;DNA DAMAGE;FACTOR RECEPTOR;FRACTAL ANALYSIS;GASTRITIS PATIENTS;GLOBAL CV;KERATINOCYTE GROWTH","9;7;7;7;6;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3",19,0.2,6.5,5,1.5,1,0,4,5,1,2.75,5.5,0,0,2,1,2.75,1,1.75,2,4,0,0,101,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,7.38,432,3.93,2,0.22,54.78,0,0,1,1,3,0,0,4,0,8,1,0,0,0,0,0,0,8,0,1,9,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS","8;2;2;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;BRAIN DISORDERS;CANCER;NEURODEGENERATIVE;ASSISTIVE TECHNOLOGY;AUTOIMMUNE DISEASE;BIOENGINEERING;CARDIOVASCULAR;HEMATOLOGY;HIV/AIDS;INFECTIOUS DISEASES;LUNG;LUNG CANCER;MENTAL HEALTH;MULTIPLE SCLEROSIS;NEUROSCIENCES;ORPHAN DRUG;PREVENTION","6;5;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD;CANCER;CARDIOVASCULAR;INFECTION;MENTAL HEALTH;NEUROLOGICAL","1;1;1;1;1;1","6.1 PHARMACEUTICALS;6.7 PHYSICAL","4;1","LEUKEMIA / LEUKAEMIA;LUNG CANCER;PROSTATE CANCER","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3215 REPRODUCTIVE MEDICINE","9;3;2;2;1;1","BIOTECHNOLOGY;CANCER;GENETICS;LUNG;LUNG CANCER;RARE DISEASES","1;1;1;1;1;1","CANCER","1",NA,NA,"BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","3","LUNG CANCER;NOT SITE-SPECIFIC CANCER","1;1",NA,NA
"AOU_SANTANDREA",2012,161,9.73913043478261,3.32919254658385,0.559006211180124,0.37888198757764,0.677018633540373,1.87412587412587,1.25,1.69444444444444,1.34567901234568,0.322981366459627,3,63,29,28,25,0.39,0.18,0.17,0.16,27.8,0.66545700639755,5.00860215053763,0.304347826086957,0.77639751552795,0.444,0.414,0.442,0.388,"MAURIZIO POMPILI;PAOLO GIRARDI;PAOLO GIRARDI;COSIMO DE NUNZIO;MARCO INNAMORATI;GIANFRANCO DELLE FAVE;LUIGI RUCO;ANDREA TUBARO;GIACINTO LA VERDE;DONATELLA CASERTA;MASSIMO MARIGNANI;ALESSANDRO MOSCETTI;MASSIMO VOLPE;GIANLUCA SERAFINI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;RICCARDO MAURIZI ENRICI;ROBERTO MARCI;VIRGINIA NASO;MARIA CHRISTINA COX","13;12;10;10;9;9;8;8;8;7;7;7;7;7;7;7;7;6;6;6","MAURIZIO POMPILI;MASSIMILIANO ROCCHIETTI MARCH;PAOLO GIRARDI;DONATELLA CASERTA;COSIMO DE NUNZIO;MARCO INNAMORATI;PAOLO GIRARDI;ANDREA TUBARO;GIANFRANCO DELLE FAVE;GIANLUCA SERAFINI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;RICCARDO MAURIZI ENRICI;SIMONE ALBISINNI;MARIA PIA VILLA;ROBERTO MARCI;MASSIMO MOSCARINI;LUIGI RUCO;GIACINTO LA VERDE;MONICA VICHI","2.14;2;1.74;1.73;1.64;1.28;1.24;1.22;1.09;0.94;0.88;0.88;0.88;0.87;0.75;0.73;0.73;0.73;0.72;0.7","MAURIZIO POMPILI;PAOLO GIRARDI;PAOLO GIRARDI;COSIMO DE NUNZIO;MARCO INNAMORATI;GIANFRANCO DELLE FAVE;LUIGI RUCO;ANDREA TUBARO;GIACINTO LA VERDE;DONATELLA CASERTA;MASSIMO MARIGNANI;ALESSANDRO MOSCETTI;MASSIMO VOLPE;GIANLUCA SERAFINI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;RICCARDO MAURIZI ENRICI;VIRGINIA NASO;MARIA CHRISTINA COX;MARIA PIA VILLA","13;12;10;10;9;9;8;8;8;7;7;7;7;7;7;7;7;6;6;6","MAURIZIO POMPILI;MASSIMILIANO ROCCHIETTI MARCH;PAOLO GIRARDI;DONATELLA CASERTA;COSIMO DE NUNZIO;MARCO INNAMORATI;PAOLO GIRARDI;ANDREA TUBARO;GIANFRANCO DELLE FAVE;GIANLUCA SERAFINI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;RICCARDO MAURIZI ENRICI;SIMONE ALBISINNI;MARIA PIA VILLA;MASSIMO MOSCARINI;LUIGI RUCO;GIACINTO LA VERDE;MASSIMO MARIGNANI;ALESSANDRO MOSCETTI","2.14;2;1.74;1.73;1.64;1.28;1.24;1.22;1.09;0.94;0.88;0.88;0.88;0.87;0.75;0.73;0.73;0.72;0.68;0.66","PAOLO GIRARDI;ANDREA TUBARO;ANDREAS NEISIUS;ARJUN NAMBIAR;DIRK DE RIDDER;FIONA C. BURKHARD;FRANCISCO CRUZ;MALCOLM G LUCAS;R.S. PICKARD;RUUD BOSCH;T.B. MADDEN;WILLIAM H. TURNER;MAURIZIO POMPILI;MARCO INNAMORATI;GIANFRANCO DELLE FAVE;BEATA KOS‐KUDŁA;DIK J. KWEKKEBOOM;E. VAN CUTSEM;GUIDO RINDI;HIRONOBU SASANO","729;604;390;390;390;390;390;390;390;390;390;390;373;364;333;301;301;301;301;301","ANDREA TUBARO;PAOLO GIRARDI;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;COSIMO DE NUNZIO;STEFANO VALABREGA;GIANLUCA SERAFINI;FRANCESCO E. PONTIERI;GIOVANNI ANTONINI;SALVATORE DI SOMMA;MASSIMO VOLPE;MARIA ROSARIA TORRISI;ANTONELLA DE CAROLIS;ALESSANDRO BOZZAO;MARCO INNAMORATI;CLAUDIA SCARINGI;GIUSEPPE MINNITI;DONATELLA CASERTA;SALVATORE RAFFA;MASSIMO MOSCARINI","591;355;312;297;284;254;225;214;194;192;191;184;161;152;146;141;141;134;133;128","PAOLO GIRARDI;MAURIZIO POMPILI;COSIMO DE NUNZIO;ANDREA TUBARO;DONATELLA CASERTA;GIANLUCA SERAFINI;GIANFRANCO DELLE FAVE;MARIA PIA VILLA;MASSIMO MOSCARINI;MASSIMO MARIGNANI;MARCO INNAMORATI;MASSIMO VOLPE;ALESSANDRO MOSCETTI;GEORGIOS D. KOTZALIDIS;GERARDO SALERNO;LUIGI RUCO;MARIA ROSARIA TORRISI;MARIO BARRETO;MATTIA FALCHETTO OSTI;PAOLO MARCHETTI","15;12;10;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;POLITICAL SCIENCE;ECONOMICS;ENGINEERING;SOCIOLOGY;MATHEMATICS;MATERIALS SCIENCE;BUSINESS;GEOGRAPHY;HISTORY;PHILOSOPHY","152;34;21;10;10;6;6;5;4;4;3;2;1;1;1;1","INTERNAL MEDICINE;PSYCHIATRY;SURGERY;GASTROENTEROLOGY;ONCOLOGY;RADIOLOGY;PATHOLOGY;IMMUNOLOGY;GENETICS;ENVIRONMENTAL HEALTH;CLINICAL PSYCHOLOGY;CARDIOLOGY;ENDOCRINOLOGY;PEDIATRICS;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;UROLOGY;NUCLEAR MEDICINE;SOCIAL PSYCHOLOGY","116;33;29;27;26;25;24;20;18;17;16;14;13;12;11;11;11;8;7;7","CANCER;CHEMOTHERAPY;POPULATION;DISEASE;GENE;ANTIBODY;HEART FAILURE;PSYCHOSIS;RADIATION THERAPY;RECEPTOR;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);CONFIDENCE INTERVAL;MAGNETIC RESONANCE IMAGING;ANXIETY;BLOOD PRESSURE;COGNITION;HORMONE;LYMPHOMA;STIMULATION;MULTIPLE MYELOMA;OBESITY;VIRUS","24;19;17;16;11;10;9;9;9;9;9;8;8;7;7;7;7;7;7;6;6;6","COLORECTAL CANCER;PROSTATE CANCER;IN VITRO FERTILISATION;PROSTATE;BIPOLAR DISORDER;HEPATITIS C VIRUS;LENALIDOMIDE;SUICIDE PREVENTION;TEMPERAMENT;ANDROGEN;BEVACIZUMAB;BORTEZOMIB;BREAST CANCER;DIASTOLE;GENE EXPRESSION;GLUTAMATE RECEPTOR;HELICOBACTER;POLYSOMNOGRAPHY;PREGNANCY RATE;RITUXIMAB;SCHIZOAFFECTIVE DISORDER;SEROLOGY;THALIDOMIDE;THYROID NODULES","7;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","KRAS;PROSTATE BIOPSY;AL AMYLOIDOSIS;BECK HOPELESSNESS SCALE;CAPECITABINE;DNA METHYLATION;EXHALED NITRIC OXIDE;FONDAPARINUX;HEART RATE VARIABILITY;MEDULLARY THYROID CANCER;METABOTROPIC GLUTAMATE RECEPTOR;STROKE VOLUME;VOXEL-BASED MORPHOMETRY;ADOLESCENT SUICIDE;AMPA RECEPTOR;ANDROGEN DEFICIENCY;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ANGIOID STREAKS;ANTHRACYCLINE;ATROPHIC GASTRITIS;AUTONOMIC NERVOUS SYSTEM;AXILLA;AXILLARY LYMPH NODES;BIPOLAR II DISORDER;CADASIL;CARDIAC RESYNCHRONIZATION THERAPY;CHEMOIMMUNOTHERAPY;CHRONIC GASTRITIS;COLONOSCOPY;CONTACT ALLERGY;CONTROLLED OVARIAN HYPERSTIMULATION;CORONARY ANATOMY;CYTOKINESIS;DEEP BRAIN STIMULATION;DEEP TRANSCRANIAL MAGNETIC STIMULATION;DIHYDROTESTOSTERONE;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;DUST MITES;ERBB3;ERBB4;FILGRASTIM;FLAVIVIRIDAE;FOLLICLE-STIMULATING HORMONE;FRACTIONAL ANISOTROPY;GENE EXPRESSION PROFILING;GENE MUTATION;GERMINAL CENTER;GLUTAMATERGIC;GREY MATTER;HAPLOINSUFFICIENCY;HEPACIVIRUS;HISTONE H2B;HOUSE DUST MITE;HYPOPNEA;IFOSFAMIDE;IMMUNOGLOBULIN D;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;INTRACYTOPLASMIC SPERM INJECTION;ISOPROSTANE;KERATINOCYTE GROWTH FACTOR;LACHMAN TEST;LACTOBACILLUS PARACASEI;LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2;LOWER RESPIRATORY TRACT INFECTION;MANIA;METABOTROPIC RECEPTOR;METASTATIC BREAST CANCER;METHYLENETETRAHYDROFOLATE REDUCTASE;MULTINODULAR GOITER;MULTINODULAR GOITRE;OVARIAN HYPERSTIMULATION SYNDROME;OVARIAN TUMOR;PAPILLARY THYROID CANCER;PARAMETRIUM;PERIRHINAL CORTEX;PERITONEAL EQUILIBRATION TEST;PIVOT-SHIFT TEST;POLYCYSTIC OVARY;POMALIDOMIDE;PRIMARY SYSTEMIC AMYLOIDOSIS;PROSTATE CARCINOMA;PROSTATE DISEASE;PROSTATE DISEASES;PROSTATE-SPECIFIC ANTIGEN;PURE TONE AUDIOMETRY;RECEPTOR ANTAGONIST;RIBAVIRIN;RNA-BINDING PROTEIN;SANGER SEQUENCING;SELECTED REACTION MONITORING;SENTINEL LYMPH NODE;SENTINEL NODE;SOMATIZATION DISORDER;SUBLINGUAL IMMUNOTHERAPY;SUICIDAL IDEATION;SUICIDE ATTEMPT;SUMATRIPTAN;SYSTOLE;TOLL-LIKE RECEPTOR;TRAIL MAKING TEST;TRANSLATION (BIOLOGY);TREATMENT-RESISTANT DEPRESSION;TRIPLE-NEGATIVE BREAST CANCER;URETHROTOMY;WISCONSIN CARD SORTING TEST","4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;AGED, 80 AND OVER;TREATMENT OUTCOME;YOUNG ADULT;RETROSPECTIVE STUDIES;ADOLESCENT;PROSTATIC NEOPLASMS;ITALY;GONADOTROPIN-RELEASING HORMONE;THYROID NEOPLASMS;THYROID NODULE;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;BRAIN NEOPLASMS;FOLLOW-UP STUDIES","93;73;65;64;58;53;48;21;21;19;17;16;14;13;12;12;12;11;11;11","SCHIZOPHRENIA RESEARCH AND TREATMENT;LYMPHOID NEOPLASMS;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;HEPATITIS C INFECTION AND TREATMENT;INTEROCEPTION AND SOMATIC SYMPTOMS;LONG-TERM EFFECTS OF TESTOSTERONE ON HEALTH;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;PANCREATIC CANCER RESEARCH AND TREATMENT;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;DIAGNOSIS AND TREATMENT OF HEART FAILURE","6;5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2","TREATMENT;METASTATIC PROSTATE CANCER;DEPRESSION (ECONOMICS);PROSTATE CANCER;GASTRIC CANCER;HELICOBACTER;HEPATITIS C;HYPERTENSION;INTERNATIONAL MYELOMA WORKING GROUP;MANTLE CELL LYMPHOMA;MEDULLARY THYROID CANCER;METASTATIC BREAST CANCER;METASTATIC COLORECTAL CANCER;OBSTRUCTIVE SLEEP APNEA;PANCREATIC DISEASE;PATHOGENESIS;PEDIATRIC SLEEP APNEA;PROSTATE BIOPSY;SUICIDE;THYROID NODULES","8;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","COLORECTAL CANCER;MULTIPLE MYELOMA;PROSTATE CANCER;APNEA SYNDROME;BIPOLAR DISORDER;BLOOD PRESSURE;BREAST CANCER;CANCER PATIENTS;MAGNETIC RESONANCE;METASTATIC COLORECTAL;OBSTRUCTIVE SLEEP;RISK STRATIFICATION;SLEEP APNEA;ACTH PRODUCTION;ACUTE ABDOMEN;ACUTELY ILL;ADAPTIVE RADIATION;AL AMYLOIDOSIS;ANTI-HELICOBACTER PYLORI;ATYPICAL THYMIC;B-CELL NON-HODGKINS;BILATERAL OVARIAN;CELL CARCINOMA;CLINICAL PICTURE;COMPLETED SUICIDE;DIVERTICULAR DISEASE;ECTOPIC ACTH;EMERGENCY DEPARTMENT;FOLLICULAR STIMULATION;FONDAIR STUDY","5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SPINAL ANAESTHESIA;HCV INFECTION;MG CONCENTRATIONS;PSYCHOTIC SYMPTOMS;GROWTH FACTOR;PATIENTS UNDERGOING;INTERPERSONAL SENSITIVITY;MGLU RECEPTORS;ABDOMINAL PAIN;CSF MG;DRUG ADDICTS;GM VOLUME;HIGH-FIBRE DIET;IONIZED MG;OROPHARYNGEAL SWABS;RR MPFS;UHR QDS;ADJUVANT CHEMOTHERAPY;APACHE II;BREAST CANCER;LESION LOAD;VIROLOGICAL RESPONSE;WAGRIJ RATS;WM LESION;AD PATIENTS;B-NHL PATIENTS;BRAF WT;CADASIL PATIENTS;CENTRAL MG;CLINICAL RESPONSE","13;11;10;10;8;8;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4",35,0.22,5.22,5,1,1,0,1,4,0,1,6,0,1,4.75,2,1.75,0,2.25,4,1,0,0,80,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,7.94,1729.75,6.08,6,0.38,75.44,0,0,3,0,6,0,1,6,0,11,5,0,0,0,0,0,0,16,0,0,16,0,0,0,0,0,0,0,0,0,"United States;Italy;Netherlands;United Kingdom","5;4;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3209 NEUROSCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","14;9;7;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;PAIN RESEARCH;RARE DISEASES;CHRONIC PAIN;PATIENT SAFETY;PREVENTION;HEMATOLOGY;LYMPHOMA;BIOENGINEERING;BRAIN DISORDERS;COMPARATIVE EFFECTIVENESS RESEARCH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEADACHES;LUNG;LUNG CANCER;NEURODEGENERATIVE;BREAST CANCER","13;8;7;5;5;5;4;4;4;3;3;2;2;2;2;2;2;2;2;1","CANCER;CARDIOVASCULAR;NEUROLOGICAL;INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL","7;2;2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS","9;2;1;1;1;1;1;1;1;1","NON-HODGKIN'S LYMPHOMA;LUNG CANCER;BREAST CANCER;COLON AND RECTAL CANCER;HEAD AND NECK CANCER;HODGKIN'S DISEASE;ORAL CAVITY AND LIP CANCER","3;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4206 PUBLIC HEALTH;3101 BIOCHEMISTRY AND CELL BIOLOGY","11;4;4;3;2;2;1","CLINICAL RESEARCH;CARDIOVASCULAR;HEART DISEASE;CANCER;DIABETES;NUTRITION;PREVENTION;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETICS;HYPERTENSION;NEUROBLASTOMA;NEUROSCIENCES;OBESITY;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;CANCER;METABOLIC AND ENDOCRINE","3;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.7 PHYSICAL","1;1;1","CLINICAL;BIOMEDICAL","4;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","3;1","ADRENOCORTICAL CANCER;NEUROBLASTOMA","1;1",NA,NA
"AOU_SANTANDREA",2013,182,11.6978021978022,3.3021978021978,0.494505494505495,0.406593406593407,0.653846153846154,1.74709302325581,1.30434782608696,1.76190476190476,1.4,0.456043956043956,0,86,39,18,23,0.47,0.21,0.1,0.13,35.77,1.02512472460936,4.79857397504456,0.351648351648352,0.818681318681319,0.442,0.385,0.457,0.421,"PAOLO GIRARDI;GEORGIOS D. KOTZALIDIS;PAOLO GIRARDI;MAURIZIO POMPILI;MARCO INNAMORATI;ANTONIO DEL CASALE;PAOLO MARCHETTI;ROBERTO TATARELLI;MARIA PIA VILLA;CHIARA RAPINESI;ANDREA TUBARO;COSIMO DE NUNZIO;MARIO AMORE;STEFANO FERRACUTI;DAVID LESTER;GLORIA ANGELETTI;GIUSEPPE MINNITI;DANIELE SERATA;RICCARDO MAURIZI ENRICI;FABIO SANTANELLI DI POMPEO","16;13;12;12;10;9;9;8;8;7;7;7;6;6;6;6;6;6;6;5","MAURIZIO POMPILI;PAOLO GIRARDI;PAOLO GIRARDI;MARCO INNAMORATI;GEORGIOS D. KOTZALIDIS;MARIA PIA VILLA;RICCARDO MAURIZI ENRICI;FABIO SANTANELLI DI POMPEO;BENEDETTO LONGO;GIUSEPPE MINNITI;EVARISTO BELLI;ANTONIO DEL CASALE;DAVID LESTER;GIANLUCA SERAFINI;ANDREA TUBARO;COSIMO DE NUNZIO;PAOLO MARCHETTI;STEFANO FERRACUTI;CLAUDIA SCARINGI;ROBERTO TATARELLI","1.94;1.74;1.71;1.41;1.22;1.05;0.98;0.96;0.96;0.9;0.88;0.86;0.79;0.76;0.75;0.75;0.72;0.71;0.69;0.68","PAOLO GIRARDI;GEORGIOS D. KOTZALIDIS;PAOLO GIRARDI;MAURIZIO POMPILI;MARCO INNAMORATI;ANTONIO DEL CASALE;PAOLO MARCHETTI;ROBERTO TATARELLI;MARIA PIA VILLA;CHIARA RAPINESI;ANDREA TUBARO;COSIMO DE NUNZIO;MARIO AMORE;STEFANO FERRACUTI;DAVID LESTER;GLORIA ANGELETTI;GIUSEPPE MINNITI;DANIELE SERATA;RICCARDO MAURIZI ENRICI;FABIO SANTANELLI DI POMPEO","16;13;12;12;10;9;9;8;8;7;7;7;6;6;6;6;6;6;6;5","MAURIZIO POMPILI;PAOLO GIRARDI;PAOLO GIRARDI;MARCO INNAMORATI;GEORGIOS D. KOTZALIDIS;MARIA PIA VILLA;RICCARDO MAURIZI ENRICI;FABIO SANTANELLI DI POMPEO;BENEDETTO LONGO;GIUSEPPE MINNITI;EVARISTO BELLI;ANTONIO DEL CASALE;DAVID LESTER;GIANLUCA SERAFINI;ANDREA TUBARO;COSIMO DE NUNZIO;PAOLO MARCHETTI;STEFANO FERRACUTI;CLAUDIA SCARINGI;ROBERTO TATARELLI","1.94;1.74;1.71;1.41;1.22;1.05;0.98;0.96;0.96;0.9;0.88;0.86;0.79;0.76;0.75;0.75;0.72;0.71;0.69;0.68","PAOLO GIRARDI;CHRISTIAN MUELLER;W. FRANK PEACOCK;MARCO SALVETTI;ALAIN COHEN‐SOLAL;ALEXANDRE MEBAZAA;DOMINGO A. PASCUAL‐FIGAL;JAMES L. JANUZZI;JINDŘICH ŠPINAR;JIŘÍ PAŘENICA;JOHAN LASSUS;MARCO METRA;NAOKI SATO;ROLAND VAN KIMMENADE;SALVATORE DISOMMA;THOMAS MUELLER;VELI‐PEKKA HARJOLA;ÉTIENNE GAYAT;ROSELLA MECHELLI;VIVIANA ANNIBALI","798;686;686;648;566;566;566;566;566;566;566;566;566;566;566;566;566;566;545;545","PAOLO GIRARDI;SALVATORE DISOMMA;MARCO SALVETTI;ROSELLA MECHELLI;VIVIANA ANNIBALI;ARIANNA FORNASIERO;CLAUDIA POLICANO;DANILA VITTORI;GIOVANNI RISTORI;GIULIA COARELLI;MARIA CHIARA BUSCARINU;RENATO UMETON;SILVIA ROMANO;VITO A. G. RICIGLIANO;ANDREA VECCHIONE;PAOLO MARCHETTI;MAURIZIO POMPILI;CLAUDIA SCARINGI;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI","734;566;545;545;545;512;512;512;512;512;512;512;512;512;372;347;345;304;301;293","PAOLO GIRARDI;GEORGIOS D. KOTZALIDIS;MAURIZIO POMPILI;ANTONIO DEL CASALE;MARIA PIA VILLA;MARCO INNAMORATI;PAOLO MARCHETTI;ANDREA TUBARO;COSIMO DE NUNZIO;GIANLUCA SERAFINI;ROBERTO TATARELLI;RICCARDO MAURIZI ENRICI;CHIARA RAPINESI;GIUSEPPE MINNITI;STEFANO VALABREGA;ALESSANDRO BOZZAO;CARLOTTA BIANCHINI;DANIELE SERATA;GABRIELE CAPURSO;GABRIELE SANI","25;11;11;8;8;7;7;7;7;5;5;5;5;5;5;4;4;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;ECONOMICS;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;SOCIOLOGY;POLITICAL SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;HISTORY","165;50;35;14;10;9;9;7;7;6;4;2;2;1","INTERNAL MEDICINE;SURGERY;PSYCHIATRY;PATHOLOGY;RADIOLOGY;ONCOLOGY;GENETICS;BIOCHEMISTRY;CARDIOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;ENDOCRINOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;CLINICAL PSYCHOLOGY;CELL BIOLOGY;DERMATOLOGY;NEUROSCIENCE;UROLOGY;MACROECONOMICS;PALEONTOLOGY","117;47;37;34;27;26;21;19;17;17;16;16;16;14;13;11;10;10;10;9;9","CANCER;GENE;ANXIETY;COHORT;DISEASE;MOOD;POPULATION;CHEMOTHERAPY;RECEPTOR;DEPRESSION (ECONOMICS);MAGNETIC RESONANCE IMAGING;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);COGNITION;ODDS RATIO;CONFIDENCE INTERVAL;HEART FAILURE;MYOCARDIAL INFARCTION;POISON CONTROL;RANDOMIZED CONTROLLED TRIAL;THYROID","36;19;13;11;11;11;11;10;10;9;9;9;8;8;7;7;7;7;7;7","BIPOLAR DISORDER;BREAST CANCER;PROSTATE CANCER;SUICIDE PREVENTION;BECK DEPRESSION INVENTORY;DOWNREGULATION AND UPREGULATION;METASTASIS;ADENOCARCINOMA;COLORECTAL CANCER;CRAVING;INJURY PREVENTION;MAJOR DEPRESSIVE DISORDER;MICRORNA;MUTATION;PROSTATE;THYROID CARCINOMA;CD8;CYTOTOXIC T CELL;DIFFUSION MRI;ELECTROCONVULSIVE THERAPY;HAZARD RATIO;IMMUNOTHERAPY;LENALIDOMIDE;MOOD DISORDERS;MULTICENTER STUDY;NATRIURETIC PEPTIDE;NEUROPSYCHOLOGY;PARKINSON'S DISEASE;PERCUTANEOUS CORONARY INTERVENTION;POLYSOMNOGRAPHY;PROCALCITONIN;SPIROMETRY;THYROID CANCER;THYROID NODULES;UNIVARIATE ANALYSIS","8;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MANIA;TAXANE;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;BECK HOPELESSNESS SCALE;DORSOLATERAL PREFRONTAL CORTEX;DRUG-ELUTING STENT;ERLOTINIB;EXHALED NITRIC OXIDE;GEFITINIB;IPILIMUMAB;PROSTATE BIOPSY;SINGLE-NUCLEOTIDE POLYMORPHISM;SUICIDE RATES;AGORAPHOBIA;ANCA-ASSOCIATED VASCULITIS;ANTIGEN-PRESENTING CELL;AUTONOMIC NERVOUS SYSTEM;BINGE-EATING DISORDER;BIOMARKER DISCOVERY;BREAST RECONSTRUCTION;CARBOXYHEMOGLOBIN;CAROTID STENTING;CELL CYCLE PROTEIN;CERVICAL INTRAEPITHELIAL NEOPLASIA;CERVICAL LYMPH NODES;CERVICAL SCREENING;CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING;CHROMOPHOBE CELL;CIRCULATING TUMOR CELL;COGNITIVE DECLINE;COGNITIVE RESERVE;COLONOSCOPY;COLPOSCOPY;CONVERGENT VALIDITY;CYCLIN;CYCLIN-DEPENDENT KINASE;CYSTECTOMY;CYTOLYSIS;DEEP TRANSCRANIAL MAGNETIC STIMULATION;DIFFUSING CAPACITY;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DISEASE MANAGEMENT;DOUBLE BLIND;DYSTHYMIC DISORDER;EGFR INHIBITORS;ENDOCRINE DISRUPTOR;ERBB3;EXTERNAL BEAM RADIOTHERAPY;FACTOR V LEIDEN;GENE EXPRESSION PROFILING;GENE MUTATION;GREY MATTER;GS ALPHA SUBUNIT;HEART RATE VARIABILITY;HYPERINSULINEMIA;HYPOPNEA;IDH1;IMATINIB MESYLATE;IMMUNOGENIC CELL DEATH;INTERLEUKIN 21;INTERNATIONAL PROGNOSTIC INDEX;INTRAOPERATIVE MRI;INTRAOPERATIVE RADIOTHERAPY;JOINT DISEASE;JUVENILE MYELOMONOCYTIC LEUKEMIA;KERATINOCYTE GROWTH FACTOR;KRAS;LACHMAN TEST;LACTOBACILLUS RHAMNOSUS;MACE;MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY;MEDULLARY THYROID CANCER;MENTALLY ILL;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;METASTASIS SUPPRESSOR;METHYLENETETRAHYDROFOLATE REDUCTASE;MICROSPORUM GYPSEUM;MITOCHONDRIAL DISEASE;MONOCLONAL;NKG2D;NPR1;NPR2;NUCLEAR RECEPTOR;OBESITY PARADOX;OLIGODENDROGLIOMA;OSWESTRY DISABILITY INDEX;OVARIAN CARCINOMA;OVARIAN RESERVE;PAPILLARY THYROID CANCER;PENETRANCE;PENTAGASTRIN;PERCUTANEOUS ETHANOL INJECTION;PERFLUOROOCTANE;PLASMACYTOID DENDRITIC CELL;PLEURAL DISEASE;POLYCYSTIC OVARY;POMALIDOMIDE;PRIMARY TUMOR;PROBAND;PROSTATE-SPECIFIC ANTIGEN;PROSTATIC DISEASES;RECTAL EXAMINATION;RYANODINE RECEPTOR 2;SEROUS CARCINOMA;SEX HORMONE-BINDING GLOBULIN;SUMATRIPTAN;SUPERCONTINUUM;TARGET LESION;TNM STAGING SYSTEM;TOLL-LIKE RECEPTOR;TRACTOGRAPHY;TRANSITIONAL CELL CARCINOMA;TRANSURETHRAL RESECTION OF THE PROSTATE;TRIPLE-NEGATIVE BREAST CANCER;UROTHELIAL CARCINOMA;VERBAL FLUENCY TEST;VINCRISTINE;VOXEL-BASED MORPHOMETRY","4;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;;AGED;TREATMENT OUTCOME;AGED, 80 AND OVER;BIPOLAR DISORDER;ITALY;THYROID NEOPLASMS;HEART FAILURE;YOUNG ADULT;ANTINEOPLASTIC AGENTS;PROSPECTIVE STUDIES;BIOMARKERS, TUMOR;BRAIN;DEPRESSIVE DISORDER, MAJOR;FOLLOW-UP STUDIES","126;86;81;77;53;52;52;31;25;25;24;24;23;23;19;16;14;14;14;14","EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GLIOMAS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;BROWN ADIPOSE TISSUE FUNCTION AND PHYSIOLOGY;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EFFICACY AND SAFETY OF ELECTROCONVULSIVE THERAPY;GENETIC DISORDERS CAUSING TISSUE MINERALIZATION ABNORMALITIES;HEALTH EFFECTS OF PRECARIOUS EMPLOYMENT AND UNEMPLOYMENT;HEPATOCELLULAR CARCINOMA","7;7;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","DEPRESSION (ECONOMICS);THYROID NODULES;MEDULLARY THYROID CANCER;DEPRESSION;RADIOTHERAPY;SUICIDE;TREATMENT;CONCOMITANT;MICRORNAS;OBSTRUCTIVE SLEEP APNEA;PEDIATRIC SLEEP APNEA;PROCALCITONIN;REFRACTORY (PLANETARY SCIENCE);SUICIDAL BEHAVIOR;TAXANE;TREATMENT-RESISTANT DEPRESSION;UNIVARIATE ANALYSIS;;AORTIC DISSECTION;AORTIC ROOT REPLACEMENT","6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2","HEART FAILURE;MULTIPLE SCLEROSIS;MAGNETIC RESONANCE;PROSTATE CANCER;THYROID CARCINOMA;BREAST CANCER;CANCER PATIENTS;CELL CARCINOMA;CORONARY ARTERY;ELDERLY PATIENTS;ELECTROCONVULSIVE THERAPY;FOLLOW-UP STUDY;HEPATOCELLULAR CARCINOMA;MEDULLARY THYROID;MULTIPLE MYELOMA;POPULATION-BASED STUDY;RADIATION THERAPY;SERUM LEVELS;ACUTE HEART;ACUTELY DECOMPENSATED;AGGRESSIVENESS RESULTS;ANXIETY DISORDERS;ARTERY DISEASE;ATRIAL FIBRILLATION;B-TYPE NATRIURETIC;BIOPSY COHORT;BIPOLAR DISORDER;CANCER DIAGNOSIS;CLINICAL FEATURES;CLINICAL OUTCOMES","6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","BLOOD GLUCOSE;BREAST CANCER;ADULT ADHD;LUNG CANCER;ANXIETY DISORDERS;CI -P;GORD-RELATED SYMPTOMS;AORTIC ARCH;DEPRESSIVE SYMPTOMS;DORSOLATERAL PREFRONTAL;FLUID INFUSION;MESENTERIC ISCHEMIA;MGLU RECEPTOR;MULTIPLE SCLEROSIS;OXIDATIVE STRESS;PATIENTS TREATED;PREFRONTAL CORTEX;STATISTICALLY SIGNIFICANT;SUICIDE RATES;APOPTOTIC EPITOPES;BLOOD PRESSURE;CANCER PATIENTS;COLORECTAL CANCER;EVIDENCE SUPPORTING;FACTOR RECEPTOR;GENE EXPRESSION;GROWTH FACTOR;INCREASED ODDS;MAGNETIC RESONANCE;PATIENTS UNDERGOING","10;9;8;8;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5",58,0.32,8.79,6,2,1,2.5,4.5,2,0,1,6.75,1,1,4,1,1,1,2,4.25,1,0,0,92.75,93,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,5.33,556.44,2.89,4,0.44,99.11,1,0,0,2,2,0,0,4,0,7,2,0,0,0,0,0,0,7,2,0,9,0,0,0,0,0,0,0,0,0,"United States;United Kingdom","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4205 NURSING","9;6;3;1;1;1","CLINICAL RESEARCH;CANCER;BIOENGINEERING;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;ASSISTIVE TECHNOLOGY;BREAST CANCER;COLO-RECTAL CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;HEMATOLOGY;LIVER DISEASE;LYMPHOMA;ORPHAN DRUG;OVARIAN CANCER;PATIENT SAFETY;STEM CELL RESEARCH","7;6;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR","4;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES","5;1;1","BLADDER CANCER;BREAST CANCER;COLON AND RECTAL CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER","1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","5;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"PUBLIC LIBRARY OF SCIENCE","12","32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;44 HUMAN SOCIETY;4404 DEVELOPMENT STUDIES","16;7;4;3;2;1",NA,NA,NA,NA,NA,NA,"POPULATION & SOCIETY","3","CLINICAL MEDICINE AND SCIENCE","5",NA,NA,NA,NA
"AOU_SANTANDREA",2014,162,11.0864197530864,3.98765432098765,0.518518518518518,0.438271604938272,0.635802469135803,1.74594594594595,1.33333333333333,1.82051282051282,1.37333333333333,0.419753086419753,2,74,41,12,20,0.46,0.25,0.07,0.12,26.19,0.692881887858479,5.25,0.32716049382716,0.851851851851852,0.529,0.448,0.464,0.436,"GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;PAOLO GIRARDI;MAURIZIO POMPILI;MATTIA FALCHETTO OSTI;ALESSANDRO BOZZAO;PAOLO GIRARDI;GIANFRANCO DELLE FAVE;SALVATORE DI SOMMA;GIANLUCA SERAFINI;EDITH LAHNER;MARIO AMORE;BRUNO ANNIBALE;MAURIZIO VALERIANI;MARCO INNAMORATI;VITALIANA DE SANCTIS;CLAUDIA SCARINGI;L. MAGRINI;STEFANO FERRACUTI;GIANLUCA ESPOSITO","13;13;12;10;9;9;9;9;8;8;7;7;7;7;7;7;7;6;6;6","PAOLO GIRARDI;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;MAURIZIO POMPILI;GIANLUCA SERAFINI;PASQUALE PARISI;ANDREA FERRETTI;ALESSANDRO BOZZAO;GIANFRANCO DELLE FAVE;MATTIA FALCHETTO OSTI;MARIO AMORE;MARCO INNAMORATI;EDITH LAHNER;BRUNO ANNIBALE;SALVATORE DI SOMMA;CLAUDIA SCARINGI;PAOLO GIRARDI;EMANUELA PILOZZI;MAURIZIO VALERIANI;VITALIANA DE SANCTIS","1.81;1.65;1.61;1.48;1.36;1.2;1.17;1.13;1.02;1.02;0.96;0.96;0.88;0.88;0.87;0.81;0.8;0.76;0.75;0.75","GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;PAOLO GIRARDI;MAURIZIO POMPILI;MATTIA FALCHETTO OSTI;ALESSANDRO BOZZAO;PAOLO GIRARDI;GIANFRANCO DELLE FAVE;SALVATORE DI SOMMA;GIANLUCA SERAFINI;EDITH LAHNER;MARIO AMORE;BRUNO ANNIBALE;MAURIZIO VALERIANI;MARCO INNAMORATI;VITALIANA DE SANCTIS;CLAUDIA SCARINGI;L. MAGRINI;STEFANO FERRACUTI;GIANLUCA ESPOSITO","13;13;12;10;9;9;9;9;8;8;7;7;7;7;7;7;7;6;6;6","PAOLO GIRARDI;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;MAURIZIO POMPILI;GIANLUCA SERAFINI;PASQUALE PARISI;ANDREA FERRETTI;ALESSANDRO BOZZAO;GIANFRANCO DELLE FAVE;MATTIA FALCHETTO OSTI;MARIO AMORE;MARCO INNAMORATI;EDITH LAHNER;BRUNO ANNIBALE;SALVATORE DI SOMMA;CLAUDIA SCARINGI;PAOLO GIRARDI;EMANUELA PILOZZI;MAURIZIO VALERIANI;VITALIANA DE SANCTIS","1.81;1.65;1.61;1.48;1.36;1.2;1.17;1.13;1.02;1.02;0.96;0.96;0.88;0.88;0.87;0.81;0.8;0.76;0.75;0.75","PAOLO GIRARDI;EMANUELA PILOZZI;GIUSEPPE MINNITI;RICCARDO MAURIZI ENRICI;MARCELLA MOTTOLESE;MARCELLO MAUGERI‐SACCÀ;CLAUDIA SCARINGI;SALVATORE DI SOMMA;ALFREDO PAGLIUCA;ANNA DI BENEDETTO;CHIARA MORICONI;FRANCESCA SPERATI;G. FEDERICI;GIORGIO STASSI;MARIA IDA AMABILE;MATILDE TODARO;MAURO BIFFONI;MICHELE PATRIZII;MONICA BARTUCCI;ROSANNA DATTILO","659;498;448;425;360;360;347;329;315;315;315;315;315;315;315;315;315;315;315;315","PAOLO GIRARDI;EMANUELA PILOZZI;RICCARDO MAURIZI ENRICI;GIUSEPPE MINNITI;CLAUDIA SCARINGI;SALVATORE DI SOMMA;ANNA PAOLA LEPORACE;ANTONELLA FERRARI;MATTIA FALCHETTO OSTI;L. MAGRINI;ALESSANDRO BOZZAO;ANDREA TUBARO;COSIMO DE NUNZIO;DENISE ERBUTO;STEFANO VALABREGA;ENRICO CLARKE;MARCO INNAMORATI;BRUNO ANNIBALE;EDITH LAHNER;GIANLUCA ESPOSITO","484;446;425;369;347;310;294;294;288;262;261;259;259;227;199;195;194;179;179;173","PAOLO GIRARDI;RICCARDO MAURIZI ENRICI;GIUSEPPE MINNITI;ALESSANDRO BOZZAO;MAURIZIO POMPILI;MATTIA FALCHETTO OSTI;SALVATORE DI SOMMA;GIANFRANCO DELLE FAVE;CLAUDIA SCARINGI;MAURIZIO VALERIANI;VITALIANA DE SANCTIS;GIANLUCA SERAFINI;MARCO INNAMORATI;PAOLO MARCHETTI;STEFANO FERRACUTI;GEORGIOS D. KOTZALIDIS;BRUNO ANNIBALE;EDITH LAHNER;STEFANO VALABREGA;EMANUELA PILOZZI","18;13;11;9;9;9;8;7;7;7;7;7;6;6;6;6;6;6;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;ECONOMICS;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;BUSINESS;MATHEMATICS","152;35;28;15;13;11;7;5;5;3;2;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;PSYCHIATRY;GASTROENTEROLOGY;ONCOLOGY;RADIOLOGY;CLINICAL PSYCHOLOGY;BIOCHEMISTRY;CARDIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PALEONTOLOGY;CANCER RESEARCH;GENETICS;INTENSIVE CARE MEDICINE;PEDIATRICS;ANATOMY;DERMATOLOGY;MACROECONOMICS;NURSING","110;36;36;34;32;26;24;21;20;17;16;15;13;12;12;10;10;9;9;9;9","CANCER;POPULATION;GENE;MAGNETIC RESONANCE IMAGING;DISEASE;CHEMOTHERAPY;CONFIDENCE INTERVAL;DEPRESSION (ECONOMICS);RADIATION THERAPY;ANXIETY;PROPORTIONAL HAZARDS MODEL;BIOPSY;COHORT;EMERGENCY DEPARTMENT;HEART FAILURE;MYOCARDIAL INFARCTION;RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;ANEMIA;COGNITION;MOOD;POISON CONTROL;THYROID","30;16;13;11;10;9;9;9;9;8;8;7;7;7;7;7;7;6;6;6;6;6;6","BREAST CANCER;PROSTATE;BIPOLAR DISORDER;HAZARD RATIO;SUICIDE PREVENTION;GASTRITIS;HEPATITIS B VIRUS;MAJOR DEPRESSIVE DISORDER;METASTASIS;NATRIURETIC PEPTIDE;PROSTATE CANCER;RADIOSURGERY;TEMOZOLOMIDE;THYROID CANCER;ADENOCARCINOMA;BECK DEPRESSION INVENTORY;CANCER STEM CELL;COLORECTAL CANCER;PROINFLAMMATORY CYTOKINE;ADJUVANT THERAPY;ALCOHOL USE DISORDER;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;ANTIDEPRESSANT;ANTRUM;AORTIC VALVE STENOSIS;ATOPY;AUTOIMMUNE HEMOLYTIC ANEMIA;CARDIOMYOPATHY;DIFFUSE LARGE B-CELL LYMPHOMA;DOWNREGULATION AND UPREGULATION;EMBRYONIC STEM CELL;ESCHERICHIA COLI;GLOBAL ASSESSMENT OF FUNCTIONING;GROWTH HORMONE;HYPERINTENSITY;INJURY PREVENTION;IRON-DEFICIENCY ANEMIA;MOOD DISORDERS;MUTATION;OPTIC CHIASM;OSTEOARTHRITIS;OVARIAN CANCER;PERCUTANEOUS CORONARY INTERVENTION;PERNICIOUS ANEMIA;PITUITARY ADENOMA;POLYRADICULONEUROPATHY;PREFRONTAL CORTEX;PROTEIN KINASE B;RECEPTOR TYROSINE KINASE;RITUXIMAB;SEROLOGY;TEMPERAMENT;THYROID CARCINOMA;THYROID NODULES;TRANSCRANIAL MAGNETIC STIMULATION;TYPE 2 DIABETES;VASCULAR ENDOTHELIAL GROWTH FACTOR","7;7;6;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ATROPHIC GASTRITIS;BECK HOPELESSNESS SCALE;HBSAG;ACROMEGALY;CHILD ABUSE;DEEP TRANSCRANIAL MAGNETIC STIMULATION;DOMESTIC VIOLENCE;DORSOLATERAL PREFRONTAL CORTEX;INDUCED PLURIPOTENT STEM CELL;LOWER URINARY TRACT SYMPTOMS;SUICIDAL IDEATION;ACUTE PROMYELOCYTIC LEUKEMIA;ADJUVANT CHEMOTHERAPY;ALTERNATIVE SPLICING;ANAPLASTIC ASTROCYTOMA;ANTEROLATERAL LIGAMENT;ARTICULAR CARTILAGE;ATG5;AUTOIMMUNE GASTRITIS;AUTONOMIC NERVOUS SYSTEM;AUTOPHAGOSOME;AZOOSPERMIA;BECN1;BENDAMUSTINE;BENIGN PROSTATIC HYPERPLASIA (BPH);BILE REFLUX;BLADDER OUTLET OBSTRUCTION;BRAIN METASTASIS;CA15-3;CALPROTECTIN;CAPECITABINE;CERVICAL CANAL;CHEMOIMMUNOTHERAPY;CHLAMYDOPHILA PNEUMONIAE;CHRONIC GASTRITIS;COLONOSCOPY;CORTICOSPINAL TRACT;CREB;DEPERSONALIZATION;DIFFERENTIAL ITEM FUNCTIONING;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DISSOCIATIVE EXPERIENCES SCALE;DNA GLYCOSYLASE;DUTASTERIDE;DYSTHYMIC DISORDER;EMBRYO CRYOPRESERVATION;EPITHELIAL–MESENCHYMAL TRANSITION;EPWORTH SLEEPINESS SCALE;EVANS SYNDROME;EXCESSIVE DAYTIME SLEEPINESS;FACIAL NERVE PALSY;FERTILITY PRESERVATION;FINASTERIDE;GASTRINOMA;GEFITINIB;HEART RATE VARIABILITY;HEARTBURN;HORMONAL THERAPY;HYPOTHALAMIC HAMARTOMA;IDH1;IN SITU HYBRIDIZATION;INTERFERON ALFA;JOSAMYCIN;LAMIVUDINE;LASER CAPTURE MICRODISSECTION;MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY;MALE INFERTILITY;MEDULLARY THYROID CANCER;METABOTROPIC RECEPTOR;METASTATIC BREAST CANCER;METHYLTRANSFERASE;MIGRAINE WITH AURA;MODIFIED RANKIN SCALE;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;OVARIAN CARCINOMA;OVARIAN TUMOR;PARANEOPLASTIC PEMPHIGUS;PITUITARY APOPLEXY;PIVOT-SHIFT TEST;PLACENTAL ABRUPTION;PREMENSTRUAL DYSPHORIC DISORDER;PRESSURE OVERLOAD;PROSTATE ADENOCARCINOMA;PROSTATE-SPECIFIC ANTIGEN;PROSTATIC ADENOCARCINOMA;RECTAL EXAMINATION;RNA SPLICING;SEMEN ANALYSIS;SENTINEL LYMPH NODE;SERRATIA MARCESCENS;SEXUAL ABUSE;SHIGELLA FLEXNERI;SKIN INFECTION;SOLITARY FIBROUS TUMOR;SPINAL CANAL STENOSIS;SUICIDAL BEHAVIOR;SYNOVIAL FLUID;TRACTOGRAPHY;TRANSSPHENOIDAL SURGERY;TRASTUZUMAB;TROPONIN COMPLEX;V600E;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VILLOUS ATROPHY;WISCONSIN CARD SORTING TEST","3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;;AGED;ADULT;RETROSPECTIVE STUDIES;ITALY;AGED, 80 AND OVER;BREAST NEOPLASMS;DEPRESSIVE DISORDER, MAJOR;ADOLESCENT;BIOMARKERS;BRAIN NEOPLASMS;TREATMENT OUTCOME;YOUNG ADULT;STOMACH NEOPLASMS;THYROID NEOPLASMS;DACARBAZINE","103;84;80;58;57;53;45;26;24;23;21;20;18;18;18;18;16;15;15;13","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF BRAIN METASTASES IN CANCER PATIENTS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;GLIOMAS;HEPATITIS B INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;PROSTATE CANCER RESEARCH AND TREATMENT;ADVANCEMENTS IN LUNG CANCER RESEARCH;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BIOLOGICAL AND CLINICAL EFFECTS OF IONIZING RADIATION;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIFFUSION MAGNETIC RESONANCE IMAGING;DISEASES RELATED TO BLOOD GROUP VARIANTS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;EPIDEMIOLOGY AND MANAGEMENT OF STROKE","6;5;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","DEPRESSION (ECONOMICS);BRAIN METASTASES;CONCOMITANT;RADIOTHERAPY;THYROID NODULES;DISCONTINUATION;PATHOPHYSIOLOGY;STROKE (ENGINE);TEMOZOLOMIDE;ATROPHIC GASTRITIS;BECK HOPELESSNESS SCALE;DEGENERATION (MEDICAL);DIAGNOSIS;GASTRIC CANCER;HEPATITIS B;PROINFLAMMATORY CYTOKINE;RADIOSURGERY;SUICIDAL BEHAVIOR;ADJUVANT THERAPY;ALCOHOL USE DISORDER","7;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2","CANCER PATIENTS;BREAST CANCER;CLINICAL PRACTICE;MULTICENTER STUDY;STEREOTACTIC RADIOSURGERY;AFFECTIVE DISORDERS;BRAIN METASTASES;ELDERLY PATIENTS;EMERGENCY DEPARTMENT;FRACTIONATED STEREOTACTIC;HEART FAILURE;MAJOR AFFECTIVE;PROSTATE CANCER;SUICIDAL BEHAVIOR;ACUTE HEART;ANALYSIS BIVA;ANTERIOR VISUAL;AUTOIMMUNE HEMOLYTIC;BASE METASTASES;CANCER AGGRESSIVENESS;CANCER STEM;CARCINOID SYNDROME;CARCINOMA CORRELATE;CARE PATIENTS;CELL CARCINOMA;CERVICAL SPINE;CHRONIC HEPATITIS;CLINICAL FEATURES;CLINICAL GUIDELINES;CLINICAL MANIFESTATION","9;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER PATIENTS;GASTRIC CANCER;PROSTATE CANCER;BREAST CANCER;CP PATIENTS;MEDIAN FOLLOW-UP;LOCAL CONTROL;MULTI-FRACTION SRS;MULTIVARIATE ANALYSIS;HEART FAILURE;STATISTICALLY SIGNIFICANT;CERVICAL SPINE;CONFIDENCE INTERVAL;EMERGENCY DEPARTMENT;MONTHS RANGE;OLIVARY NUCLEUS;PATIENTS ADMITTED;PATIENTS TREATED;ADJUVANT CHEMOTHERAPY;BRAIN METASTASES;DISTANT FAILURE;GU TOXICITY;MBS METHOD;PATIENTS RECEIVED;RENAL INJURY;RISK FACTORS;SKULL BASE;STEM CELLS;ACUTE HEART;AORTIC STENOSIS","13;13;11;10;10;10;9;9;9;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5",55,0.34,3.62,4,1,1,0,1.75,3,0,1,4,1,0,3,0,1.5,1,1,3,1,0,0,82,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,4.57,1081.57,2,3,0.43,63.71,0,0,1,1,1,0,0,4,0,3,4,0,0,0,0,0,0,7,0,0,6,0,0,1,0,0,0,0,0,0,"Italy;Switzerland;United Kingdom;United States","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;4205 NURSING","5;2;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AGING;BRAIN DISORDERS;EYE DISEASE AND DISORDERS OF VISION;HEMATOLOGY;NEURODEGENERATIVE;NEUROSCIENCES;PATIENT SAFETY;PREVENTION;RARE DISEASES;REGENERATIVE MEDICINE;TRANSPLANTATION;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ANTIMICROBIAL RESISTANCE;BIOMEDICAL IMAGING;DEMENTIA","7;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;EYE;INFECTION;NEUROLOGICAL","2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;2.4 SURVEILLANCE AND DISTRIBUTION;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES","4;2;2;1;1;1;1","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","2;2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"PUBLIC LIBRARY OF SCIENCE","8","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","13;3;2;2;1;1","CANCER;GENETICS","1;1",NA,NA,"7.3 MANAGEMENT AND DECISION MAKING","1",NA,NA,"CLINICAL MEDICINE AND SCIENCE","3","NON-HODGKIN'S LYMPHOMA","3",NA,NA
"AOU_SANTANDREA",2015,199,13.3467336683417,3.2462311557789,0.376884422110553,0.396984924623116,0.472361809045226,1.74594594594595,1.29310344827586,1.64583333333333,1.30555555555556,0.49748743718593,4,102,41,18,17,0.51,0.21,0.09,0.09,24.8,0.665554409902517,5.0811170212766,0.361809045226131,0.849246231155779,0.445,0.404,0.414,0.405,"PAOLO MARCHETTI;GIANFRANCO DELLE FAVE;MARIA ROSARIA TORRISI;MARIA CHRISTINA COX;MARIA PIA VILLA;RICCARDO MAURIZI ENRICI;GEORGIOS D. KOTZALIDIS;GIUSEPPE MINNITI;VALENTINA SINI;MATTIA FALCHETTO OSTI;GABRIELE CAPURSO;VITALIANA DE SANCTIS;PAOLO GIRARDI;AGOSTINO TAFURI;ROBERTO VALENTE;STEFANO BRACCI;PAOLO GIRARDI;ANDREA TUBARO;ISABELLA SPERDUTI;COSIMO DE NUNZIO","11;10;9;9;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6;6","ALESSANDRO BOZZAO;MARIA PIA VILLA;MAURIZIO POMPILI;MARIA ROSARIA TORRISI;RICCARDO MAURIZI ENRICI;ENRICO ROSINI;MARIA GIULIA MUTOLO;GIANFRANCO DELLE FAVE;MELANIA EVANGELISTI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;MARIO BARRETO;MATTIA FALCHETTO OSTI;GEORGIOS D. KOTZALIDIS;GABRIELE CAPURSO;PAOLO MARCHETTI;STEFANO BRACCI;MICHELE ROSSI;COSIMO DE NUNZIO;MARIA CHRISTINA COX","1.41;1.37;1.36;1.33;1.08;1;1;0.91;0.86;0.84;0.83;0.82;0.81;0.8;0.77;0.74;0.74;0.72;0.71;0.71","PAOLO MARCHETTI;GIANFRANCO DELLE FAVE;MARIA ROSARIA TORRISI;MARIA CHRISTINA COX;MARIA PIA VILLA;RICCARDO MAURIZI ENRICI;GEORGIOS D. KOTZALIDIS;GIUSEPPE MINNITI;VALENTINA SINI;MATTIA FALCHETTO OSTI;GABRIELE CAPURSO;VITALIANA DE SANCTIS;PAOLO GIRARDI;AGOSTINO TAFURI;ROBERTO VALENTE;STEFANO BRACCI;PAOLO GIRARDI;ANDREA TUBARO;COSIMO DE NUNZIO;CLAUDIA SCARINGI","11;10;9;9;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6;6","ALESSANDRO BOZZAO;MARIA PIA VILLA;MAURIZIO POMPILI;MARIA ROSARIA TORRISI;RICCARDO MAURIZI ENRICI;ENRICO ROSINI;MARIA GIULIA MUTOLO;GIANFRANCO DELLE FAVE;MELANIA EVANGELISTI;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;MARIO BARRETO;MATTIA FALCHETTO OSTI;GEORGIOS D. KOTZALIDIS;GABRIELE CAPURSO;PAOLO MARCHETTI;STEFANO BRACCI;MICHELE ROSSI;COSIMO DE NUNZIO;MARIA CHRISTINA COX","1.41;1.37;1.36;1.33;1.08;1;1;0.91;0.86;0.84;0.83;0.82;0.81;0.8;0.77;0.74;0.74;0.72;0.71;0.71","CARLO CARNAGHI;DO‐YOUN OH;EDWARD M. WOLIN;ERIC VAN CUTSEM;GIANFRANCO DELLE FAVE;HARALD LAHNER;JAMES C. YAO;JIŘÍ TOMÁŠEK;JONATHAN STROSBERG;JUAN W. VALLE;MARGOT TESSELAAR;MARIANNE PAVEL;MARKUS RADERER;MATTHEW H. KULKE;NICOLA FAZIO;ROBERTO BUZZONI;SIMRON SINGH;YASUHIRO SHIMADA;CAROLIN SACHS;LIDA PACAUD","1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1080;1074;1074","GIANFRANCO DELLE FAVE;MARCO SALVETTI;SILVIA ROMANO;MARIA ROSARIA TORRISI;PAOLO GIRARDI;GIUSEPPE MINNITI;VIVIANA ANNIBALI;RICCARDO MAURIZI ENRICI;FRANCESCO ORZI;GIULIA COARELLI;MATTIA FALCHETTO OSTI;FEDERICA PONZELLI;MICHELA FERRALDESCHI;CLAUDIA SCARINGI;MARIA PIA VILLA;AGOSTINO TAFURI;MARIA ROSARIA RICCIARDI;MARTINA CURTO;MARIA CHRISTINA COX;STEFANO BRACCI","1080;467;458;402;314;306;272;247;221;195;191;186;186;183;182;181;178;155;153;153","PAOLO GIRARDI;GIANFRANCO DELLE FAVE;MARIA PIA VILLA;PAOLO MARCHETTI;MARIA ROSARIA TORRISI;MARIA CHRISTINA COX;RICCARDO MAURIZI ENRICI;GEORGIOS D. KOTZALIDIS;GIUSEPPE MINNITI;VITALIANA DE SANCTIS;MATTIA FALCHETTO OSTI;AGOSTINO TAFURI;CLAUDIA SCARINGI;ROBERTO VALENTE;STEFANO BRACCI;COSIMO DE NUNZIO;ANDREA TUBARO;MAURIZIO POMPILI;MAURIZIO VALERIANI;ALESSANDRO BOZZAO","11;10;9;9;9;9;9;7;7;7;7;6;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;PHYSICS;MATHEMATICS;PHILOSOPHY;ENGINEERING;POLITICAL SCIENCE;MATERIALS SCIENCE;SOCIOLOGY","188;47;27;13;12;11;11;8;6;3;3;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;PATHOLOGY;GASTROENTEROLOGY;PSYCHIATRY;RADIOLOGY;IMMUNOLOGY;GENETICS;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;CLINICAL PSYCHOLOGY;PEDIATRICS;CARDIOLOGY;UROLOGY;CANCER RESEARCH;ENDOCRINOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;CELL BIOLOGY;PHYSICAL THERAPY","141;58;45;38;36;36;22;20;19;17;16;15;15;14;13;11;11;11;11;10;10","CANCER;CHEMOTHERAPY;GENE;DISEASE;POPULATION;RADIATION THERAPY;COHORT;CONFIDENCE INTERVAL;LYMPHOMA;COGNITION;RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;TOXICITY;BIOPSY;DEPRESSION (ECONOMICS);LUNG CANCER;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);ANXIETY;LOGISTIC REGRESSION;LUNG;MAGNETIC RESONANCE IMAGING;MULTIVARIATE ANALYSIS;THROMBOSIS","33;24;15;14;14;14;12;11;11;10;10;9;9;8;8;8;8;7;7;7;7;7;7","BREAST CANCER;CLINICAL ENDPOINT;PROGRESSION-FREE SURVIVAL;PROGRESSIVE DISEASE;RADIOSURGERY;BEVACIZUMAB;BIPOLAR DISORDER;COLORECTAL CANCER;GENOTYPE;HAZARD RATIO;PLACEBO;PROSTATE CANCER;RITUXIMAB;CYCLOPHOSPHAMIDE;NEUTROPENIA;PANCREATIC CANCER;PNEUMONITIS;PROSTATE;UNIVARIATE ANALYSIS;ACUTE CORONARY SYNDROME;DOWNREGULATION AND UPREGULATION;EJECTION FRACTION;ELECTROCONVULSIVE THERAPY;ESCHERICHIA COLI;INJURY PREVENTION;KIDNEY TRANSPLANTATION;MAJOR DEPRESSIVE DISORDER;PHASES OF CLINICAL RESEARCH;POLYSOMNOGRAPHY;SUICIDE PREVENTION;VENOUS THROMBOSIS","12;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","METASTATIC BREAST CANCER;GASTROINTESTINAL CANCER;PROSTATE BIOPSY;SINGLE-NUCLEOTIDE POLYMORPHISM;TRASTUZUMAB;VINCRISTINE;AMPK;ANDROGEN DEPRIVATION THERAPY;BENDAMUSTINE;CETUXIMAB;ERBB3;HYPOPNEA;IRINOTECAN;ITEM BANK;KLEBSIELLA PNEUMONIAE;LOWER URINARY TRACT SYMPTOMS;METHYLENETETRAHYDROFOLATE REDUCTASE;NODULAR SCLEROSIS;OXALIPLATIN;PAZOPANIB;RECTAL EXAMINATION;TAXANE","5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;NEOPLASM RECURRENCE, LOCAL;ITALY;LUNG NEOPLASMS;TREATMENT OUTCOME;ADOLESCENT;YOUNG ADULT;FOLLOW-UP STUDIES;PROGNOSIS;CARCINOMA, NON-SMALL-CELL LUNG;BIOMARKERS;LEUKEMIA, MYELOID, ACUTE","107;89;82;81;68;63;57;27;25;25;24;24;24;20;20;18;15;14;13;13","LYMPHOID NEOPLASMS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;FIBROBLAST GROWTH FACTOR SIGNALING PATHWAY;MOLECULAR RESEARCH ON BREAST CANCER;PANCREATIC CANCER RESEARCH AND TREATMENT;SCHIZOPHRENIA RESEARCH AND TREATMENT;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;BROWN ADIPOSE TISSUE FUNCTION AND PHYSIOLOGY;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPILEPSY AND SEIZURES","7;6;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2","RADIOTHERAPY;DEPRESSION (ECONOMICS);CLINICAL ENDPOINT;PROGRESSION-FREE SURVIVAL;MANTLE CELL LYMPHOMA;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;TREATMENT;PEDIATRIC SLEEP APNEA;PNEUMONITIS;STEREOTACTIC BODY RADIATION THERAPY;UNIVARIATE ANALYSIS;ADJUVANT THERAPY;AFFECT (LINGUISTICS);BREAST CANCER;DIAGNOSIS;ETIOLOGY;EVEROLIMUS;GASTROINTESTINAL CANCER;METASTATIC BREAST CANCER","9;8;7;7;6;6;6;6;5;4;4;4;3;3;3;3;3;3;3;3","BREAST CANCER;CANCER PATIENTS;LUNG CANCER;PROSTATE CANCER;METASTATIC BREAST;PHASE III;BIPOLAR DISORDER;HODGKIN LYMPHOMA;MULTICENTER STUDY;MULTIPLE SCLEROSIS;OBSERVATIONAL STUDY;PANCREATIC CANCER;ACUTE CORONARY;B-CELL LYMPHOMA;CELL LUNG;DE NOVO;DEPRESSIVE DISORDER;DISORDERED BREATHING;HEART FAILURE;MAJOR DEPRESSIVE;MULTICENTER RETROSPECTIVE;NON-SMALL CELL;PREDICTIVE FACTORS;PROGNOSTIC FACTOR;RISK FACTORS;SLEEP DISORDERED;ACUTE MYELOID;AL PREVALENCE;BASELINE DEMOGRAPHICS;BEVACIZUMAB MAINTENANCE","7;7;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","BREAST CANCER;DIPARTIMENTO DI;MEDIAN AGE;STATISTICALLY SIGNIFICANT;MBC PTS;PROSTATE CANCER;SPONTANEOUS SMILE;COGNITIVE SYMPTOMS;ITALY DIPARTIMENTO;SURVIVAL OS;CLINICAL OUTCOMES;DI MEDICINA;GY ARM;LOGISTIC REGRESSION;PATIENTS AFFECTED;PATIENTS RECEIVED;RESPONSE RATE;ROME ITALY;SURVIVAL PFS;FACIAL PARALYSIS;HEART FAILURE;LUNG CANCER;MEDIAN FOLLOW-UP;OXIDATIVE STRESS;PROGRESSION-FREE SURVIVAL;ABDOMINAL PAIN;GLEASON SCORE;MEDIAN OS;MO CI;MODERATEHIGH CVR","14;13;12;11;10;10;10;9;9;9;8;8;8;8;8;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6",64,0.32,5.19,5,2,1,1,7.5,1,0,1.75,6,0,0,5,1,1,1,2.5,4,2.75,0,0,91,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,4.71,355.43,2.01,5,0.71,90.57,0,0,4,0,2,0,0,1,0,6,1,0,0,0,0,0,0,7,0,0,7,0,0,0,0,0,0,0,0,0,"Belgium;United States;France;Japan","2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","7;5;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;BRAIN DISORDERS;HEMATOLOGY;BRAIN CANCER;CARDIOVASCULAR;DIGESTIVE DISEASES;INFECTIOUS DISEASES;NEUROSCIENCES;PANCREATIC CANCER;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;SEPSIS;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","7;5;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","4;1;1","BRAIN TUMOR;LEUKEMIA / LEUKAEMIA;PANCREATIC CANCER","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3107 MICROBIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3009 VETERINARY SCIENCES;3202 CLINICAL SCIENCES;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3504 COMMERCIAL SERVICES;3508 TOURISM;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4301 ARCHAEOLOGY","5;4;2;2;2;1;1;1;1;1;1;1","INFECTIOUS DISEASES;VECTOR-BORNE DISEASES;PEDIATRIC;CLINICAL RESEARCH;NUTRITION;PATIENT SAFETY","3;3;2;1;1;1","INFECTION","3","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","2",NA,NA,"CLINICAL MEDICINE AND SCIENCE","1","BREAST CANCER;COLON AND RECTAL CANCER","1;1","3 GOOD HEALTH AND WELL BEING","2"
"AOU_SANTANDREA",2016,198,12.6161616161616,3.1969696969697,0.419191919191919,0.333333333333333,0.51010101010101,1.55147058823529,1.36065573770492,1.3469387755102,1.32894736842105,0.5,13,104,44,18,22,0.53,0.22,0.09,0.11,23.51,0.723766083236366,5.02040816326531,0.393939393939394,0.858585858585859,0.566,0.429,0.484,0.466,"PAOLO MARCHETTI;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;GIAN MARIA PACIFICI;PAOLO GIRARDI;GABRIELE CAPURSO;LUANA LIONETTO;TERESA GAMUCCI;ISABELLA SPERDUTI;COSIMO DE NUNZIO;MAURIZIO SIMMACO;ADRIANA ROMITI;SEVERINO PERSECHINO;MARIO AMORE;NICOLA FAZIO;ANDREA BOTTICELLI;MICHELA ROBERTO;CLARA NATOLI;ROBERTO BUZZONI;ALESSANDRO PESCE","18;15;10;10;8;8;7;7;7;7;6;6;6;5;5;5;5;5;5;5","GIAN MARIA PACIFICI;SEVERINO PERSECHINO;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;PAOLO MARCHETTI;GABRIELE CAPURSO;FILIPPO GALLI;ALESSANDRO PESCE;GIANLUCA SERAFINI;MARIO AMORE;PAOLO GIRARDI;VINCENZO TOSCANO;ANTONIO STIGLIANO;GIANLUCA SCUDERI;ANTONELLA TAMMARO;COSIMO DE NUNZIO;EMILIO DI GIULIO;FRANCESCA ROMANA PARISELLA;MAURIZIO TAURINO;LUIGI MARROCCO","10;2.79;2.1;1.58;1.31;1.3;1;0.93;0.9;0.87;0.84;0.83;0.83;0.82;0.79;0.75;0.72;0.59;0.59;0.57","PAOLO MARCHETTI;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;GIAN MARIA PACIFICI;PAOLO GIRARDI;GABRIELE CAPURSO;LUANA LIONETTO;COSIMO DE NUNZIO;MAURIZIO SIMMACO;ADRIANA ROMITI;SEVERINO PERSECHINO;ANDREA BOTTICELLI;MICHELA ROBERTO;ALESSANDRO PESCE;CONCETTA ELISA ONESTI;GEORGIOS D. KOTZALIDIS;ANDREA TUBARO;GIANLUCA SERAFINI;EMANUELA PILOZZI;ROSA FALCONE","18;15;10;10;8;8;7;7;6;6;6;5;5;5;5;5;5;5;5;5","GIAN MARIA PACIFICI;SEVERINO PERSECHINO;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;PAOLO MARCHETTI;GABRIELE CAPURSO;FILIPPO GALLI;ALESSANDRO PESCE;GIANLUCA SERAFINI;PAOLO GIRARDI;VINCENZO TOSCANO;ANTONIO STIGLIANO;GIANLUCA SCUDERI;ANTONELLA TAMMARO;COSIMO DE NUNZIO;EMILIO DI GIULIO;MAURIZIO TAURINO;LUANA LIONETTO;MARIA RINZIVILLO;BATYA ENGEL‐YEGER","10;2.79;2.1;1.58;1.31;1.3;1;0.93;0.9;0.84;0.83;0.83;0.82;0.79;0.75;0.72;0.59;0.57;0.52;0.51","GIANFRANCO DELLE FAVE;PHILIPPE RUSZNIEWSKI;ANDERS SUNDÍN;ANDREAS PASCHER;BABS G. TAAL;DERMOT O’TOOLE;DIEGO FERONE;JOHN RAMAGE;PIERO FEROLLÀ;TETSUHIDE ITO;WOLFGANG WEBER;WOUTER W. DE HERDER;Z. ZHENG-PEI;CLAUS BELKA;ANDREA FERRETTI;GIUSEPPE MINNITI;EDOARDO MONACO;ALBA FIORENTINO;ANCA‐LIGIA GROSU;ANTHONY J. CHALMERS","590;476;434;434;434;434;434;434;434;434;434;434;434;426;359;353;345;328;328;328","GIANFRANCO DELLE FAVE;ANDREA FERRETTI;EDOARDO MONACO;GIUSEPPE MINNITI;SALVATORE DI SOMMA;MAURIZIO POMPILI;PAOLO GIRARDI;COSIMO DE NUNZIO;ANGELO DE CARLI;BRUNO ANNIBALE;MATTIA FABBRI;GIANLUCA ESPOSITO;BARBARA MAESTRI;PAOLO MARCHETTI;LINDA AGOLLI;ANDREA NEGRO;ANDREA TUBARO;ANTONIO PONZO;FABIO CONTEDUCA;GABRIELE SANI","590;359;345;328;273;255;237;226;225;225;225;215;211;205;171;164;150;134;134;134","PAOLO MARCHETTI;GIANFRANCO DELLE FAVE;PAOLO GIRARDI;GIAN MARIA PACIFICI;MAURIZIO POMPILI;GABRIELE CAPURSO;COSIMO DE NUNZIO;ADRIANA ROMITI;ALESSANDRO PESCE;ANDREA BOTTICELLI;ANDREA TUBARO;CONCETTA ELISA ONESTI;GEORGIOS D. KOTZALIDIS;MICHELA ROBERTO;ROSA FALCONE;EMILIO DI GIULIO;ALDO MILANO;ANNA COSTANTINI;C. PASQUAZZI;EMANUELA PILOZZI","17;15;13;10;10;8;7;5;5;5;5;5;5;5;5;5;4;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;ENGINEERING;SOCIOLOGY;PHILOSOPHY;MATERIALS SCIENCE;POLITICAL SCIENCE;ART","189;39;24;16;13;13;11;11;9;7;4;3;3;2","INTERNAL MEDICINE;SURGERY;PSYCHIATRY;GASTROENTEROLOGY;ONCOLOGY;PATHOLOGY;RADIOLOGY;CARDIOLOGY;ENDOCRINOLOGY;GENETICS;ANESTHESIA;ENVIRONMENTAL HEALTH;UROLOGY;BIOCHEMISTRY;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;DERMATOLOGY;PALEONTOLOGY;PEDIATRICS","134;46;36;32;32;29;22;20;18;18;16;16;15;13;13;12;11;10;10;10","CANCER;CHEMOTHERAPY;POPULATION;CONFIDENCE INTERVAL;GENE;ADVERSE EFFECT;CLINICAL TRIAL;DISEASE;COGNITION;DEPRESSION (ECONOMICS);EVEROLIMUS;MYOCARDIAL INFARCTION;NEUROENDOCRINE TUMORS;RETROSPECTIVE COHORT STUDY;LYMPHOMA;MAGNETIC RESONANCE IMAGING;ALTERNATIVE MEDICINE;ASYMPTOMATIC;BLOOD PRESSURE;CONCOMITANT;DIABETES MELLITUS;POISON CONTROL;PREGNANCY;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;TOXICITY","43;15;15;14;12;10;9;9;8;8;8;8;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6","COLORECTAL CANCER;BREAST CANCER;GENOTYPE;PROGRESSION-FREE SURVIVAL;PROSTATE CANCER;BIPOLAR DISORDER;CLINICAL ENDPOINT;HAZARD RATIO;HEART RATE;PANCREATIC CANCER;SUICIDE PREVENTION;FLUOROURACIL;HEPATITIS C VIRUS;PROSTATE;ACUTE CORONARY SYNDROME;ADENOCARCINOMA;ALLELE;BEVACIZUMAB;CARDIOGENIC SHOCK;DOCETAXEL;GASTRITIS;INTESTINAL METAPLASIA;METABOLIC SYNDROME;OVERWEIGHT;PI3K/AKT/MTOR PATHWAY;PLACEBO;TEMPERAMENT;TOLERABILITY","14;7;7;6;6;5;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","METASTATIC BREAST CANCER;PHARMACOGENETICS;RIBAVIRIN;ANDROGEN DEPRIVATION THERAPY;CAPECITABINE;COLONOSCOPY;IRINOTECAN;MANIA;ACROMEGALY;ANTIRETROVIRAL THERAPY;ATROPHIC GASTRITIS;BRENTUXIMAB VEDOTIN;BRONCHOPULMONARY DYSPLASIA;DEEP TRANSCRANIAL MAGNETIC STIMULATION;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DOMESTIC VIOLENCE;DORSOLATERAL PREFRONTAL CORTEX;GENOTYPING;LOWER URINARY TRACT SYMPTOMS;OXALIPLATIN;SUICIDAL IDEATION;SUICIDE ATTEMPT","6;5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;AGED, 80 AND OVER;YOUNG ADULT;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADOLESCENT;FOLLOW-UP STUDIES;COLORECTAL NEOPLASMS;MIGRAINE DISORDERS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;STOMACH NEOPLASMS;BREAST NEOPLASMS;CORONARY ARTERY DISEASE","109;89;78;72;60;50;47;38;22;20;19;19;17;15;14;13;12;12;11;11","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;LYMPHOID NEOPLASMS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;HEPATITIS C INFECTION AND TREATMENT;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;SCHIZOPHRENIA RESEARCH AND TREATMENT;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;BODY ART AND MODIFICATION PRACTICES IN SOCIETY;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS","13;7;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","TREATMENT;PANCREATIC NEUROENDOCRINE TUMORS;EVEROLIMUS;CONCOMITANT;DEPRESSION (ECONOMICS);NEUROENDOCRINE TUMORS;PROGRESSION-FREE SURVIVAL;CLINICAL ENDPOINT;DISCONTINUATION;DPYD;METASTATIC PROSTATE CANCER;STROKE (ENGINE);BREAST CANCER;ETIOLOGY;METASTATIC BREAST CANCER;PROSTATE CANCER;REGIMEN;CARDIOVASCULAR RISK ASSESSMENT;GROUP B;INTERQUARTILE RANGE","11;9;8;6;6;6;6;5;5;5;5;5;4;4;4;4;4;3;3;3","BREAST CANCER;NEUROENDOCRINE TUMORS;COLORECTAL CANCER;CANCER PATIENTS;PROSTATE CANCER;RETROSPECTIVE ANALYSIS;DEGRADATION RATE;FLUOROURACIL DEGRADATION;METASTATIC BREAST;OBSERVATIONAL STUDY;PANCREATIC NEUROENDOCRINE;REAL LIFE;CARDIOGENIC SHOCK;CLINICAL PHARMACOLOGY;DIRECT ACTING;GASTROINTESTINAL CANCER;MENTAL HEALTH;MULTICENTER RETROSPECTIVE;NEONATES EFFECTS;PANCREATIC CANCER;PATIENTS TREATED;PHASE III;PROSPECTIVE STUDY;SUICIDE RISK;TUMORS NET;ABIRATERONE ACETATE;ACTING ANTIVIRAL;ACUTE CORONARY;ACUTE HEART;ADVANCED PANCREATIC","8;8;7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","MEDIAN AGE;DEGRADATION RATE;FU DEGRADATION;NORMOGLYCEMIC PTS;ROME ITALY;MO CI;MEDIAN PFS;STATISTICALLY SIGNIFICANT;ACT SCORES;CARCINOMA PTS;LUNG NET;MEDICAL ONCOLOGY;SUICIDE RISK;HAZARD RATIO;RETROSPECTIVE ANALYSIS;ADVANCED PNETS;ADVISORY COMMITTEES;ANDOR SA;CONFIDENCE INTERVAL;ENTITYS BOARD;EVE ANDOR;HR CI;ITALY DEPARTMENT;PATIENTS PTS;PATIENTS TREATED;SURVIVAL PFS;ADVERSE EVENTS;BREAST CANCER;DOSE REDUCTION;DUCTUS ARTERIOSUS","20;18;17;17;13;12;11;11;10;10;10;10;10;9;9;8;8;8;8;8;8;8;8;8;8;8;7;7;7;7",78,0.39,3.19,4.75,2.5,1,1,2,1.25,0,1,5,0,1,4,0,2.5,1,2,3,2.75,0,0,83,83.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,3.3,933.89,2.55,2,0.2,54.5,0,1,1,0,2,0,0,6,0,5,5,0,0,0,0,0,0,10,0,0,9,0,0,0,1,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES","10;8;4;3","CLINICAL RESEARCH;LUNG;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PREVENTION;LUNG CANCER;AGING;BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;PATIENT SAFETY;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CARDIOVASCULAR;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;COMPARATIVE EFFECTIVENESS RESEARCH;HEALTH SERVICES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","10;5;4;4;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;NEUROLOGICAL;RESPIRATORY","3;1;1;1","6.1 PHARMACEUTICALS;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","5;1;1","LUNG CANCER;NON-HODGKIN'S LYMPHOMA","3;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.6 COMPLEMENTARY AND ALTERNATIVE TREATMENT APPROACHES;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","6;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOU_SANTANDREA",2017,222,14.6801801801802,2.84684684684685,0.378378378378378,0.337837837837838,0.504504504504504,1.91515151515152,1.52727272727273,1.70454545454545,1.36585365853659,0.509009009009009,4,115,52,25,14,0.52,0.23,0.11,0.06,17.17,0.582566764516113,5.06399132321041,0.351351351351351,0.900900900900901,0.526,0.44,0.525,0.444,"PAOLO MARCHETTI;MAURIZIO POMPILI;PAOLO GIRARDI;GIANFRANCO DELLE FAVE;ANDREA TUBARO;MARIO AMORE;ANDREA BOTTICELLI;MASSIMO VOLPE;MASSIMO FALCONI;GIANLUCA SERAFINI;COSIMO DE NUNZIO;VALERIA CENTO;MASSIMO PUOTI;GIULIANO TOCCI;GIULIANO RIZZARDINI;CLARA NATOLI;C. PASQUAZZI;SERGIO BABUDIERI;M. ANGÉLICO;MASSIMO ANDREONI","30;14;13;12;9;8;8;8;8;8;8;7;7;7;7;7;7;7;7;7","GIAN MARIA PACIFICI;GIOVANNA MARCHINI;PAOLO MARCHETTI;EDOARDO MONACO;MAURIZIO POMPILI;PAOLO GIRARDI;MARIA PIA VILLA;GIOVANNI FABBRINI;D. ERROI;MARIO AMORE;GIANLUCA SERAFINI;ANDREA FERRETTI;ALESSANDRO PESCE;ANDREA TUBARO;ISABELLA BERARDELLI;MATTIA FABBRI;GIANFRANCO DELLE FAVE;MELANIA EVANGELISTI;COSIMO DE NUNZIO;MATTIA FALCHETTO OSTI","4.5;3;1.86;1.82;1.81;1.49;1.34;1.17;1.12;1.08;1.08;1.07;1.07;1.05;1;0.91;0.83;0.8;0.77;0.77","PAOLO MARCHETTI;MAURIZIO POMPILI;PAOLO GIRARDI;GIANFRANCO DELLE FAVE;ANDREA TUBARO;ANDREA BOTTICELLI;MASSIMO VOLPE;COSIMO DE NUNZIO;GIULIANO TOCCI;CLARA NATOLI;C. PASQUAZZI;MATTIA FALCHETTO OSTI;GABRIELE CAPURSO;ANDREA FERRETTI;GIAN MARIA PACIFICI;FRANCESCA SIMONELLI;GIOVANNA GALLO;MATTIA FABBRI;LORENZO LIVI;VIVIANNE PRESTA","30;14;13;12;9;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6","GIAN MARIA PACIFICI;GIOVANNA MARCHINI;PAOLO MARCHETTI;EDOARDO MONACO;MAURIZIO POMPILI;PAOLO GIRARDI;MARIA PIA VILLA;GIOVANNI FABBRINI;D. ERROI;ANDREA FERRETTI;ALESSANDRO PESCE;ANDREA TUBARO;ISABELLA BERARDELLI;MATTIA FABBRI;GIANFRANCO DELLE FAVE;MELANIA EVANGELISTI;COSIMO DE NUNZIO;MATTIA FALCHETTO OSTI;MASSIMO VOLPE;RICCARDO MARIA LANZETTI","4.5;3;1.86;1.82;1.81;1.49;1.34;1.17;1.12;1.07;1.07;1.05;1;0.91;0.83;0.8;0.77;0.77;0.75;0.71","GIANFRANCO DELLE FAVE;PAOLO MARCHETTI;MATTHEW H. KULKE;ANNE COUVELARD;AUREL PERREN;DAVID J. GROSS;GUIDO RINDI;JEAN‐YVES SCOAZEC;KJELL ÖBERG;ROBERT T. JENSEN;STAFFAN WELIN;MASSIMO FALCONI;FRANCESCO PANZUTO;PHILIPPE RUSZNIEWSKI;NICOLA FAZIO;STEFANO PARTELLI;ANDREA BOTTICELLI;ASHLEY GROSSMAN;FREDERICO COSTA;HALFDAN SØRBYE","800;390;364;362;362;362;362;362;362;362;362;304;293;261;230;227;220;214;214;214","GIANFRANCO DELLE FAVE;FRANCESCO PANZUTO;PAOLO MARCHETTI;ANDREA FERRETTI;ANDREA TUBARO;MARIA RINZIVILLO;ADRIANA BONIFACINO;GABRIELE CAPURSO;MATTIA FABBRI;EDOARDO MONACO;RICCARDO MARIA LANZETTI;MARIA PIA VILLA;ALESSANDRO PESCE;PAOLO GIRARDI;MELANIA EVANGELISTI;COSIMO DE NUNZIO;PIETRO DE ROSSI;ANDREA BOTTICELLI;MAURIZIO POMPILI;ANGELO DE CARLI","800;293;247;181;180;180;175;174;150;149;137;128;123;123;121;118;117;113;113;112","PAOLO MARCHETTI;PAOLO GIRARDI;MAURIZIO POMPILI;GIANFRANCO DELLE FAVE;ANDREA TUBARO;ANDREA FERRETTI;COSIMO DE NUNZIO;GABRIELE CAPURSO;EDOARDO MONACO;GIAN MARIA PACIFICI;C. PASQUAZZI;GIULIANO TOCCI;GIOVANNA MARCHINI;MATTIA FABBRI;ANDREA BOTTICELLI;MARIA PIA VILLA;MATTIA FALCHETTO OSTI;DARIA PIACENTINO;FRANCESCO PANZUTO;MAURIZIO VALERIANI","28;14;14;12;9;8;8;7;7;7;7;7;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;ECONOMICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;SOCIOLOGY;ART;GEOLOGY;HISTORY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","217;50;30;15;14;12;11;9;5;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;GASTROENTEROLOGY;PSYCHIATRY;PATHOLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;BIOCHEMISTRY;PALEONTOLOGY;CLINICAL PSYCHOLOGY;CARDIOLOGY;IMMUNOLOGY;UROLOGY;ENDOCRINOLOGY;PHARMACOLOGY;GENETICS;NUCLEAR MEDICINE;NURSING;PEDIATRICS","170;61;57;34;30;29;24;24;19;18;16;15;15;14;13;13;11;10;10;10","CANCER;COHORT;POPULATION;DISEASE;ADVERSE EFFECT;CHEMOTHERAPY;CONFIDENCE INTERVAL;GENE;STAGE (STRATIGRAPHY);RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;BLOOD PRESSURE;CLINICAL TRIAL;LUNG CANCER;NEUROENDOCRINE TUMORS;POISON CONTROL;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;ANTIBIOTICS;ANXIETY;DEPRESSION (ECONOMICS);INCIDENCE (GEOMETRY);MULTIVARIATE ANALYSIS;MYOCARDIAL INFARCTION","72;24;20;19;17;12;12;12;12;11;10;10;10;9;9;9;9;9;8;8;8;8;8;8","BREAST CANCER;PROSTATE CANCER;COLORECTAL CANCER;IMMUNOTHERAPY;PROSTATE;CLINICAL ENDPOINT;HAZARD RATIO;BIPOLAR DISORDER;GENOTYPE;INJURY PREVENTION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;HEPATITIS C VIRUS;PANCREATIC CANCER;UNIVARIATE ANALYSIS;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;PHASES OF CLINICAL RESEARCH;ADJUVANT THERAPY;ALLELE;AMBULATORY BLOOD PRESSURE;BECK DEPRESSION INVENTORY;CERVICAL DYSTONIA;EJECTION FRACTION;METFORMIN;PLACEBO;POLYSOMNOGRAPHY;PROGRESSION-FREE SURVIVAL;RADIOSURGERY;RITUXIMAB;SUICIDE PREVENTION","16;13;12;10;9;8;8;6;6;6;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","LOWER URINARY TRACT SYMPTOMS;NIVOLUMAB;SUICIDAL IDEATION;ANTEROLATERAL LIGAMENT;METASTATIC BREAST CANCER;MANIA;OXALIPLATIN;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBAVIRIN;TRASTUZUMAB;ANDROGEN DEPRIVATION THERAPY;BECK HOPELESSNESS SCALE;HEPACIVIRUS;SINGLE-NUCLEOTIDE POLYMORPHISM;TAXANE;ANAPLASTIC LYMPHOMA KINASE;ANDROGEN RECEPTOR;ANTHRACYCLINE;BONE METASTASIS;CAPECITABINE;CARDIAC RESYNCHRONIZATION THERAPY;CEFTAZIDIME;CRIZOTINIB;DOMESTIC VIOLENCE;FRACTIONAL FLOW RESERVE;IPILIMUMAB;IRINOTECAN;MASKED HYPERTENSION;MASTECTOMY;NEOADJUVANT THERAPY;SUICIDE ATTEMPT;TRIPLE-NEGATIVE BREAST CANCER;WATCHFUL WAITING","6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;ITALY;TREATMENT OUTCOME;NEUROENDOCRINE TUMORS;PANCREATIC NEOPLASMS;RETROSPECTIVE STUDIES;YOUNG ADULT;ANTINEOPLASTIC AGENTS;ADOLESCENT;RISK FACTORS;AGED, 80 AND OVER;BREAST NEOPLASMS;BIPOLAR DISORDER;CHILD","114;106;89;88;73;66;54;39;32;25;24;23;19;18;17;17;16;15;14;14","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;CANCER IMMUNOTHERAPY;PHARMACOKINETICS OF ANTIBIOTICS IN CRITICALLY ILL PATIENTS;EPIDEMIOLOGY AND MANAGEMENT OF BIPOLAR DISORDER;HEPATITIS C INFECTION AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF LUNG CANCER;ADVANCEMENTS IN LUNG CANCER RESEARCH;CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS IN BREAST CANCER;GLIOMAS;HER2 SIGNALING IN BREAST CANCER TREATMENT;LYMPHOID NEOPLASMS;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;PANCREATIC CANCER RESEARCH AND TREATMENT;ROLE OF AMP-ACTIVATED PROTEIN KINASE IN CELLULAR METABOLISM;SCHIZOPHRENIA RESEARCH AND TREATMENT;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES","11;8;8;7;7;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3","TREATMENT;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;CLINICAL ENDPOINT;DEPRESSION (ECONOMICS);NEOADJUVANT THERAPY;BIOMARKERS FOR IMMUNOTHERAPY;BREAST CANCER;DISCONTINUATION;EVEROLIMUS;KNEE BIOMECHANICS;ANTEROLATERAL LIGAMENT;CLINICAL PHARMACOLOGY;EXPANDED ACCESS;METASTATIC BREAST CANCER;TUMOR MICROENVIRONMENT;UNIVARIATE ANALYSIS;CARDIOVASCULAR RISK ASSESSMENT;GASTROENTEROPANCREATIC NEOPLASMS;PANCREATIC CANCER","11;10;9;8;8;8;7;6;6;6;6;5;5;5;5;5;5;4;4;4","BREAST CANCER;CANCER PATIENTS;ACCESS PROGRAM;CLINICAL PHARMACOLOGY;COHORT STUDY;EXPANDED ACCESS;NEUROENDOCRINE TUMORS;PROSTATE CANCER;BENIGN PROSTATIC;METASTATIC BREAST;OBSERVATIONAL STUDY;PANCREATIC NEUROENDOCRINE;PATIENTS PTS;PATIENTS TREATED;ANTEROLATERAL LIGAMENT;CANCER MBC;CASTRATION-RESISTANT PROSTATE;COLON CANCER;IIIII COLON;ITALIAN EXPANDED;LEFT VENTRICULAR;METASTATIC CASTRATION-RESISTANT;PROGRAM EAP;PROSTATIC ENLARGEMENT;REAL LIFE;STAGE IIIII;TOSCA TRIAL;ABIRATERONE ACETATE;ADJUVANT TOSCA;ADVANCED SQUAMOUS","10;7;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","HR CI;ADVERSE EVENTS;PTS TREATED;MENTAL STATUS;CLINICAL TRIALS;PROGRESSION-FREE SURVIVAL;MEDIAN AGE;ALTERED MENTAL;CLINICAL PRACTICE;PTS RECEIVED;RESPONSE RATE;ACHILLES TENDON;LUNG CANCER;MIRABEGRON MG;OBSERVATIONAL STUDY;PHASE III;RISK FACTORS;COHORT STUDY;COMPLETE RESPONSE;ENTITY RESPONSIBLE;INTERPERSONAL SENSITIVITY;LEGAL ENTITY;PATIENTS PTS;PD-L EXPRESSION;ROME ITALY;STATISTICALLY SIGNIFICANT;SURVIVAL OS;BREAST CANCER;CANCER PATIENTS;CONFIDENCE INTERVAL","19;15;15;14;13;12;11;10;10;10;10;9;9;9;9;9;9;8;8;8;8;8;8;8;8;8;8;7;7;7",75,0.34,5.8,6,3,1,1,3,1,0,1,7,0,0,6,1,1,2.5,2.5,4,2,0,0,66.5,66.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,4.5,1026.75,6.27,8,0.44,104.89,0,0,0,0,6,0,2,10,0,10,8,0,0,0,0,0,0,17,1,0,15,0,0,1,2,0,0,0,0,0,"Italy;United States;Denmark;Japan","8;3;2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","15;7;4;4;3;3;2;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;BRAIN DISORDERS;CARDIOVASCULAR;HEART DISEASE;NEUROSCIENCES;LUNG;AGING;AUTOIMMUNE DISEASE;BREAST CANCER;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;HEMATOLOGY;MENTAL HEALTH;NEURODEGENERATIVE;PAIN RESEARCH;RARE DISEASES;SERIOUS MENTAL ILLNESS","15;8;5;5;4;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2","CANCER;CARDIOVASCULAR;NEUROLOGICAL;MENTAL HEALTH;ORAL AND GASTROINTESTINAL;RESPIRATORY","4;4;2;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","11;2;2;1","BREAST CANCER;LUNG CANCER;MYELOMA","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"PUBLIC LIBRARY OF SCIENCE;THE CAMBRIDGE STRUCTURAL DATABASE","11;1","42 HEALTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;4206 PUBLIC HEALTH;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3103 ECOLOGY;3203 DENTISTRY;39 EDUCATION;3901 CURRICULUM AND PEDAGOGY;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4301 ARCHAEOLOGY;47 LANGUAGE, COMMUNICATION AND CULTURE;4905 STATISTICS","7;6;3;3;2;2;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;CLINICAL RESEARCH;DIABETES;MIND AND BODY;NUTRITION;OBESITY;PREVENTION","1;1;1;1;1;1;1","CARDIOVASCULAR;CANCER;INFECTION;METABOLIC AND ENDOCRINE;STROKE","3;1;1;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.7 PHYSICAL","1;1","CLINICAL;POPULATION & SOCIETY","2;1","CLINICAL MEDICINE AND SCIENCE","3","BREAST CANCER","1",NA,NA
"AOU_SANTANDREA",2018,241,15.5103734439834,2.98755186721992,0.381742738589212,0.327800829875519,0.556016597510373,1.8,1.33333333333333,1.68085106382979,1.28846153846154,0.485477178423237,7,113,59,18,25,0.47,0.24,0.07,0.1,21.86,0.716492034047228,4.4244741873805,0.352697095435685,0.921161825726141,0.485,0.395,0.472,0.43,"PAOLO MARCHETTI;COSIMO DE NUNZIO;MAURIZIO POMPILI;ANDREA FERRETTI;ANDREA TUBARO;GABRIELE CAPURSO;LÍVIA ARCHIBUGI;ANDREA BOTTICELLI;MARCO MAZZOTTA;GIANFRANCO DELLE FAVE;GENNARO CILIBERTO;GEORGIOS D. KOTZALIDIS;PAOLO GIRARDI;MARCELLO MAUGERI‐SACCÀ;LAURA PIZZUTI;PATRIZIA VICI;GABRIELE SANI;MADDALENA BARBA;RICCARDO LOMBARDO;ALESSANDRO FRATI","21;12;12;11;10;10;9;9;9;9;8;8;8;7;7;7;7;7;7;6","GIAN MARIA PACIFICI;ANDREA FERRETTI;PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA TUBARO;MAURIZIO POMPILI;ANNA COMPARELLI;LÍVIA ARCHIBUGI;GABRIELE CAPURSO;MARIA PIA VILLA;RICCARDO LOMBARDO;EDOARDO MONACO;FABIO CONTEDUCA;ANTONINO RACO;ALESSANDRO PESCE;MELANIA EVANGELISTI;ANDREA REDLER;GABRIELE SANI;ALESSANDRO FRATI;GEORGIOS D. KOTZALIDIS","6;1.63;1.51;1.3;1.29;1.07;1.05;1.04;1.01;0.92;0.85;0.85;0.84;0.84;0.84;0.82;0.81;0.79;0.78;0.78","PAOLO MARCHETTI;COSIMO DE NUNZIO;MAURIZIO POMPILI;ANDREA FERRETTI;ANDREA TUBARO;GABRIELE CAPURSO;LÍVIA ARCHIBUGI;ANDREA BOTTICELLI;MARCO MAZZOTTA;GIANFRANCO DELLE FAVE;GEORGIOS D. KOTZALIDIS;PAOLO GIRARDI;GABRIELE SANI;RICCARDO LOMBARDO;ALESSANDRO FRATI;MAURIZIO SIMMACO;FRANCESCO PANZUTO;ANTONINO RACO;ALESSANDRO PESCE;MARIA RINZIVILLO","21;12;12;11;10;10;9;9;9;9;8;8;7;7;6;6;6;6;6;6","GIAN MARIA PACIFICI;ANDREA FERRETTI;PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA TUBARO;MAURIZIO POMPILI;ANNA COMPARELLI;LÍVIA ARCHIBUGI;GABRIELE CAPURSO;MARIA PIA VILLA;RICCARDO LOMBARDO;EDOARDO MONACO;FABIO CONTEDUCA;ANTONINO RACO;ALESSANDRO PESCE;MELANIA EVANGELISTI;ANDREA REDLER;GABRIELE SANI;ALESSANDRO FRATI;GEORGIOS D. KOTZALIDIS","6;1.63;1.51;1.3;1.29;1.07;1.05;1.04;1.01;0.92;0.85;0.85;0.84;0.84;0.84;0.82;0.81;0.79;0.78;0.78","ANNA COSTANTINI;PAOLO MARCHETTI;BERNHARD HOLZNER;GEORG KEMMLER;MORTEN AAGAARD PETERSEN;PETER FAYERS;NEIL K. AARONSON;ANNIKA WALDMANN;C. DANIEL JOHNSON;GREGOR LIEGL;K TOMASZEWSKI;M. GROENVOLD;MATTHIAS ROSE;SANDRA NOLTE;T. YOUNG;GIANFRANCO DELLE FAVE;MAURIZIO POMPILI;FRANCESCO PANZUTO;MARIA RINZIVILLO;COSIMO DE NUNZIO","509;490;457;457;457;457;411;379;379;379;379;379;379;379;379;368;311;289;289;275","ANNA COSTANTINI;GIANFRANCO DELLE FAVE;PAOLO MARCHETTI;FRANCESCO PANZUTO;COSIMO DE NUNZIO;MARIA RINZIVILLO;MAURIZIO POMPILI;GIANLUCA SCUDERI;JÁNOS FEHÉR;MAURIZIO SIMMACO;ANDREA TUBARO;MARIA ROSARIA TORRISI;GIOVANNI ANTONINI;ANDREA FERRETTI;GABRIELE CAPURSO;ALBERTO SIGNORE;PAOLO GIRARDI;ALBERTO FORTE;ANDREA REDLER;GABRIELE SANI","509;368;327;289;275;271;270;201;201;194;169;168;164;156;155;150;148;140;137;136","PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA FERRETTI;ANDREA TUBARO;MAURIZIO POMPILI;GIANFRANCO DELLE FAVE;GABRIELE CAPURSO;GEORGIOS D. KOTZALIDIS;LÍVIA ARCHIBUGI;MARCO MAZZOTTA;PAOLO GIRARDI;RICCARDO LOMBARDO;FRANCESCO PANZUTO;GIAN MARIA PACIFICI;ALESSANDRO PESCE;ANDREA REDLER;ANTONINO RACO;EDOARDO MONACO;MARIA PIA VILLA;ANDREA BOTTICELLI","15;12;11;10;10;9;9;8;8;7;7;7;6;6;6;6;6;6;6;5","MEDICINE;BIOLOGY;PSYCHOLOGY;ECONOMICS;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;CHEMISTRY;ENGINEERING;POLITICAL SCIENCE;HISTORY;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;GEOGRAPHY;GEOLOGY;ART;ENVIRONMENTAL SCIENCE","233;49;30;19;19;17;16;15;9;8;3;3;3;3;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;PSYCHIATRY;ONCOLOGY;GASTROENTEROLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;CARDIOLOGY;IMMUNOLOGY;GENETICS;BIOCHEMISTRY;PEDIATRICS;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE;MACROECONOMICS;NURSING;PHYSICAL THERAPY;UROLOGY;CANCER RESEARCH;PALEONTOLOGY","166;65;47;47;38;37;34;24;22;22;19;17;17;16;16;15;13;13;13;12;12","CANCER;DISEASE;POPULATION;COHORT;GENE;CHEMOTHERAPY;DEPRESSION (ECONOMICS);ANXIETY;QUALITY OF LIFE (HEALTHCARE);ALTERNATIVE MEDICINE;MULTIVARIATE ANALYSIS;PROSPECTIVE COHORT STUDY;ADVERSE EFFECT;RETROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;MOOD;NEUROLOGY;POISON CONTROL;BODY MASS INDEX;HEART FAILURE;LUNG CANCER;LYMPHOMA;MAGNETIC RESONANCE IMAGING","52;28;23;21;19;17;15;14;14;12;12;12;11;11;9;9;9;9;8;8;8;8;8","COLORECTAL CANCER;PROSTATE;PROSTATE CANCER;IMMUNOTHERAPY;SUICIDE PREVENTION;ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION;BREAST CANCER;CLINICAL ENDPOINT;PANCREATIC CANCER;RITUXIMAB;BECK DEPRESSION INVENTORY;GENOTYPE;HAZARD RATIO;MAJOR DEPRESSIVE DISORDER;PARKINSON'S DISEASE;DEMENTIA;METASTASIS;MUTATION;NEURORADIOLOGY;NEUTROPENIA;PROGRESSION-FREE SURVIVAL;SPIROMETRY;TOLERABILITY","11;9;8;7;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4","NIVOLUMAB;SUICIDAL IDEATION;LOWER URINARY TRACT SYMPTOMS;METASTATIC BREAST CANCER;PROSTATE BIOPSY;PROSTATECTOMY;ARTEMISININ;BECK HOPELESSNESS SCALE;BENDAMUSTINE;COLONOSCOPY;CORTICOSPINAL TRACT;FRACTIONAL ANISOTROPY;IRINOTECAN;KYNURENINE;LACHMAN TEST;OXALIPLATIN;PANCREATIC DUCTAL ADENOCARCINOMA;RECTAL EXAMINATION;RIBAVIRIN;SINGLE-NUCLEOTIDE POLYMORPHISM;TIMI;TRACTOGRAPHY","5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;MIDDLE AGED;AGED;;ADULT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;YOUNG ADULT;PANCREATIC NEOPLASMS;ADOLESCENT;AGED, 80 AND OVER;RISK FACTORS;PROSPECTIVE STUDIES;PROSTATIC NEOPLASMS;NEOPLASMS;NEUROENDOCRINE TUMORS;FOLLOW-UP STUDIES","158;129;122;101;89;79;75;53;35;33;25;24;21;21;21;20;20;19;19;18","PROSTATE CANCER RESEARCH AND TREATMENT;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;PANCREATIC CANCER RESEARCH AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;CANCER IMMUNOTHERAPY;CANCER SURVIVORSHIP AND QUALITY OF LIFE;LYMPHOID NEOPLASMS;MALARIA;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIFFUSION MAGNETIC RESONANCE IMAGING;EMOTION REGULATION AND PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HEPATITIS C INFECTION AND TREATMENT;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS","8;7;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","DEPRESSION (ECONOMICS);PANCREATIC NEUROENDOCRINE TUMORS;TREATMENT;CLINICAL ENDPOINT;ETIOLOGY;PROSTATE CANCER;DIAGNOSIS;KNEE BIOMECHANICS;NEUROENDOCRINE TUMORS;SUICIDE RISK;DEPRESSION;DISCONTINUATION;GRADING (ENGINEERING);NEURORADIOLOGY;PANCREATIC CANCER;PROGRESSION-FREE SURVIVAL;PSYCHOLOGICAL AUTOPSY;REGIMEN;TOLERABILITY;ANTERIOR CRUCIATE LIGAMENT","12;8;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;3","CANCER PATIENTS;COHORT STUDY;OBSERVATIONAL STUDY;PROSTATE CANCER;BREAST CANCER;HEART FAILURE;LUNG CANCER;MULTICENTER STUDY;NEUROENDOCRINE TUMORS;RISK FACTORS;COLORECTAL CANCER;DISORDERED BREATHING;PANCREATIC CANCER;SLEEP DISORDERED;ANTERIOR CRUCIATE;CELL LUNG;CELL LYMPHOMA;CLINICAL PHARMACOLOGY;CRUCIATE LIGAMENT;EMERGENCY DEPARTMENT;HEALTH-RELATED QUALITY;ITALIAN COHORT;ITALIAN MULTICENTRE;LIGAMENT RECONSTRUCTION;MULTIPLE SCLEROSIS;NON-SMALL CELL;PANCREATIC NEUROENDOCRINE;PARKINSONS DISEASE;PATIENTS TREATED;PRELIMINARY RESULTS","9;8;6;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PATIENTS TREATED;DEPRESSIVEANXIOUS MOOD;HR CI;ADVISORY BOARD;CANCER PATIENTS;THYROID CARCINOMA;CONFIDENCE INTERVAL;MEDULLARY THYROID;PROGRESSION-FREE SURVIVAL;MULTIVARIATE ANALYSIS;PROSTATE CANCER;RISK FACTORS;SURVIVAL OS;VALVE TREATMENT;ADVERSE EVENTS;BODY MASS;CONSECUTIVE PATIENTS;LOGISTIC REGRESSION;MEDIAN PFS;MULTIVARIATE COX;CARDIAC SYNCOPE;KYNTRP RATIO;MONTHS CI;RESPONSE RATE;SOMATOSTATIN ANALOGUES;SUICIDE RISK;TYPICAL CIDP;BREAST CANCER;HAZARD RATIO;MASS INDEX","20;17;13;12;12;12;11;11;11;10;10;10;10;10;9;9;9;9;9;9;8;8;8;8;8;8;8;7;7;7",120,0.5,7,6,1.75,1,1,1.25,1,0,1,6,1,1,6,1,1,1.25,3,5,2.5,0,0,67,67,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,3.94,1141.5,5.08,4,0.21,81.89,0,0,0,1,4,0,2,12,0,8,10,0,0,0,0,0,0,18,0,1,18,1,0,0,0,0,0,0,0,0,"Italy;United States;Germany","5;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;46 INFORMATION AND COMPUTING SCIENCES;4605 DATA MANAGEMENT AND DATA SCIENCE","16;9;5;3;3;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;AUTOIMMUNE DISEASE;CARDIOVASCULAR;MULTIPLE SCLEROSIS;PREVENTION;CANCER;HEART DISEASE;PATIENT SAFETY;GENETICS;RARE DISEASES;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS","16;10;5;5;5;4;4;4;4;3;3;3;2;2;1;1;1;1;1;1","CANCER;NEUROLOGICAL;MUSCULOSKELETAL;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE","3;3;2;1;1;1","6.1 PHARMACEUTICALS;6.7 PHYSICAL;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","8;2;1;1;1","BLADDER CANCER;COLON AND RECTAL CANCER;KIDNEY CANCER;LEUKEMIA / LEUKAEMIA;LIVER CANCER","1;1;1;1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;51 PHYSICAL SCIENCES","5;2;2;1;1;1","CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;DIABETES;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE","1;1;1;1;1;1;1;1;1","INFECTION;METABOLIC AND ENDOCRINE","1;1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","2;1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","3","LIVER CANCER","2",NA,NA
"AOU_SANTANDREA",2019,228,16.6052631578947,2.79385964912281,0.307017543859649,0.241228070175439,0.350877192982456,1.65025906735751,1.32075471698113,1.48648648648649,1.31147540983607,0.548245614035088,0,95,72,26,15,0.42,0.32,0.11,0.07,19.04,0.782792942140717,4.65816326530612,0.337719298245614,0.907894736842105,0.468,0.387,0.468,0.42,"PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA TUBARO;MARIA CHRISTINA COX;GABRIELE CAPURSO;STEFAN HOHAUS;MARIO VETRANO;GIORGIA TEMA;ANDREA FERRETTI;SEVERINO PERSECHINO;MAURIZIO POMPILI;AGOSTINO TAFURI;ARIANNA DI NAPOLI;LUIGI SCHIPS;BRUNO ANNIBALE;MARIA CHIARA VULPIANI;FRANCESCO PANZUTO;MARIA RINZIVILLO;ALESSANDRO ANTONELLI;PAOLO MARTELLETTI","22;14;13;11;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;5","PAOLO MARCHETTI;ALDO PEZZUTO;ANDREA TUBARO;MARIA PIA VILLA;COSIMO DE NUNZIO;MELANIA EVANGELISTI;ROBERTO BECELLI;GIORGIO MATARAZZO;ANDREA FERRETTI;ALBERTO RÍCCI;MAURIZIO POMPILI;SEVERINO PERSECHINO;GIUSEPPE VANELLA;GABRIELE SANI;GIORGIA TEMA;PAOLO MARTELLETTI;MICHELA D’ASCANIO;MARIO VETRANO;DANIELE MAZZA;PAOLA BEGINI","1.48;1.19;1.18;1.12;1.01;1;1;1;0.81;0.81;0.8;0.77;0.75;0.67;0.65;0.63;0.62;0.59;0.59;0.58","PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA TUBARO;MARIA CHRISTINA COX;GABRIELE CAPURSO;MARIO VETRANO;GIORGIA TEMA;ANDREA FERRETTI;SEVERINO PERSECHINO;MAURIZIO POMPILI;AGOSTINO TAFURI;ARIANNA DI NAPOLI;BRUNO ANNIBALE;MARIA CHIARA VULPIANI;FRANCESCO PANZUTO;MARIA RINZIVILLO;PAOLO MARTELLETTI;RAFFAELE GIUSTI;MATTEO GARIBALDI;MAURIZIO SIMMACO","22;14;13;11;8;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5","PAOLO MARCHETTI;ALDO PEZZUTO;ANDREA TUBARO;MARIA PIA VILLA;COSIMO DE NUNZIO;MELANIA EVANGELISTI;ROBERTO BECELLI;ANDREA FERRETTI;ALBERTO RÍCCI;MAURIZIO POMPILI;SEVERINO PERSECHINO;GIUSEPPE VANELLA;GABRIELE SANI;GIORGIA TEMA;PAOLO MARTELLETTI;MICHELA D’ASCANIO;MARIO VETRANO;DANIELE MAZZA;PAOLA BEGINI;MASSIMO MARIGNANI","1.48;1.19;1.18;1.12;1.01;1;1;0.81;0.81;0.8;0.77;0.75;0.67;0.65;0.63;0.62;0.59;0.59;0.58;0.58","JEANIN E. VAN HOOFT;JEAN‐MARC DUMONCEAU;MÁRIO DINIS‐RIBEIRO;BRUNO ANNIBALE;DIOGO LIBÂNIO;ERNST J. KUIPERS;FRANÇIS MÉGRAUD;FÁTIMA CARNEIRO;GIANLUCA ESPOSITO;ILZE ĶIKUSTE;JEAN–FRANÇOIS FLÉJOU;MIGUEL AREIA;MÓNICA GARRIDO;MĀRCIS LEJA;PEDRO PIMENTEL‐NUNES;RICARDO MARCOS‐PINTO;RITA BARROS;TAMARA MATYSIAK‐BUDNIK;LORENZO FUCCIO;GIUSEPPE VANELLA","1192;1166;1166;903;737;737;737;737;737;737;737;737;737;737;737;737;737;737;450;433","BRUNO ANNIBALE;GIANLUCA ESPOSITO;GIUSEPPE VANELLA;PAOLO MARCHETTI;AGOSTINO TAFURI;COSIMO DE NUNZIO;ANDREA TUBARO;FRANCESCO PANZUTO;MARIA RINZIVILLO;MAURIZIO POMPILI;SALVATORE DI SOMMA;MARIA CHRISTINA COX;GIORGIA TEMA;ENRICO MONTEFUSCO;GIANLUCA COSTA;SEVERINO PERSECHINO;GIOVANNI ANTONINI;ALDO PEZZUTO;CAROLINA CASINI;RICCARDO LOMBARDO","860;737;433;389;235;220;186;167;131;126;111;100;99;96;95;95;88;84;78;77","PAOLO MARCHETTI;COSIMO DE NUNZIO;ANDREA TUBARO;MARIA CHRISTINA COX;ANDREA FERRETTI;GIORGIA TEMA;MAURIZIO POMPILI;GABRIELE CAPURSO;SEVERINO PERSECHINO;ALBERTO RÍCCI;FRANCESCO PANZUTO;GIUSEPPE VANELLA;BRUNO ANNIBALE;DANIELE MAZZA;GIANLUCA COSTA;MARIA RINZIVILLO;MAURIZIO SIMMACO;RICCARDO LOMBARDO;ALDO PEZZUTO;AGOSTINO TAFURI","18;15;13;10;7;7;7;7;6;5;5;5;5;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;ENGINEERING;MATHEMATICS;ECONOMICS;CHEMISTRY;COMPUTER SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;GEOLOGY;BUSINESS;MATERIALS SCIENCE;ART;GEOGRAPHY;HISTORY","221;47;22;21;13;10;9;8;8;7;5;4;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;PATHOLOGY;GASTROENTEROLOGY;PSYCHIATRY;RADIOLOGY;GENETICS;IMMUNOLOGY;CARDIOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;UROLOGY;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;CANCER RESEARCH;NURSING;ANESTHESIA;CLINICAL PSYCHOLOGY;PALEONTOLOGY","160;69;46;40;31;29;23;22;22;20;19;16;16;15;15;14;13;12;11;11","CANCER;COHORT;DISEASE;CHEMOTHERAPY;GENE;POPULATION;RETROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;ADVERSE EFFECT;LYMPHOMA;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);CLINICAL TRIAL;MULTIVARIATE ANALYSIS;OBSERVATIONAL STUDY;DISCONTINUATION;MAGNETIC RESONANCE IMAGING;ANTIBODY;ANXIETY;INTERQUARTILE RANGE;LUNG CANCER;QUALITY OF LIFE (HEALTHCARE);RECEPTOR","50;21;18;16;16;16;15;14;13;12;10;10;9;9;9;8;8;7;7;7;7;7;7","BREAST CANCER;COLORECTAL CANCER;HAZARD RATIO;CLINICAL ENDPOINT;DIFFUSE LARGE B-CELL LYMPHOMA;PROSTATE;PROSTATE CANCER;RITUXIMAB;IMMUNOTHERAPY;TOLERABILITY;UNIVARIATE ANALYSIS;LENALIDOMIDE;NEPHRECTOMY;T CELL;BIPOLAR DISORDER;CERVICAL CANCER;CHRONIC LYMPHOCYTIC LEUKEMIA;GENOTYPE;INTERIM ANALYSIS;METASTASIS;MUTATION;NEUTROPENIA;PERFORMANCE STATUS;PLACEBO;PROGRESSION-FREE SURVIVAL;SUICIDE PREVENTION;VIRAL DISEASE","13;9;8;7;7;7;7;7;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","LOWER URINARY TRACT SYMPTOMS;ANTHRACYCLINE;COLONOSCOPY;METASTATIC BREAST CANCER;PROSTATECTOMY;SUICIDAL IDEATION;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ARTERY DISSECTION;ATROPHIC GASTRITIS;CAPECITABINE;CYSTECTOMY;ELISPOT;HUMAN PAPILLOMA VIRUS;IBRUTINIB;INTERNATIONAL PROGNOSTIC INDEX;LYMPH NODE METASTASIS;PHARMACOGENETICS;ABSCOPAL EFFECT;ACINIC CELL CARCINOMA;ACROMEGALY;ACUTE PROMYELOCYTIC LEUKEMIA;ADENOSQUAMOUS CARCINOMA;ADJUVANT CHEMOTHERAPY;ANAPLASTIC ASTROCYTOMA;ANTEROLATERAL LIGAMENT;ANTIBODY-DRUG CONJUGATE;ANTIRETROVIRAL THERAPY;AROMATASE;ARTHROPATHY;AUTISTIC TRAITS;AUTOIMMUNE GASTRITIS;AXITINIB;BENDAMUSTINE;BONE METASTASIS;BRAIN-DERIVED NEUROTROPHIC FACTOR;CANCER VACCINE;CARBOPLATIN;CHEMOIMMUNOTHERAPY;CHILDHOOD OBESITY;CHRONIC GASTRITIS;CLINICAL GLOBAL IMPRESSION;CONCURRENT VALIDITY;CONVERGENT VALIDITY;CORONAVIRUS DISEASE 2019 (COVID-19);DIFFUSING CAPACITY;DOCOSAHEXAENOIC ACID;ENDODERMAL SINUS TUMOR;ENTHESITIS;ERLOTINIB;ETV6;EXHALED NITRIC OXIDE;EXTERNAL BEAM RADIOTHERAPY;FERTILITY PRESERVATION;FRACTIONAL ANISOTROPY;GEFITINIB;GENETIC HETEROGENEITY;GENOTYPING;GERMINAL CENTER;HAPLOINSUFFICIENCY;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HEPACIVIRUS;HERPESVIRIDAE;HLA-DRB1;HORMONE RECEPTOR;HPV INFECTION;HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2;HYPOPNEA;IFOSFAMIDE;IL-2 RECEPTOR;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;INTRAEPITHELIAL NEOPLASIA;ITEM BANK;KRAS;LAMINOTOMY;LONG NON-CODING RNA;LYMPHOVASCULAR INVASION;MAMMAGLOBIN;MAMMARY GLAND;MANIA;MASTECTOMY;MEMBRANOUS NEPHROPATHY;METATARSALGIA;MICRONUCLEUS;MICROSATELLITE;MONTREAL COGNITIVE ASSESSMENT;NEOADJUVANT THERAPY;NIVOLUMAB;NON-CODING RNA;NON-SMALL CELL LUNG CANCER (NSCLC);ORAI1;OSWESTRY DISABILITY INDEX;PAPILLOMAVIRIDAE;PDCA;PEMBROLIZUMAB;PHENYLALANINE HYDROXYLASE;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POINT MUTATION;PROSTATE BIOPSY;PROSTATE-SPECIFIC ANTIGEN;RECURRENT MISCARRIAGE;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;REVERSE TRANSCRIPTASE;RUXOLITINIB;SANGER SEQUENCING;SUBICULUM;SUICIDE ATTEMPT;SØRENSEN–DICE COEFFICIENT;TLR2;TOLL-LIKE RECEPTOR;TRANSCRIPTOME;TRANSURETHRAL RESECTION OF THE PROSTATE;TRASTUZUMAB;TRIPLE-NEGATIVE BREAST CANCER;UNDERWEIGHT;UNEXPLAINED INFERTILITY;URINARY URGENCY;VENETOCLAX;VINCRISTINE;VINORELBINE;ZONA","6;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;RETROSPECTIVE STUDIES;ITALY;AGED, 80 AND OVER;POSTOPERATIVE COMPLICATIONS;TREATMENT OUTCOME;NEUROENDOCRINE TUMORS;PROGNOSIS;KIDNEY NEOPLASMS;YOUNG ADULT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CARCINOMA, RENAL CELL;FOLLOW-UP STUDIES;LYMPHOMA, LARGE B-CELL, DIFFUSE","123;104;97;97;77;63;54;40;33;29;28;26;18;18;17;17;15;15;15;15","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;LYMPHOID NEOPLASMS;RENAL CELL CARCINOMA;SLEEP-DISORDERED BREATHING AND HEALTH OUTCOMES;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PANCREATIC CANCER RESEARCH AND TREATMENT;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ACUTE MYELOID LEUKEMIA;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GASTRIC CANCER RESEARCH AND TREATMENT;IMMUNOBIOLOGY OF DENDRITIC CELLS;PROSTATE CANCER RESEARCH AND TREATMENT;STANDARDISATION AND MANAGEMENT OF COPD;;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ADVANCEMENTS IN LUNG CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BODY ART AND MODIFICATION PRACTICES IN SOCIETY","7;6;5;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2","TREATMENT;DISCONTINUATION;CLINICAL ENDPOINT;INTERQUARTILE RANGE;BREAST CANCER;MANTLE CELL LYMPHOMA;REGIMEN;DEPRESSION (ECONOMICS);GRADING (ENGINEERING);RADIOTHERAPY;STROKE (ENGINE);TOLERABILITY;UNIVARIATE ANALYSIS;CONCOMITANT;MIGRAINE PREVENTION;NEPHROLOGY;PANCREATIC NEUROENDOCRINE TUMORS;PULMONARY DISEASE;REFRACTORY (PLANETARY SCIENCE);ASSOCIATION (PSYCHOLOGY)","12;8;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;3","BREAST CANCER;CANCER PATIENTS;COHORT STUDY;ELDERLY PATIENTS;LUNG CANCER;MULTIPLE SCLEROSIS;B-CELL LYMPHOMA;CELL LUNG;MULTICENTER STUDY;PATIENTS TREATED;REAL WORLD;RETROSPECTIVE STUDY;RISK FACTORS;ADVANCED BREAST;CELL LYMPHOMA;CLINICAL PRACTICE;ERECTILE DYSFUNCTION;EUROPEAN SOCIETY;FONDAZIONE ITALIANA;ITALIANA LINFOMI;MAGNETIC RESONANCE;MULTICENTER COHORT;MULTICENTRE STUDY;NEUROENDOCRINE NEOPLASIA;NON-SMALL CELL;OBSERVATIONAL STUDY;PATIENTS PTS;PRELIMINARY RESULTS;PROSPECTIVE COHORT;PROSPECTIVE OBSERVATIONAL","9;7;7;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ADVISORY COMMITTEES;ENTITYS BOARD;ADVISORY CONSULTANCY;RESEARCH FUNDING;BUREAU EXPERT;EXPERT TESTIMONY;SPEAKER BUREAU;CONSULTANCY MEMBERSHIP;SPEAKERS BUREAU;CONSULTANCY SPEAKER;COMMITTEES SPEAKERS;CONSULTANCY HONORARIA;NOVARTIS HONORARIA;PFIZER HONORARIA;ACCOMMODATION EXPENSES;TRAVEL ACCOMMODATION;CONSULTANCY RESEARCH;ROCHE HONORARIA;CELGENE HONORARIA;EQUITY OWNERSHIP;FUNDING INSTITUTION;GRANT FUNDING;PATIENTS TREATED;RESEARCH GRANT;SUICIDAL IDEATION;ADVISORY BOARD;CONSULTANCY SPEAKERS;HONORARIA PFIZER;MEDIAN AGE;MULTIVARIATE ANALYSIS","107;107;85;71;61;61;61;60;52;45;25;24;22;22;19;19;15;15;13;13;13;13;13;13;13;12;12;12;12;12",95,0.42,6.05,6,3.25,1,0,1,1,0,1,7,0,1,6,1,0,1,2.75,4,3,0,0,46.5,46.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,4.93,2087.2,4.35,8,0.5,107.31,0,0,1,0,5,0,3,7,0,12,3,0,0,0,0,0,0,14,0,2,15,1,0,0,0,0,0,0,0,0,"Italy;United States;Germany","3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3209 NEUROSCIENCES;4205 NURSING","14;8;3;3;3;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;CARDIOVASCULAR;NEUROSCIENCES;AGING;BRAIN DISORDERS;HEART DISEASE;PREVENTION;RARE DISEASES;ATHEROSCLEROSIS;CANCER;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;NEURODEGENERATIVE;UROLOGIC DISEASES;AUTOIMMUNE DISEASE;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;EMERGING INFECTIOUS DISEASES","15;12;8;5;5;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1","CARDIOVASCULAR;NEUROLOGICAL;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL;STROKE","3;3;2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.4 SURGERY","11;3;2;1;1","BLADDER CANCER;KIDNEY CANCER;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER;PROSTATE CANCER","1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.2 SURVEILLANCE","2;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2020,276,16.8768115942029,2.55072463768116,0.257246376811594,0.231884057971014,0.463768115942029,1.82857142857143,1.33962264150943,1.48837209302326,1.25490196078431,0.648550724637681,4,115,64,25,15,0.42,0.23,0.09,0.05,22.1,0.876947744242339,5.53202328966521,0.351449275362319,0.960144927536232,0.535,0.415,0.408,0.454,"PAOLO MARCHETTI;MAURIZIO POMPILI;MAURIZIO SIMMACO;ANDREA TUBARO;COSIMO DE NUNZIO;FRANCESCO PANZUTO;GIOVANNI ANTONINI;RAFFAELE GIUSTI;PASQUALE PARISI;MARIA PIA VILLA;PAOLO MARTELLETTI;MARIA RINZIVILLO;ALESSIO CORTELLINI;AGOSTINO TAFURI;CORRADO FICORELLA;ALESSANDRO REPICI;ANDREA BOTTICELLI;BRUNO ANNIBALE;MELANIA EVANGELISTI;LUCA LEONARDI","18;15;12;12;11;10;10;9;9;9;8;8;8;7;7;7;7;7;7;7","MAURIZIO POMPILI;PAOLO MARTELLETTI;STEFANO BALDUCCI;MARIA PIA VILLA;PAOLO MARCHETTI;NOEMI CIFANI;GIANLUCA COSTA;MAURIZIO SIMMACO;MELANIA EVANGELISTI;SILVIA RIGUCCI;COSIMO DE NUNZIO;PIETRO FRANSVEA;FRANCESCO PANZUTO;ANTONELLA TAMMARO;MICHELANGELO LUCIANI;ENRICO BENTIVEGNA;ANDREA TUBARO;GIOVANNI ANTONINI;MATTEO GARIBALDI;GEORGIOS D. KOTZALIDIS","2.65;1.59;1.5;1.26;1.23;1.2;1.13;1.11;1.1;1;0.98;0.96;0.89;0.83;0.83;0.83;0.81;0.78;0.75;0.74","PAOLO MARCHETTI;MAURIZIO POMPILI;MAURIZIO SIMMACO;ANDREA TUBARO;COSIMO DE NUNZIO;FRANCESCO PANZUTO;GIOVANNI ANTONINI;RAFFAELE GIUSTI;PASQUALE PARISI;MARIA PIA VILLA;PAOLO MARTELLETTI;MARIA RINZIVILLO;AGOSTINO TAFURI;BRUNO ANNIBALE;MELANIA EVANGELISTI;LUCA LEONARDI;EMANUELA PILOZZI;MATTEO GARIBALDI;ANDREA LAGHI;GIANLUCA COSTA","18;15;12;12;11;10;10;9;9;9;8;8;7;7;7;7;7;6;6;6","MAURIZIO POMPILI;PAOLO MARTELLETTI;STEFANO BALDUCCI;MARIA PIA VILLA;PAOLO MARCHETTI;NOEMI CIFANI;GIANLUCA COSTA;MAURIZIO SIMMACO;MELANIA EVANGELISTI;SILVIA RIGUCCI;COSIMO DE NUNZIO;PIETRO FRANSVEA;FRANCESCO PANZUTO;ANTONELLA TAMMARO;MICHELANGELO LUCIANI;ENRICO BENTIVEGNA;ANDREA TUBARO;GIOVANNI ANTONINI;MATTEO GARIBALDI;GEORGIOS D. KOTZALIDIS","2.65;1.59;1.5;1.26;1.23;1.2;1.13;1.11;1.1;1;0.98;0.96;0.89;0.83;0.83;0.83;0.81;0.78;0.75;0.74","A BRIGNONE;ANDREA ANGHEBEN;ANGELINA PASSARO;CARLO SALVARANI;CATERINA TURRÀ;CLAUDIO NORBIATO;DOMENICO FRANCO MERLO;ELISABETTA TEOPOMPI;FABRIZIO BONI;G SECONDO;GIOVANNI CENDERELLO;GIOVANNI DOLCI;ILARIA PIAZZA;LORENZO DONGHI;LORENZO ZAMMARCHI;LUCA BRAGLIA;LUISA SAVOLDI;MARCO FALCONE;MARCO MASSARI;MARIO SALIO","655;655;655;655;655;655;655;655;655;655;655;655;655;655;655;655;655;655;655;655","A BRIGNONE;AGOSTINO TAFURI;PAOLO MARTELLETTI;COSIMO DE NUNZIO;ANDREA TUBARO;GUIDO IACCARINO;MAURIZIO POMPILI;GIOVANNI ANTONINI;PAOLO MARCHETTI;RAFFAELE GIUSTI;MAURIZIO SIMMACO;FRANCESCO PANZUTO;BRUNO ANNIBALE;ADRIANO MARCOLONGO;LUCA LEONARDI;C. ASCHELE;MARIA RINZIVILLO;MARIA CHRISTINA COX;MARCO FILETTI;GIOVANNI DI NARDO","655;516;467;461;422;365;300;190;189;176;143;140;136;135;130;121;121;120;114;99","MAURIZIO POMPILI;COSIMO DE NUNZIO;PAOLO MARCHETTI;ANDREA TUBARO;FRANCESCO PANZUTO;GIOVANNI ANTONINI;MARIA PIA VILLA;MARIA RINZIVILLO;RAFFAELE GIUSTI;AGOSTINO TAFURI;LUCA LEONARDI;PASQUALE PARISI;ANTONELLA TAMMARO;BRUNO ANNIBALE;EMILIO DI GIULIO;MARIA CHRISTINA COX;MATTEO GARIBALDI;MELANIA EVANGELISTI;C. ASCHELE;EMANUELA PILOZZI","14;13;12;11;10;10;8;8;8;7;7;7;6;6;6;6;6;6;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;ECONOMICS;POLITICAL SCIENCE;COMPUTER SCIENCE;CHEMISTRY;SOCIOLOGY;MATHEMATICS;MATERIALS SCIENCE;PHILOSOPHY;ENGINEERING;BUSINESS;HISTORY;ART;GEOGRAPHY","271;52;38;25;20;16;13;12;9;8;6;6;5;4;3;2;2","INTERNAL MEDICINE;SURGERY;PATHOLOGY;PSYCHIATRY;ONCOLOGY;GASTROENTEROLOGY;GENETICS;CLINICAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;CARDIOLOGY;INTENSIVE CARE MEDICINE;OPTICS;NURSING;MEDICAL EMERGENCY;PHYSICAL THERAPY;RADIOLOGY;PEDIATRICS;BIOCHEMISTRY;FAMILY MEDICINE;LAW","199;81;60;54;47;29;24;22;21;21;20;20;20;19;18;18;18;16;15;15;15","CANCER;DISEASE;RETROSPECTIVE COHORT STUDY;GENE;COHORT;CHEMOTHERAPY;INCIDENCE (GEOMETRY);OUTBREAK;POPULATION;ADVERSE EFFECT;PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;ANXIETY;CONFIDENCE INTERVAL;LUNG CANCER;DEPRESSION (ECONOMICS);MOOD;MULTIVARIATE ANALYSIS;OBSERVATIONAL STUDY;QUALITY OF LIFE (HEALTHCARE)","53;53;24;22;20;19;19;19;15;14;14;13;12;12;12;11;11;11;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);COLORECTAL CANCER;2019-20 CORONAVIRUS OUTBREAK;SUICIDE PREVENTION;HAZARD RATIO;PROSTATE;CLINICAL ENDPOINT;UNIVARIATE ANALYSIS;TOLERABILITY;RADIOSURGERY;ADENOCARCINOMA;BIPOLAR DISORDER;BREAST CANCER;CONVENTIONAL PCI;MUTATION;NEURORADIOLOGY;PARKINSON'S DISEASE;PROSTATE CANCER;TYPE 2 DIABETES;EJECTION FRACTION;INFLAMMATORY BOWEL DISEASE;METASTASIS;PROGRESSION-FREE SURVIVAL;THYROID CANCER","34;17;16;10;9;9;8;8;7;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);KRAS;LOWER URINARY TRACT SYMPTOMS;MANIA;PROSTATECTOMY;SUICIDAL IDEATION;COLONOSCOPY;DASATINIB;IMATINIB MESYLATE;LEVODOPA;PERIPHERAL T-CELL LYMPHOMA;SUICIDE ATTEMPT;ADJUVANT CHEMOTHERAPY;BECK HOPELESSNESS SCALE;BENDAMUSTINE;CEFTAZIDIME;CETUXIMAB;EDINBURGH POSTNATAL DEPRESSION SCALE;GESTATIONAL DIABETES;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;KLEBSIELLA PNEUMONIAE;KYNURENINE;NILOTINIB;SABR VOLATILITY MODEL;VATS LOBECTOMY","34;5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;MALE;FEMALE;MIDDLE AGED;ITALY;AGED;ADULT;COVID-19;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;LUNG NEOPLASMS;POSTOPERATIVE COMPLICATIONS;YOUNG ADULT;BRAIN NEOPLASMS;TREATMENT OUTCOME;ADOLESCENT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CHILD;CORONAVIRUS INFECTIONS","164;111;62;60;53;49;43;36;26;25;24;18;16;16;14;14;13;13;13;12","IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;CORONAVIRUS DISEASE 2019;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;COLORECTAL CANCER RESEARCH AND TREATMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;IMPACT OF MATERNAL MENTAL HEALTH ON OFFSPRING;SCHIZOPHRENIA RESEARCH AND TREATMENT;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;CANCER IMMUNOTHERAPY;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFICACY AND RESISTANCE IN CML TREATMENT;GLIOMAS","16;8;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;CONCOMITANT;DEPRESSION (ECONOMICS);UNIVARIATE ANALYSIS;NEUROENDOCRINE TUMORS;TOLERABILITY;TREATMENT;CANCER RISK;ETIOLOGY;PANCREATIC NEUROENDOCRINE TUMORS;RADIOTHERAPY;SUICIDE RISK;BIOMARKERS FOR IMMUNOTHERAPY;GUIDELINE;IMMUNE CHECKPOINT BLOCKADE;NEURORADIOLOGY;CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY;CLINICAL PRACTICE","21;15;8;8;8;8;7;7;7;6;6;6;6;6;5;5;5;5;4;4","COVID- PANDEMIC;CANCER PATIENTS;COHORT STUDY;CLINICAL PRACTICE;COLORECTAL CANCER;LUNG CANCER;OBSERVATIONAL STUDY;PARKINSONS DISEASE;PILOT STUDY;TYPE DIABETES;CHRONIC INFLAMMATORY;COVID- PATIENTS;DISEASE PATIENTS;EMERGENCY DEPARTMENT;GASTROINTESTINAL BLEEDING;INFLAMMATORY DEMYELINATING;MULTIPLE SCLEROSIS;NEUROENDOCRINE NEOPLASIA;PATIENTS TREATED;PROSPECTIVE COHORT;ADVANCED NEUROENDOCRINE;ADVANCED PARKINSONS;AWAKE SURGERY;BOWEL DISEASE;CHECKPOINT INHIBITORS;COLON CANCER;COVID- OUTBREAK;ELDERLY PATIENTS;INFLAMMATORY BOWEL;ITALIAN SOCIETY","10;8;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","LUNG CANCER;HR CI;CONSULTANCY HONORARIA;PATIENTS TREATED;RESEARCH FUNDING;MEDIAN AGE;COVID- PANDEMIC;MEDIAN FOLLOW-UP;CANCER PATIENTS;CONSECUTIVE PATIENTS;STAGE II;STATISTICALLY SIGNIFICANT;ADVISORY COMMITTEES;ENTITYS BOARD;KYNTRP RATIO;MONTHS NA;PROGNOSTIC FACTORS;SURVIVAL OS;ADVERSE EVENTS;CLINICAL PRACTICE;LOGISTIC REGRESSION;PATIENTS UNDERGOING;SPEAKERS BUREAU;COLORECTAL CANCER;CORONAVIRUS DISEASE;COVERT SMIC;DISEASE COVID-;ITALIAN CENTERS;MULTIVARIATE ANALYSIS;VEVCO SLOPE","34;31;22;22;21;18;17;14;13;13;13;13;12;12;12;12;12;12;11;11;11;11;11;10;10;10;10;10;10;10",142,0.51,9.5,7,1,2,0,2.75,1,1,1.25,9.75,1,0,7,1,2.5,1.75,4,5,4,0,0,55,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,4.89,606.72,5.43,11,0.58,74.32,0,0,7,0,6,0,1,5,0,15,3,0,0,0,0,0,0,18,0,1,18,1,0,0,0,0,0,0,0,0,"Italy;United States;Japan;Switzerland","5;5;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","18;9;9;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;LUNG;PREVENTION;RARE DISEASES;UROLOGIC DISEASES;NEUROSCIENCES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CARDIOVASCULAR;DIGESTIVE DISEASES;HEART DISEASE;INFECTIOUS DISEASES;LUNG CANCER;PNEUMONIA;PNEUMONIA & INFLUENZA;AGING;ATHEROSCLEROSIS","17;13;10;5;4;4;4;4;3;2;2;2;2;2;2;2;2;2;1;1","CANCER;CARDIOVASCULAR;MENTAL HEALTH;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","7;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","11;2;1;1;1","BLADDER CANCER;COLON AND RECTAL CANCER;LUNG CANCER;BREAST CANCER;NON-HODGKIN'S LYMPHOMA;PROSTATE CANCER","3;3;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","6;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;ZENODO;FRONTIERS;KARGER PUBLISHERS","5;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3401 ANALYTICAL CHEMISTRY;49 MATHEMATICAL SCIENCES;4905 STATISTICS;46 INFORMATION AND COMPUTING SCIENCES;4612 SOFTWARE ENGINEERING","15;4;4;3;2;2;2;2;2;1;1","CLINICAL RESEARCH;NEURODEGENERATIVE;NUTRITION;PREVENTION;CANCER;HEMATOLOGY;INFECTIOUS DISEASES;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;RARE DISEASES;SEPSIS","2;2;2;2;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;INFECTION","3;2;1","5.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","3;2;2;1;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH;PUBLIC HEALTH","4;1;1","LUNG CANCER;PANCREATIC CANCER","2;1","3 GOOD HEALTH AND WELL BEING","1"
"AOU_SANTANDREA",2021,269,16.8884758364312,2.68773234200743,0.312267657992565,0.315985130111524,0.330855018587361,1.90263157894737,1.29230769230769,1.57407407407407,1.28985507246377,0.672862453531598,2,119,59,20,24,0.44,0.22,0.07,0.09,12.91,0.836995311692001,5.84298584298583,0.353159851301115,0.929368029739777,0.472,0.432,0.483,0.439,"PAOLO MARCHETTI;COSIMO DE NUNZIO;AGOSTINO TAFURI;ANDREA TUBARO;MAURIZIO POMPILI;FRANCESCO PANZUTO;GIOVANNI ANTONINI;MAURIZIO SIMMACO;LUCA LEONARDI;RICCARDO LOMBARDO;RAFFAELE GIUSTI;MATTEO GARIBALDI;ARIANNA DI NAPOLI;FRANCESCO MERLI;LUIGI MARCHESELLI;ALESSANDRO BOZZAO;LUCA RICCIARDI;ANDREA ROMANO;PATRIZIA VICI;GUIDO GINI","16;16;15;15;12;11;11;8;8;8;7;7;7;7;7;7;7;6;6;6","FRANCESCO PANZUTO;MAURIZIO POMPILI;COSIMO DE NUNZIO;PAOLO MARCHETTI;ANDREA TUBARO;LUCA RICCIARDI;RAFFAELE D’AMELIO;ANTONINO RACO;ARIANNA DI NAPOLI;AGOSTINO TAFURI;SIMONETTA MONINI;CHIARA FILIPPI;MAURIZIO BARBARA;MARIA RINZIVILLO;GERARDO SALERNO;DANIELE MAZZA;RAFFAELE GIUSTI;ALESSANDRO CARROZZO;GEORGIOS D. KOTZALIDIS;MAURIZIO SIMMACO","1.98;1.82;1.52;1.35;1.13;1.02;1;0.97;0.86;0.82;0.79;0.79;0.79;0.78;0.76;0.75;0.74;0.73;0.71;0.69","PAOLO MARCHETTI;COSIMO DE NUNZIO;AGOSTINO TAFURI;ANDREA TUBARO;MAURIZIO POMPILI;FRANCESCO PANZUTO;GIOVANNI ANTONINI;MAURIZIO SIMMACO;LUCA LEONARDI;RICCARDO LOMBARDO;RAFFAELE GIUSTI;MATTEO GARIBALDI;ARIANNA DI NAPOLI;ALESSANDRO BOZZAO;LUCA RICCIARDI;ANDREA ROMANO;MARCO FILETTI;ANTONINO RACO;DANIELE MAZZA;MARIA RINZIVILLO","16;16;15;15;12;11;11;8;8;8;7;7;7;7;7;6;6;6;6;6","FRANCESCO PANZUTO;MAURIZIO POMPILI;COSIMO DE NUNZIO;PAOLO MARCHETTI;ANDREA TUBARO;LUCA RICCIARDI;RAFFAELE D’AMELIO;ANTONINO RACO;ARIANNA DI NAPOLI;AGOSTINO TAFURI;SIMONETTA MONINI;CHIARA FILIPPI;MAURIZIO BARBARA;MARIA RINZIVILLO;GERARDO SALERNO;DANIELE MAZZA;RAFFAELE GIUSTI;ALESSANDRO CARROZZO;GEORGIOS D. KOTZALIDIS;MAURIZIO SIMMACO","1.98;1.82;1.52;1.35;1.13;1.02;1;0.97;0.86;0.82;0.79;0.79;0.79;0.78;0.76;0.75;0.74;0.73;0.71;0.69","GIUSEPPE MINNITI;CHRISTIAN MAWRIN;D. VAN NIEUWENHUIZEN;DAMIEN C. WEBER;EMANUEL HOUDART;FELIX SAHM;FLORENCE LEFRANC;GHAZALEH TABATABAI;KITA SALLABANDA;MATTHIAS PREUSSER;MICHAEL D. JENKINSON;MICHAEL WELLER;MORTEN LUND‐JOHANSEN;PANTELIS STAVRINOU;RICCARDO SOFFIETTI;ROLAND GOLDBRUNNER;ÉMILIE LE RHUN;CARLO POZZILLI;PAOLO MARCHETTI;GUIDO COSTAMAGNA","396;378;378;378;378;378;378;378;378;378;378;378;378;378;378;378;378;225;219;183","GIUSEPPE MINNITI;CARLO POZZILLI;PAOLO MARCHETTI;MARIA PIA VILLA;GIOVANNI ANTONINI;FRANCESCO PANZUTO;COSIMO DE NUNZIO;RAFFAELE GIUSTI;MARIANNA SIGNORETTI;MARCO FILETTI;CARLO OLIVIERI;AGOSTINO TAFURI;ANDREA TUBARO;MARIA CHRISTINA COX;MATTEO GARIBALDI;LUCA PASQUINI;ALESSANDRO BOZZAO;ANDREA ROMANO;EMILIO DI GIULIO;A. DI NAPOLI","378;225;179;177;136;130;127;127;120;115;105;102;99;99;95;93;90;77;76;75","COSIMO DE NUNZIO;AGOSTINO TAFURI;ANDREA TUBARO;FRANCESCO PANZUTO;PAOLO MARCHETTI;GIOVANNI ANTONINI;MAURIZIO POMPILI;LUCA LEONARDI;RICCARDO LOMBARDO;MATTEO GARIBALDI;RAFFAELE GIUSTI;ALESSANDRO BOZZAO;ANTONINO RACO;MARCO SALVETTI;MARIA RINZIVILLO;MAURIZIO SIMMACO;GERARDO SALERNO;ANDREA FERRETTI;ANDREA ROMANO;ANTONIO NACCHIA","15;13;13;11;11;11;9;8;8;7;7;6;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;ENGINEERING;CHEMISTRY;SOCIOLOGY;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;ART;GEOLOGY;HISTORY;MATERIALS SCIENCE;BUSINESS;GEOGRAPHY","263;48;31;22;18;16;13;11;9;6;6;6;3;3;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;PSYCHIATRY;RADIOLOGY;GASTROENTEROLOGY;CARDIOLOGY;IMMUNOLOGY;PEDIATRICS;UROLOGY;CLINICAL PSYCHOLOGY;PHYSICAL THERAPY;GENETICS;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;OPTICS;VIROLOGY","197;83;48;47;43;37;31;21;20;20;20;19;19;18;17;16;16;13;12;12","CANCER;DISEASE;COHORT;RETROSPECTIVE COHORT STUDY;GENE;PROSPECTIVE COHORT STUDY;POPULATION;CHEMOTHERAPY;CONFIDENCE INTERVAL;LYMPHOMA;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;LUNG CANCER;MAGNETIC RESONANCE IMAGING;ANXIETY;CLINICAL TRIAL;LOGISTIC REGRESSION;NEUROLOGY;OBSERVATIONAL STUDY;OUTBREAK;RADIATION THERAPY","65;49;26;22;19;19;18;17;17;16;15;14;13;12;11;11;11;11;11;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;PROSTATE;COLORECTAL CANCER;2019-20 CORONAVIRUS OUTBREAK;PROSTATE CANCER;CLINICAL ENDPOINT;HAZARD RATIO;IMMUNOTHERAPY;NEURORADIOLOGY;UNIVARIATE ANALYSIS;DIFFUSE LARGE B-CELL LYMPHOMA;RADIOSURGERY;SUICIDE PREVENTION;CHRONIC LYMPHOCYTIC LEUKEMIA;EJECTION FRACTION;INTERIM ANALYSIS;MICRORNA;PROGRESSION-FREE SURVIVAL;PROGRESSIVE DISEASE;THYROID CANCER;TYROSINE KINASE","24;14;12;10;9;8;7;7;7;6;6;5;5;5;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);LOWER URINARY TRACT SYMPTOMS;METASTATIC BREAST CANCER;SUICIDAL IDEATION;ANTHRACYCLINE;BRUTON'S TYROSINE KINASE;NEOADJUVANT THERAPY;PEMBROLIZUMAB;PROSTATECTOMY;TRANSURETHRAL RESECTION OF THE PROSTATE;ACROMEGALY;AKATHISIA;ANAPLASTIC LYMPHOMA KINASE;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ANTEROLATERAL LIGAMENT;BENIGN PROSTATIC HYPERPLASIA (BPH);BLADDER OUTLET OBSTRUCTION;CARBOPLATIN;CARDIAC RESYNCHRONIZATION THERAPY;COLONOSCOPY;CYSTECTOMY;DASATINIB;IBRUTINIB;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC INDEX;MANIA;NILOTINIB;NIVOLUMAB;OXALIPLATIN;PROSTATE-SPECIFIC ANTIGEN;PROSTATITIS;SABR VOLATILITY MODEL;TARGET LESION;TERIFLUNOMIDE;TRIPLE-NEGATIVE BREAST CANCER","24;9;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;AGED;MIDDLE AGED;COVID-19;ADULT;RETROSPECTIVE STUDIES;ITALY;AGED, 80 AND OVER;PROSPECTIVE STUDIES;TREATMENT OUTCOME;SARS-COV-2;LUNG NEOPLASMS;PANCREATIC NEOPLASMS;ADOLESCENT;NEUROENDOCRINE TUMORS;RECTAL NEOPLASMS;THYROID NEOPLASMS","135;133;62;62;58;55;47;37;33;29;26;20;20;18;17;15;12;12;12;12","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;CANCER IMMUNOTHERAPY;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;LYMPHOID NEOPLASMS;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;DRUG METABOLISM AND PHARMACOGENOMICS;EFFICACY AND RESISTANCE IN CML TREATMENT;IMPACT OF COVID-19 ON MENTAL HEALTH;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MICROSURGICAL RECONSTRUCTION TECHNIQUES;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PROSTATE CANCER RESEARCH AND TREATMENT;RADIOMICS IN MEDICAL IMAGING ANALYSIS;SUICIDAL BEHAVIOR AND PREVENTION STRATEGIES","11;9;6;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3","PANDEMIC;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;NEURORADIOLOGY;STROKE (ENGINE);UNIVARIATE ANALYSIS;BIOMARKERS FOR IMMUNOTHERAPY;CANCER IMAGING;DEPRESSION (ECONOMICS);NEOADJUVANT THERAPY;REGIMEN;TUMOR HETEROGENEITY;CANCER IMMUNOEDITING;CANCER IN OLDER ADULTS;CARDIAC IMAGING;CONCOMITANT;CORONAVIRUS;GASTROENTEROPANCREATIC NEOPLASMS","11;10;10;9;8;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4","BREAST CANCER;COHORT STUDY;FONDAZIONE ITALIANA;ITALIANA LINFOMI;MULTICENTER STUDY;MULTIPLE SCLEROSIS;PROSTATE CANCER;CELL LYMPHOMA;COVID- PANDEMIC;LUNG CANCER;CANCER PATIENTS;DU LCA;ELDERLY PROJECT;HEART FAILURE;NEUROENDOCRINE NEOPLASMS;PATIENTS TREATED;PROSPECTIVE COHORT;PROSPECTIVE STUDY;RETROSPECTIVE MULTICENTER;RETROSPECTIVE STUDY;SURGICAL TREATMENT;B-CELL LYMPHOMA;BOWEL DISEASE;CAMPUS CML;CASE-CONTROL STUDY;CHRONIC MYELOID;COVID- PATIENTS;ELDERLY PATIENTS;INFLAMMATORY BOWEL;LINFOMI FIL","9;7;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","ADVISORY COMMITTEES;ENTITYS BOARD;CONSULTANCY HONORARIA;SPEAKERS BUREAU;RESEARCH FUNDING;ADVERSE EVENTS;DIAGNOSTIC ACCURACY;PATIENTS TREATED;HR CI;CLINICAL PRACTICE;MEDIAN AGE;MONTHS CI;MAGNETIC RESONANCE;ADVISORY BOARD;JANSSEN CONSULTANCY;SARS-COV- INFECTION;SURVIVAL OS;ACCOMODATIONS EXPENSES;CORONAVIRUS DISEASE;COVID- PANDEMIC;RATIO CI;TRAVEL ACCOMODATIONS;CANCER PATIENTS;DDR GENES;LUNG CANCER;SEGOND FRACTURE;COVID- PATIENTS;DISEASE COVID-;MEDIAN FOLLOW-UP;ODDS RATIO","56;56;36;34;26;19;19;18;17;16;16;16;15;14;14;14;14;13;13;13;13;13;12;12;12;12;11;11;11;11",135,0.5,6.93,7.5,1,2,0,5.5,4,1,1,9,1.25,1,7,1,1,2,4.75,6,6,0,0,36.5,36.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,3.64,2999.43,3.89,7,0.5,112.86,0,0,0,2,8,0,0,4,0,12,2,0,0,0,0,0,0,14,0,0,14,0,0,0,0,0,0,0,0,0,"Italy;United States;Japan","6;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;42 HEALTH SCIENCES;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","14;13;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PREVENTION;BRAIN DISORDERS;INFECTIOUS DISEASES;CARDIOVASCULAR;IMMUNIZATION;NEUROSCIENCES;VACCINE RELATED;EMERGING INFECTIOUS DISEASES;HEART DISEASE;HEMATOLOGY;RARE DISEASES;STROKE;AGING;ATHEROSCLEROSIS;BIOENGINEERING;BIOTECHNOLOGY;CANCER","14;12;8;8;4;4;3;3;3;3;2;2;2;2;2;1;1;1;1;1","CARDIOVASCULAR;STROKE;CANCER;INFECTION","3;2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;6.4 SURGERY","12;1;1;1","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,"ZENODO;FRONTIERS;KARGER PUBLISHERS;TAYLOR & FRANCIS GROUP","6;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS","20;9;4;4;2;2;2;1","PATIENT SAFETY;CLINICAL RESEARCH;PREVENTION;RARE DISEASES;CANCER;DIGESTIVE DISEASES;GENETICS;HEMATOLOGY;HUMAN GENOME;NEUROSCIENCES;PANCREATIC CANCER;PSORIASIS;BIOENGINEERING;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;UROLOGIC DISEASES","4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1","CANCER;SKIN;RENAL AND UROGENITAL","2;2;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY","3;2;1","CLINICAL;BIOMEDICAL","9;2","CLINICAL MEDICINE AND SCIENCE","10","CERVICAL CANCER;PANCREATIC CANCER;LEUKEMIA / LEUKAEMIA;PROSTATE CANCER","2;2;1;1",NA,NA
"AOU_SANTANDREA",2022,269,18.3903345724907,3.10408921933086,0.342007434944238,0.260223048327138,0.338289962825279,2.16883116883117,1.46031746031746,1.59090909090909,1.37878787878788,0.739776951672863,4,92,51,31,19,0.34,0.19,0.12,0.07,6.08,0.680877935058776,5.30713857228553,0.349442379182156,0.929368029739777,0.473,0.46,0.459,0.467,"COSIMO DE NUNZIO;ANDREA TUBARO;ANTONIO CICIONE;RICCARDO LOMBARDO;CARMEN GRAVINA;ANTONIO NACCHIA;AGOSTINO TAFURI;JORDI STIRA;LUCA RICCIARDI;RAFFAELE GIUSTI;ELISA MANCINI;OLIVIA ALESSANDRA VOGLINO;FRANCESCO PANZUTO;BEATRICE TURCHI;AGOSTINO TAFURI;SARA RIOLO;MASSIMO VOLPE;MARIA RINZIVILLO;LORENZO MARIA ROVESTI;ALBERTO MENOZZI","21;18;14;14;12;12;11;10;10;9;9;9;9;9;8;8;8;8;8;8","GIAN MARIA PACIFICI;COSIMO DE NUNZIO;GIOVANNA GALLO;ANDREA TUBARO;LUCA RICCIARDI;GIAN MARIA PACIFICI;ANTONIO CICIONE;RICCARDO LOMBARDO;FRANCESCO PANZUTO;MARCO FILETTI;RAFFAELE GIUSTI;LUCA PASQUINI;MARIA RINZIVILLO;MASSIMO VOLPE;ANTONIO NACCHIA;CARMEN GRAVINA;ALBERTO RÍCCI;MAURIZIO POMPILI;MATTEO GARIBALDI;BRUNO ANNIBALE","2;1.61;1.23;1.08;1.05;1;0.97;0.9;0.88;0.83;0.83;0.83;0.8;0.76;0.75;0.74;0.73;0.72;0.7;0.7","COSIMO DE NUNZIO;ANDREA TUBARO;ANTONIO CICIONE;RICCARDO LOMBARDO;CARMEN GRAVINA;ANTONIO NACCHIA;AGOSTINO TAFURI;JORDI STIRA;LUCA RICCIARDI;RAFFAELE GIUSTI;ELISA MANCINI;OLIVIA ALESSANDRA VOGLINO;FRANCESCO PANZUTO;BEATRICE TURCHI;AGOSTINO TAFURI;SARA RIOLO;MASSIMO VOLPE;MARIA RINZIVILLO;LORENZO MARIA ROVESTI;ALBERTO MENOZZI","21;18;14;14;12;12;11;10;10;9;9;9;9;9;8;8;8;8;8;8","GIAN MARIA PACIFICI;COSIMO DE NUNZIO;GIOVANNA GALLO;ANDREA TUBARO;LUCA RICCIARDI;GIAN MARIA PACIFICI;ANTONIO CICIONE;RICCARDO LOMBARDO;FRANCESCO PANZUTO;MARCO FILETTI;RAFFAELE GIUSTI;LUCA PASQUINI;MARIA RINZIVILLO;MASSIMO VOLPE;ANTONIO NACCHIA;CARMEN GRAVINA;ALBERTO RÍCCI;MAURIZIO POMPILI;MATTEO GARIBALDI;BRUNO ANNIBALE","2;1.61;1.23;1.08;1.05;1;0.97;0.9;0.88;0.83;0.83;0.83;0.8;0.76;0.75;0.74;0.73;0.72;0.7;0.7","FRANCESCO PANZUTO;MARIA RINZIVILLO;AGOSTINO TAFURI;BRUNO ANNIBALE;LUCA RICCIARDI;COSIMO DE NUNZIO;SARA MASSIRONI;LUCA LEONARDI;MASSIMO FALCONI;GIOVANNI ANTONINI;STEFANO PARTELLI;MAURIZIO POMPILI;ALBERTO BONGIOVANNI;MAURO CIVES;LUCA PASQUINI;ISABELLA BERARDELLI;GIUSEPPE LAMBERTI;ANDREA LAGHI;DAVIDE CAMPANA;RAFFAELE GIUSTI","165;162;126;121;97;84;83;77;75;74;73;72;70;70;69;66;65;63;63;61","MARIA RINZIVILLO;FRANCESCO PANZUTO;AGOSTINO TAFURI;LUCA RICCIARDI;COSIMO DE NUNZIO;BRUNO ANNIBALE;LUCA LEONARDI;GIOVANNI ANTONINI;MAURIZIO POMPILI;LUCA PASQUINI;ISABELLA BERARDELLI;ANDREA LAGHI;MARCO FILETTI;RAFFAELE GIUSTI;MARTA PIRAS;STEFANO RIGATTIERI;DENISE ERBUTO;ELSA IANNICELLI;ALESSANDRO BOZZAO;ANDREA TUBARO","162;150;123;97;84;78;77;74;72;69;66;63;59;54;52;45;41;40;39;39","COSIMO DE NUNZIO;AGOSTINO TAFURI;ANDREA TUBARO;RICCARDO LOMBARDO;ANTONIO CICIONE;ANTONIO FRANCO;CARMEN GRAVINA;GIACOMO GALLO;JORDI STIRA;LUCA RICCIARDI;BEATRICE TURCHI;OLIVIA ALESSANDRA VOGLINO;ELISA MANCINI;ALBERTO MENOZZI;FRANCESCO PANZUTO;GIORGIO GUARNOTTA;LORENZO MARIA ROVESTI;RAFFAELE GIUSTI;SARA RIOLO;MARIA RINZIVILLO","22;18;17;14;14;12;12;11;10;10;9;9;9;8;8;8;8;8;8;8","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;ECONOMICS;CHEMISTRY;MATHEMATICS;SOCIOLOGY;PHILOSOPHY;BUSINESS;GEOGRAPHY;GEOLOGY;HISTORY;MATERIALS SCIENCE","263;44;23;18;17;16;14;13;12;11;9;8;5;3;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;CARDIOLOGY;PSYCHIATRY;GASTROENTEROLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PEDIATRICS;IMMUNOLOGY;UROLOGY;GENETICS;BIOCHEMISTRY;NURSING;PHYSICAL THERAPY;LAW;PALEONTOLOGY;FAMILY MEDICINE;GENERAL SURGERY;NEUROSCIENCE","207;72;51;44;36;33;30;30;25;25;25;20;19;18;17;16;15;13;13;11;11;11","CANCER;DISEASE;RETROSPECTIVE COHORT STUDY;POPULATION;COHORT;CLINICAL TRIAL;HEART FAILURE;GENE;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;ADVERSE EFFECT;ALTERNATIVE MEDICINE;OBSERVATIONAL STUDY;URINARY SYSTEM;LUNG;LYMPHOMA;MYOCARDIAL INFARCTION;ASYMPTOMATIC;PROSPECTIVE COHORT STUDY;HEALTH CARE;LOGISTIC REGRESSION;OUTBREAK","46;41;27;25;24;18;18;16;16;15;14;14;13;12;11;11;11;10;10;9;9;9","INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;PROSTATE;COLORECTAL CANCER;EJECTION FRACTION;PERCUTANEOUS CORONARY INTERVENTION;CONVENTIONAL PCI;2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;CHRONIC LYMPHOCYTIC LEUKEMIA;PROGRESSION-FREE SURVIVAL;PROSTATE CANCER;NEUTROPENIA;RITUXIMAB;AUTOANTIBODY;IDIOPATHIC PULMONARY FIBROSIS;IMMUNOTHERAPY;INJURY PREVENTION;MUTATION;PLACEBO;SUICIDE PREVENTION;UNIVARIATE ANALYSIS","21;13;11;10;9;8;7;6;6;6;6;6;5;5;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);CYSTECTOMY;IBRUTINIB;LOWER URINARY TRACT SYMPTOMS;MACE;METASTATIC BREAST CANCER;OSWESTRY DISABILITY INDEX;P2Y12;PROSTATECTOMY;SUICIDAL IDEATION;TICAGRELOR;VENETOCLAX;ANDROGEN DEPRIVATION THERAPY;AUTOIMMUNE GASTRITIS;BLADDER OUTLET OBSTRUCTION;COGNITIVE RESERVE;COLONOSCOPY;DNA METHYLATION;GASTRO-;INTERNATIONAL PROGNOSTIC INDEX;KRAS;NILOTINIB;PEMBROLIZUMAB;PHARMACOGENETICS;REGORAFENIB;RESIDUAL URINE;SACUBITRIL;SUICIDE ATTEMPT;TAMOXIFEN;TARGET LESION","21;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;RETROSPECTIVE STUDIES;MALE;TREATMENT OUTCOME;FEMALE;AGED;COVID-19;NEUROENDOCRINE TUMORS;ITALY;MIDDLE AGED;QUALITY OF LIFE;HEART FAILURE;BREAST NEOPLASMS;PANCREATIC NEOPLASMS;ADULT;BRAIN NEOPLASMS;PROSPECTIVE STUDIES;ANGIOTENSIN RECEPTOR ANTAGONISTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","147;122;35;29;27;25;22;22;18;15;15;14;13;11;11;10;9;9;8;8","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;ADVANCEMENTS IN LUNG CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANTERIOR CRUCIATE LIGAMENT INJURIES IN ATHLETES;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;MANAGEMENT OF VALVULAR HEART DISEASE;MOLECULAR MECHANISMS OF AMYLOIDOSIS;ACUTE MYELOID LEUKEMIA;CANCER IMMUNOTHERAPY;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EFFICACY AND RESISTANCE IN CML TREATMENT;EXERCISE PHYSIOLOGY AND CARDIOVASCULAR HEALTH;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA","14;6;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","CLINICAL ENDPOINT;PANDEMIC;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;TREATMENT;GASTROENTEROPANCREATIC NEOPLASMS;DISCONTINUATION;PROGRESSION-FREE SURVIVAL;2019-20 CORONAVIRUS OUTBREAK;CANGRELOR;CONCOMITANT;LOWER URINARY TRACT SYMPTOMS;METASTATIC PROSTATE CANCER;NEOADJUVANT THERAPY;PERCUTANEOUS CORONARY INTERVENTION;STROKE (ENGINE);UNIVARIATE ANALYSIS;CANCER TREATMENT;CARDIAC IMAGING;CLINICAL PRACTICE","13;12;11;10;8;7;6;6;5;5;5;5;5;5;5;5;5;4;4;4","ITALIAN SOCIETY;HEART FAILURE;OBSERVATIONAL STUDY;URINARY TRACT;COVID- PANDEMIC;CLINICAL OUTCOMES;CORONARY INTERVENTION;ICARUS REGISTRY;LUNG CANCER;MULTIPLE MYELOMA;PATIENTS UNDERGOING;PERCUTANEOUS CORONARY;PROSTATE CANCER;AORTIC VALVE;CELL LUNG;CLINICAL PRACTICE;ELDERLY PATIENTS;LOWER URINARY;MULTIPLE SCLEROSIS;MYELOID LEUKEMIA;NEUROENDOCRINE TUMORS;NON-SMALL CELL;POSITION PAPER;RISK FACTORS;TRACT SYMPTOMS;B-CELL LYMPHOMA;BREAST CANCER;CANCER TREATED;CANGRELOR INFUSION;CHRONIC MYELOID","11;9;7;7;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","ADVERSE EVENTS;CLINICAL PRACTICE;LUNG CANCER;PRIMARY ENDPOINT;RISK FACTORS;FFDG PETCT;MEDIAN AGE;MEDIAN FOLLOW-UP;PATIENTS UNDERGOING;VIEW LARGEDOWNLOAD;COVID- PANDEMIC;MEDIAN TIME;NEWLY DIAGNOSED;AHR CI;PATIENTS TREATED;PATIENTS UNDERWENT;SIGNIFICANT DIFFERENCES;STAGE III;BREAST CANCER;PATIENTS PTS;PROGRESSION-FREE SURVIVAL;RESPONSE RATE;SURVIVAL OS;CLINICAL CHARACTERISTICS;CLINICAL OUTCOMES;CONSECUTIVE PATIENTS;CORONARY INTERVENTION;MEDIAN PFS;OBSERVATIONAL STUDY;PATIENTS AFFECTED","18;17;17;17;16;15;15;15;14;14;13;13;13;12;12;12;12;12;11;11;11;11;11;10;10;10;10;10;10;10",104,0.39,7.25,6.25,1,1,0,2,0,1,1,9,0,0,6,0,1,1.25,3,4,3,0,0,16,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,3.33,526.67,4.26,7,0.47,94.93,0,0,1,0,5,0,2,7,0,9,6,0,0,0,0,0,0,14,1,0,15,0,0,0,0,0,0,0,0,0,"Italy;United States;Switzerland;United Kingdom","5;5;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","15;9;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CARDIOVASCULAR;HEART DISEASE;CANCER;NEUROSCIENCES;PATIENT SAFETY;AUTOIMMUNE DISEASE;BRAIN DISORDERS;DIGESTIVE DISEASES;HEMATOLOGY;MULTIPLE SCLEROSIS;NEURODEGENERATIVE;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BREAST CANCER;CHRONIC PAIN;COLO-RECTAL CANCER;EYE DISEASE AND DISORDERS OF VISION","14;7;4;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;NEUROLOGICAL","4;3;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","7;2;2;1","BREAST CANCER;COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER;MYELOMA;SARCOMA","1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_SANTANDREA",2023,252,19.4801587301587,2.91269841269841,0.325396825396825,0.257936507936508,0.333333333333333,2.05898876404494,1.39655172413793,1.66666666666667,1.59615384615385,0.761904761904762,4,93,54,23,11,0.37,0.21,0.09,0.04,4.06,0.925273284859292,4.91652566271855,0.353174603174603,0.936507936507937,0.48,0.486,0.449,0.456,"COSIMO DE NUNZIO;RICCARDO LOMBARDO;ANDREA TUBARO;GIORGIA TEMA;ANTONIO CICIONE;ANTONGIULIO FAGGIANO;AGOSTINO TAFURI;FRANCESCO PANZUTO;MATTEO GARIBALDI;RAFFAELE GIUSTI;DAMIANO MAGRÌ;MARIA RINZIVILLO;DOMENICO GABRIELLI;HAITHAM H. ELFARARGY;ALESSANDRO BOZZAO;MAURIZIO BARBARA;ISABELLA CAPODANNO;PIETRO FRANCIA;ALESSANDRO SCIARRA;MARIA ILARIA DEL PRINCIPE","27;20;14;12;11;10;9;9;8;7;7;7;7;7;7;7;6;6;6;6","COSIMO DE NUNZIO;RICCARDO LOMBARDO;LEONARDA GALIUTO;MAURIZIO SIMMACO;ANDREA TUBARO;HAITHAM H. ELFARARGY;MAURIZIO BARBARA;STEFANO PALOMBA;ANTONIO FRANCESCO CICIONE;ROCCO VERGALLO;MASSIMILIANO ROCCHIETTI MARCH;MATTEO GARIBALDI;FABIO SANTANELLI DI POMPEO;GUIDO FIRMANI;MICHAIL SOROTOS;EDOARDO COVELLI;GIORGIA TEMA;ANTONGIULIO FAGGIANO;ALDO PEZZUTO;ANTONIO CICIONE","1.94;1.62;1.5;1.29;1.12;1.02;1.02;1.02;1;1;1;0.9;0.86;0.86;0.86;0.85;0.79;0.79;0.76;0.75","COSIMO DE NUNZIO;RICCARDO LOMBARDO;ANDREA TUBARO;GIORGIA TEMA;ANTONIO CICIONE;ANTONGIULIO FAGGIANO;AGOSTINO TAFURI;FRANCESCO PANZUTO;MATTEO GARIBALDI;RAFFAELE GIUSTI;DAMIANO MAGRÌ;MARIA RINZIVILLO;DOMENICO GABRIELLI;HAITHAM H. ELFARARGY;ALESSANDRO BOZZAO;MAURIZIO BARBARA;PIETRO FRANCIA;ALESSIO GUIDOTTI;ANTONINO RACO;FILIPPO ZAMMITTI","27;20;14;12;11;10;9;9;8;7;7;7;7;7;7;7;6;6;6;6","COSIMO DE NUNZIO;RICCARDO LOMBARDO;LEONARDA GALIUTO;MAURIZIO SIMMACO;ANDREA TUBARO;HAITHAM H. ELFARARGY;MAURIZIO BARBARA;STEFANO PALOMBA;ANTONIO FRANCESCO CICIONE;MASSIMILIANO ROCCHIETTI MARCH;MATTEO GARIBALDI;FABIO SANTANELLI DI POMPEO;GUIDO FIRMANI;MICHAIL SOROTOS;EDOARDO COVELLI;GIORGIA TEMA;ANTONGIULIO FAGGIANO;ANTONIO CICIONE;DOMENICO GABRIELLI;ALESSANDRO BOZZAO","1.94;1.62;1.5;1.29;1.12;1.02;1.02;1.02;1;1;0.9;0.86;0.86;0.86;0.85;0.79;0.79;0.75;0.72;0.69","IGNACIO J. AMAT‐SANTOS;AUREL PERREN;EMANUEL CHRIST;JOHANNES HOFLAND;GIANLUCA CAMPO;EMANUELE BARBATO;FERDINANDO VARBELLA;MATTEO TEBALDI;RITA PAVASINI;SIMONE BISCAGLIA;GIORGIO CARETTA;ALBERTO MENOZZI;ALFONSO JURADO‐ROMÁN;ANDREA ERRIQUEZ;ANDREA PICCHI;ANDREA SANTARELLI;CARLO PENZO;CARLO TUMSCITZ;DARIUSZ DUDEK;ELISA MAIETTI","140;120;120;120;114;113;113;113;113;113;112;111;111;111;111;111;111;111;111;111","GIORGIO CARETTA;ALBERTO MENOZZI;ANTONGIULIO FAGGIANO;FRANCESCO PANZUTO;PIETRO FRANCIA;COSIMO DE NUNZIO;MARIA RINZIVILLO;FEDERICA MAZZUCA;RAFFAELE GIUSTI;RICCARDO LOMBARDO;FABIO SANTANELLI DI POMPEO;GUIDO FIRMANI;MICHAIL SOROTOS;VINCENZO CESARIO;ANDREA TUBARO;MATTEO GARIBALDI;FRANCESCA LO BIANCO;LUCA LEONARDI;SALVATORE MONTI;DAMIANO MAGRÌ","112;111;100;64;55;48;47;46;41;35;29;29;29;29;25;24;23;22;20;19","COSIMO DE NUNZIO;RICCARDO LOMBARDO;ANDREA TUBARO;GIORGIA TEMA;ANTONIO CICIONE;AGOSTINO TAFURI;ANTONGIULIO FAGGIANO;MATTEO GARIBALDI;MAURIZIO BARBARA;RAFFAELE GIUSTI;ALBERTO MENOZZI;ALESSIO GUIDOTTI;ANTONIO NACCHIA;DAMIANO MAGRÌ;EDOARDO COVELLI;FILIPPO ZAMMITTI;MARIA RINZIVILLO;PIETRO FRANCIA;ANTONINO RACO;FRANCESCO PANZUTO","27;20;14;12;11;9;9;8;7;7;6;6;6;6;6;6;6;6;6;6","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;MATHEMATICS;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;HISTORY;SOCIOLOGY;GEOGRAPHY;MATERIALS SCIENCE","246;47;23;22;19;10;10;10;9;9;7;3;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;ONCOLOGY;GASTROENTEROLOGY;RADIOLOGY;PSYCHIATRY;GENETICS;UROLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;IMMUNOLOGY;ENDOCRINOLOGY;NURSING;OPTICS;PALEONTOLOGY;CANCER RESEARCH;PEDIATRICS","189;74;46;43;41;32;29;25;20;17;16;16;16;16;15;14;13;11;11;10;10","CANCER;DISEASE;COHORT;HEART FAILURE;MYOCARDIAL INFARCTION;RETROSPECTIVE COHORT STUDY;GENE;POPULATION;CHEMOTHERAPY;CONFIDENCE INTERVAL;ALTERNATIVE MEDICINE;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;INCIDENCE (GEOMETRY);BLOOD PRESSURE;LOGISTIC REGRESSION;LUNG;LYMPHOMA;OBSERVATIONAL STUDY;QUALITY OF LIFE (HEALTHCARE)","42;33;25;18;18;16;15;14;13;13;12;12;11;11;10;9;9;9;9;9","EJECTION FRACTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);PROSTATE;PROSTATE CANCER;HAZARD RATIO;PERCUTANEOUS CORONARY INTERVENTION;BREAST CANCER;CLINICAL ENDPOINT;COLORECTAL CANCER;HEART RATE;CONVENTIONAL PCI;PHENOTYPE;ACUTE CORONARY SYNDROME;CHRONIC LYMPHOCYTIC LEUKEMIA;DIFFUSE LARGE B-CELL LYMPHOMA;REVASCULARIZATION;2019-20 CORONAVIRUS OUTBREAK;CORONARY ANGIOGRAPHY;GENE EXPRESSION;IMATINIB;INFERTILITY;MULTICENTER STUDY;NEURORADIOLOGY;PLACEBO;RENAL ARTERY;TELEMEDICINE;TOLERABILITY","13;12;11;11;10;8;7;7;7;7;6;6;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);LOWER URINARY TRACT SYMPTOMS;BRADYCARDIA;BREAST RECONSTRUCTION;DASATINIB;IMATINIB MESYLATE;NILOTINIB;PROSTATECTOMY;CARDIAC RESYNCHRONIZATION THERAPY;DIFFUSING CAPACITY;GERMINAL CENTER;GLUCAGONOMA;IBRUTINIB;KRAS;MACE;MASTECTOMY;NEUROENDOCRINE DIFFERENTIATION;OVARIAN RESERVE;PROSTATE BIOPSY;RIGHT CORONARY ARTERY;SUICIDAL IDEATION;TRANSCRIPTOME;VO2 MAX","12;5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADULT;MIDDLE AGED;PROSPECTIVE STUDIES;AGED;ITALY;DEPRESSIVE DISORDER, MAJOR;NEUROENDOCRINE TUMORS;PANCREATIC NEOPLASMS;HEART FAILURE;CARDIOVASCULAR DISEASES;FOLLOW-UP STUDIES;MAGNETIC RESONANCE IMAGING;PERCUTANEOUS CORONARY INTERVENTION;PROSTATE","143;110;29;29;28;19;18;18;16;15;12;10;10;10;9;8;8;8;7;7","STANDARDISATION OF LOWER URINARY TRACT FUNCTION;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;PROSTATE CANCER RESEARCH AND TREATMENT;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;EFFICACY AND RESISTANCE IN CML TREATMENT;ACUTE MYELOID LEUKEMIA;EXERCISE PHYSIOLOGY AND CARDIOVASCULAR HEALTH;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;DIAGNOSIS AND TREATMENT OF RENAL ARTERY STENOSIS;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;MOLECULAR MECHANISMS OF CARDIAC ARRHYTHMIAS;PELVIC FLOOR DISORDERS;RHEUMATOID ARTHRITIS;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS","11;10;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2","CARDIAC IMAGING;NEUROENDOCRINE TUMORS;PANCREATIC NEUROENDOCRINE TUMORS;CLINICAL ENDPOINT;CARDIOVASCULAR RISK ASSESSMENT;INTERQUARTILE RANGE;BIOMARKERS FOR IMMUNOTHERAPY;CLINICAL PRACTICE;CONCOMITANT;LOWER URINARY TRACT SYMPTOMS;PANDEMIC;PROSTATE CANCER;STROKE (ENGINE);TREATMENT;CARDIOPULMONARY EXERCISE TESTING;DISCONTINUATION;ECHOCARDIOGRAPHY;IMMUNE CHECKPOINT BLOCKADE;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;TOLERABILITY","11;9;9;8;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4","HEART FAILURE;MYELOID LEUKEMIA;COHORT STUDY;PROSTATE CANCER;ACUTE MYELOID;CHRONIC MYELOID;ACUTE CORONARY;AORTIC VALVE;CAMPUS CML;CLINICAL PRACTICE;CONTROLLED TRIAL;DELPHI CONSENSUS;IMMUNE CHECKPOINT;ITALIAN STUDY;LUNG CANCER;MODIFIED DELPHI;MULTICENTER STUDY;OBSERVATIONAL STUDY;POSITION PAPER;PROSPECTIVE OBSERVATIONAL;RANDOMIZED CONTROLLED;CELL LUNG;CHECKPOINT INHIBITORS;COLORECTAL CANCER;CORONARY INTERVENTION;EJECTION FRACTION;LOWER URINARY;MULTICENTER COHORT;MULTICENTRIC ITALIAN;MYOCARDIAL INFARCTION","9;9;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","HR CI;MEDIAN AGE;PATIENTS RECEIVED;PATIENTS TREATED;RISK FACTORS;CORONARY ARTERY;SURVIVAL OS;LOGISTIC REGRESSION;STATISTICALLY SIGNIFICANT;CHEST PAIN;CLINICAL PRACTICE;HEART FAILURE;MEDIAN FOLLOW-UP;EJECTION FRACTION;MEDIAN OS;RETROSPECTIVE STUDY;PROGRESSION-FREE SURVIVAL;SIGNIFICANT DIFFERENCES;SURVIVAL PFS;ADVERSE EVENTS;FRONTLINE TKI;INTENSIVE CHEMOTHERAPY;MONTHS NA;PRIMARY ENDPOINT;PROSTATE CANCER;STUDY INCLUDED;ADVERSE CARDIAC;CARDIAC EVENTS;CLINICAL FEATURES;CONFIDENCE INTERVAL","20;17;17;17;17;15;15;13;13;12;12;12;12;11;11;11;10;10;10;9;9;9;9;9;9;9;8;8;8;8",74,0.29,10,14,2,1.75,0,22,0,1,0,15.5,0,1,12,1,1,2,6,8.25,7,0,0,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1.5,717.5,1.2,2,0.5,23,0,0,1,0,0,0,0,3,0,3,1,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4206 PUBLIC HEALTH","3;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PREVENTION;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BRAIN DISORDERS;CARDIOVASCULAR;CHRONIC PAIN;DIABETES;DIGESTIVE DISEASES;HEMATOLOGY;HUNTINGTON'S DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;NUTRITION;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;RARE DISEASES","4;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","METABOLIC AND ENDOCRINE;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","2;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS;TAYLOR & FRANCIS GROUP","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY","6;2;2;1;1;1","CLINICAL RESEARCH;CARDIOVASCULAR;HEART DISEASE;RARE DISEASES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPARATIVE EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;GENETICS;HEPATITIS;HEPATITIS - B;IMMUNIZATION;LIVER DISEASE;PATIENT SAFETY;PREVENTION;SCLERODERMA;VACCINE RELATED","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM","2;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1;1","CLINICAL;BIOMEDICAL","2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","3;1","NOT SITE-SPECIFIC CANCER","1","3 GOOD HEALTH AND WELL BEING","2"
"AOU_SANTANDREA",2024,229,18.7816593886463,2.83406113537118,0.301310043668122,0.275109170305677,0.349344978165939,1.94011976047904,1.27272727272727,1.61538461538462,1.24615384615385,0.641921397379913,0,99,44,15,8,0.43,0.19,0.07,0.03,1.18,1.23368600289824,4.26230457440649,0.414847161572052,0.960698689956332,0.463,0.506,0.504,0.513,"COSIMO DE NUNZIO;RICCARDO LOMBARDO;LESLIE CLAIRE LICARI;ANDREA TUBARO;RICCARDO AUTORINO;COSTANTINO LEONARDO;FRANCESCO DITONNO;EUGENIO BOLOGNA;ANTONIO FRANCO;BEATRICE TURCHI;ANTONIO LUIGI PASTORE;PASQUALE PARISI;GIUSEPPE SIMONE;GIORGIO FRANCO;EMANUELE BARBATO;CELESTE MANFREDI;ANTONIO CICIONE;EDWARD E. CHERULLO;ALESSANDRO ANTONELLI;GIORGIA TEMA","32;21;16;16;15;15;14;13;13;13;12;11;10;10;10;9;8;8;8;8","LEONARDA GALIUTO;COSIMO DE NUNZIO;ROCCO VERGALLO;RICCARDO LOMBARDO;LESLIE CLAIRE LICARI;RICCARDO AUTORINO;ANDREA TUBARO;COSTANTINO LEONARDO;ANTONIO FRANCO;BEATRICE TURCHI;FRANCESCO DITONNO;EMANUELE BARBATO;EUGENIO BOLOGNA;ANTONIO LUIGI PASTORE;GIOVANNI DI NARDO;PASQUALE PARISI;GIORGIO FRANCO;CELESTE MANFREDI;MAURIZIO MENNINI;MAURIZIO POMPILI","3.17;2.5;2;1.63;1.24;1.23;1.23;1.18;1.18;1.16;1.07;1.04;0.97;0.87;0.85;0.84;0.73;0.72;0.7;0.67","COSIMO DE NUNZIO;RICCARDO LOMBARDO;ANDREA TUBARO;ANTONIO FRANCO;BEATRICE TURCHI;PASQUALE PARISI;EMANUELE BARBATO;ANTONIO CICIONE;GIORGIA TEMA;ANTONIO NACCHIA;GIOVANNI DI NARDO;LEONARDA GALIUTO;MAURIZIO POMPILI;ANTONGIULIO FAGGIANO;PIETRO FRANCIA;CARMEN GRAVINA;BRUNO ANNIBALE;ALESSANDRO FERRETTI;MATTEO GARIBALDI;FRANCESCO PANZUTO","32;21;16;13;13;11;10;8;8;7;7;7;7;6;6;6;6;6;5;5","LEONARDA GALIUTO;COSIMO DE NUNZIO;RICCARDO LOMBARDO;ANDREA TUBARO;ANTONIO FRANCO;BEATRICE TURCHI;EMANUELE BARBATO;GIOVANNI DI NARDO;PASQUALE PARISI;MAURIZIO MENNINI;MAURIZIO POMPILI;GIORGIA TEMA;RAFFAELLA MISTRULLI;JACOPO PREZIOSI STANDOLI;ANTONIO CICIONE;BRUNO ANNIBALE;CARMEN GRAVINA;GIULIA MOLTONI;ANTONIO NACCHIA;FRANCESCO PANZUTO","3.17;2.5;1.63;1.23;1.18;1.16;1.04;0.85;0.84;0.7;0.67;0.62;0.6;0.58;0.53;0.51;0.51;0.5;0.49;0.45","ANTONIO FRANCO;SIMONE FREA;FRANCESCO DITONNO;CELESTE MANFREDI;COSIMO DE NUNZIO;EUGENIO BOLOGNA;LESLIE CLAIRE LICARI;RICCARDO AUTORINO;ENRICO BALDI;GIANFRANCO TOLA;GIULIO CONTE;GIANMARCO IANNOPOLLO;SAVIO DOMENICO PANDOLFO;GIANLUCA CAMPO;SIMONE BISCAGLIA;GIUSEPPE DATTILO;ALBERTO BARENGO;ALESSANDRO FASOLINO;ALESSANDRO GALLUZZO;ALESSANDRO LUPI","45;44;37;35;34;32;30;29;28;28;28;27;26;25;25;24;22;22;22;22","ANTONIO FRANCO;COSIMO DE NUNZIO;ALESSANDRO GALLUZZO;ROBERTA FALCETTI;MAURIZIO POMPILI;PASQUALE PARISI;RICCARDO LOMBARDO;CARLO CAPALBO;ISABELLA BERARDELLI;MARCO ARENA;MATTEO GARIBALDI;FRANCESCO PANZUTO;MARIA RINZIVILLO;AGOSTINO TAFURI;ALESSANDRO FERRETTI;DENISE DRITTONE;FEDERICA MAZZUCA;GIACOMO TINI;ALBERTO MENOZZI;ANDREA TUBARO","40;34;22;22;14;13;13;12;12;12;12;10;10;9;9;9;9;9;8;8","COSIMO DE NUNZIO;ANTONIO FRANCO;RICCARDO LOMBARDO;ANDREA TUBARO;BEATRICE TURCHI;PASQUALE PARISI;GIORGIA TEMA;ANTONIO CICIONE;ANTONIO NACCHIA;MAURIZIO POMPILI;LEONARDA GALIUTO;ALESSANDRO FERRETTI;PIETRO FRANCIA;EMANUELE BARBATO;AGOSTINO TAFURI;ANTONGIULIO FAGGIANO;BRUNO ANNIBALE;FRANCESCO PANZUTO;GIOVANNI DI NARDO;GIULIA MOLTONI","33;23;21;16;13;11;8;8;7;7;7;6;6;6;5;5;5;5;5;5","MEDICINE;COMPUTER SCIENCE;BIOLOGY;PSYCHOLOGY;PHYSICS;ENGINEERING;MATHEMATICS;CHEMISTRY;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;BUSINESS;GEOGRAPHY;GEOLOGY;ART;HISTORY","223;34;33;25;18;14;12;11;9;9;9;7;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;ONCOLOGY;UROLOGY;PSYCHIATRY;PATHOLOGY;INTENSIVE CARE MEDICINE;RADIOLOGY;ENVIRONMENTAL HEALTH;GENERAL SURGERY;GENETICS;IMMUNOLOGY;PHYSICAL THERAPY;GASTROENTEROLOGY;NURSING;OPERATING SYSTEM;PEDIATRICS;CANCER RESEARCH;LAW","163;59;40;30;26;25;24;22;21;18;17;16;16;16;13;13;11;10;9;9","CANCER;DISEASE;RANDOMIZED CONTROLLED TRIAL;POPULATION;MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;COHORT;GENE;RETROSPECTIVE COHORT STUDY;HEART FAILURE;ADVERSE EFFECT;ALTERNATIVE MEDICINE;RECEPTOR;QUALITY OF LIFE (HEALTHCARE);URINARY SYSTEM;NEUROENDOCRINE TUMORS;PROSPECTIVE COHORT STUDY;ATRIAL FIBRILLATION;CLINICAL TRIAL;KIDNEY","38;20;16;15;14;13;12;12;12;11;9;9;9;8;8;7;7;6;6;6","PROSTATE;PROSTATE CANCER;BREAST CANCER;MULTICENTER STUDY;PHENOTYPE;CARDIOMYOPATHY;IMMUNOTHERAPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);NEPHRECTOMY;REVASCULARIZATION;BLADDER CANCER;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;CULPRIT;EJECTION FRACTION;PERCUTANEOUS CORONARY INTERVENTION;AGE OF ONSET;AGONIST;ANGINA;COLORECTAL CANCER;HAZARD RATIO;INTRACEREBRAL HEMORRHAGE;PROGRESSION-FREE SURVIVAL;REPRODUCTIVE HEALTH;WHITE MATTER","9;9;7;7;6;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);IBRUTINIB;LOWER URINARY TRACT SYMPTOMS;OBETICHOLIC ACID;PROSTATITIS;BENIGN PROSTATIC HYPERPLASIA (BPH);BRUTON'S TYROSINE KINASE;CYSTECTOMY;FRACTIONAL FLOW RESERVE;IMMUNE CHECKPOINT;METASTATIC BREAST CANCER;OSWESTRY DISABILITY INDEX;P2Y12;PROSTATECTOMY;PROSTATIC DISEASES;SUICIDAL IDEATION;ACROMEGALY;ANAPLASTIC THYROID CANCER;ANTIBODY-DRUG CONJUGATE;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;BASDAI;BRONCHODILATION;CANADIAN CARDIOVASCULAR SOCIETY;CANCER IMMUNOTHERAPY;CANNABINOID RECEPTOR;CARDIAC SKELETON;CEFTAZIDIME;COW'S MILK ALLERGY;CYP1A2;DASATINIB;DIRECT BILIRUBIN;ENTEROBACTERIACEAE;ENTHESITIS;ESTROGEN RECEPTOR;EXOME SEQUENCING;EXTRAVERSION AND INTROVERSION;FEBRILE NEUTROPENIA;GENETIC ARCHITECTURE;GERMLINE MUTATION;GLUTAMATERGIC;GRAVES' OPHTHALMOPATHY;GREY MATTER;HEARTBURN;HORMONE RECEPTOR;HORMONE THERAPY;INFLUENZA SEASON;KNEE PAIN;KRAS;LARYNGOTRACHEAL STENOSIS;LDL RECEPTOR;LENVATINIB;LYMPHANGIOGENESIS;LYMPHOVASCULAR INVASION;MACE;MALE BREAST CANCER;MANAGEMENT OF PROSTATE CANCER;MEN1;MILK ALLERGY;MISSENSE MUTATION;MTORC1;MULTIFOCAL MOTOR NEUROPATHY;MYELIN OLIGODENDROCYTE GLYCOPROTEIN;NEOADJUVANT THERAPY;NILOTINIB;PD-L1;PENETRANCE;PHENOCOPY;POMALIDOMIDE;PRASUGREL;PROBAND;PURE TONE AUDIOMETRY;PYELOPLASTY;RILUZOLE;SEROTONERGIC;SINGLE-NUCLEOTIDE POLYMORPHISM;SUICIDE RATES;SYMPTOM CHECKLIST 90;TICAGRELOR;TOTAL MESORECTAL EXCISION;TRANSURETHRAL RESECTION OF THE PROSTATE;TRASTUZUMAB;TRAZODONE;TRINUCLEOTIDE REPEAT EXPANSION;TRIPLE-NEGATIVE BREAST CANCER;URETEROPELVIC JUNCTION;URINARY BLADDER CANCER;UROTHELIAL CARCINOMA;VANCOMYCIN;VARIABLE NUMBER TANDEM REPEAT;VASOACTIVE INTESTINAL PEPTIDE;VEDOLIZUMAB;VENETOCLAX;WATCHFUL WAITING;ZYGAPOPHYSEAL JOINT","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;FEMALE;AGED;MIDDLE AGED;ADULT;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;ITALY;PROSPECTIVE STUDIES;CHILD;RISK FACTORS;ADOLESCENT;SURVEYS AND QUESTIONNAIRES;YOUNG ADULT;INCIDENCE;TIME FACTORS;CHILD, PRESCHOOL","139;90;51;46;36;34;25;24;17;12;12;12;11;11;9;9;7;6;6;5","EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ARTIFICIAL INTELLIGENCE IN MEDICINE;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;PROSTATE CANCER RESEARCH AND TREATMENT;RENAL CELL CARCINOMA;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MOLECULAR MECHANISMS OF AMYLOIDOSIS;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT;SHOULDER PATHOLOGY AND TREATMENT OUTCOMES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF OTITIS MEDIA;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EPIDEMIOLOGY AND TREATMENT OF URINARY TRACT INFECTIONS","9;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","TREATMENT;PANCREATIC NEUROENDOCRINE TUMORS;CARDIAC IMAGING;NEUROENDOCRINE TUMORS;CLINICAL ENDPOINT;GRADING (ENGINEERING);PROSTATE CANCER;BREAST CANCER;CULPRIT;DEPRESSION (ECONOMICS);MYOCARDIAL REVASCULARIZATION;REFRACTORY (PLANETARY SCIENCE);SPINAL FUSION;STROKE (ENGINE);ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;BENIGN PROSTATIC HYPERPLASIA;CARDIAC AMYLOIDOSIS;DISCONTINUATION;ELEVATION (BALLISTICS);GASTROENTEROPANCREATIC NEOPLASMS","9;8;7;7;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3","MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;PROSTATE CANCER;BREAST CANCER;PATIENTS UNDERGOING;URINARY TRACT;BENIGN PROSTATIC;HEART FAILURE;JOURNAL SCAN;MULTICENTER STUDY;PARTIAL NEPHRECTOMY;WEEKLY JOURNAL;BILIARY CHOLANGITIS;BPH SURGERY;CANCER TREATED;CHRONIC LYMPHOCYTIC;CORONARY INTERVENTION;GANGLION BLOCK;LONG-TERM RISK;LUNG CANCER;LYMPHOCYTIC LEUKEMIA;MULTIPLE SCLEROSIS;NEUROENDOCRINE TUMORS;PATIENTS TREATED;PERCUTANEOUS CORONARY;PERCUTANEOUS STELLATE;PRIMARY BILIARY;PROSPECTIVE MULTICENTER;PROSTATIC HYPERPLASIA;PULMONARY EMBOLISM","7;7;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HR CI;PATIENTS UNDERGOING;PATIENTS TREATED;STATISTICALLY SIGNIFICANT;CLINICAL PRACTICE;CONSECUTIVE PATIENTS;DISEASE PROGRESSION;BREAST CANCER;CI -FOR;CLINICAL OUTCOMES;HEART FAILURE;NONCULPRIT VESSELS;ADVERSE EVENTS;BPH SURGERY;LEFT VENTRICULAR;RENAL FUNCTION;REPEAT SIZE;SIGNIFICANT DIFFERENCE;CANCER PATIENTS;LOGISTIC REGRESSION;ORBITAL DECOMPRESSION;PRIMARY ENDPOINT;PRIMARY OUTCOME;RV UPTAKE;FASTING TEST;HOSPITAL STAY;INTERSCAPULAR PAIN;LDL CHOLESTEROL;PATIENTS UNDERWENT;PIPO PATIENTS","18;14;11;11;10;10;10;9;9;9;9;9;8;8;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6",3,0.01,39.55,67,0,0,0,0,0,1,0,72,0,0,66.5,0,0,3.25,15,45.5,22,0,0,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
